FN Thomson Reuters Web of Science™
VR 1.0
PT J
AU Mori, S
   van Zijl, PCM
AF Mori, S
   van Zijl, PCM
TI Fiber tracking: principles and strategies - a technical review
SO NMR IN BIOMEDICINE
LA English
DT Review
DE axonal tracking; diffusion tensor imaging; DTI; brain; methods
ID APPARENT DIFFUSION-COEFFICIENT; HUMAN WHITE-MATTER; HUMAN BRAIN;
   IN-VIVO; WATER DIFFUSION; MULTIPLE-SCLEROSIS; AXONAL PROJECTIONS;
   SELF-DIFFUSION; NERVOUS-SYSTEM; WEIGHTED MRI
AB The state of the art of reconstruction of the axonal tracts in the central nervous system (CNS) using diffusion tensor imaging (DTI) is reviewed. This relatively new technique has generated much enthusiasm and high expectations because it presently is the only approach available to non-invasively study the three-dimensional architecture of white matter tracts. While there is no doubt that DTI fiber tracking is providing exciting new opportunities to study CNS anatomy, it is very important to understand its limitations. In this review we therefore assess the basic principles and the assumptions that need to be made for each step of the study, including both data acquisition and the elaborate fiber reconstruction algorithms. Special attention is paid to situations where complications may arise, and possible solutions are reviewed. Validation issues and potential future directions and improvements are also discussed. Copyright (C) 2002 John Wiley Sons, Ltd.
C1 Johns Hopkins Univ, Sch Med, Dept Radiol & Radiol Sci, Baltimore, MD 21205 USA.
   Kennedy Krieger Inst, FM Kirby Res Ctr Funct Brain Imaging, Baltimore, MD 21205 USA.
RP Mori, S (reprint author), Johns Hopkins Univ, Sch Med, Dept Radiol, 217 Traylor Bldg,720 Rutland Ave, Baltimore, MD 21205 USA.
RI van Zijl, Peter/B-8680-2008
CR Albers GW, 2000, NEUROLOGY, V54, P1562
   Jones DK, 1999, MAGNET RESON MED, V42, P37, DOI 10.1002/(SICI)1522-2594(199907)42:1<37::AID-MRM7>3.0.CO;2-O
   MORI S, 1995, MAGNET RESON MED, V33, P41, DOI 10.1002/mrm.1910330107
   Ulug AM, 1999, JMRI-J MAGN RESON IM, V9, P804
   Makris N, 1997, ANN NEUROL, V42, P951, DOI 10.1002/ana.410420617
   MOSELEY ME, 1990, RADIOLOGY, V176, P439
   Mori S, 2000, ANN NEUROL, V47, P412, DOI 10.1002/1531-8249(200003)47:3<412::AID-ANA28>3.0.CO;2-H
   Baird AE, 1998, J CEREBR BLOOD F MET, V18, P583
   CHENEVERT TL, 1990, RADIOLOGY, V177, P401
   Poupon C, 2000, NEUROIMAGE, V12, P184, DOI 10.1006/nimg.2000.0607
   Neil J, 2002, NMR BIOMED, V15, P543, DOI 10.1002/nbm.784
   Sotak CH, 2002, NMR BIOMED, V15, P561, DOI 10.1002/nbm.786
   Pierpaoli C, 1996, MAGNET RESON MED, V36, P893, DOI 10.1002/mrm.1910360612
   VANGELDEREN P, 1994, MAGNET RESON MED, V31, P154, DOI 10.1002/mrm.1910310209
   Xue R, 1999, MAGNET RESON MED, V42, P1123, DOI 10.1002/(SICI)1522-2594(199912)42:6<1123::AID-MRM17>3.0.CO;2-H
   Neil JJ, 1998, RADIOLOGY, V209, P57
   DORAN M, 1990, J COMPUT ASSIST TOMO, V14, P865, DOI 10.1097/00004728-199011000-00001
   Mori S, 1999, ANN NEUROL, V45, P265, DOI 10.1002/1531-8249(199902)45:2<265::AID-ANA21>3.0.CO;2-3
   BASSER PJ, 1994, BIOPHYS J, V66, P259
   Scollan DF, 1998, AM J PHYSIOL-HEART C, V275, pH2308
   Klingberg T, 2000, NEURON, V25, P493, DOI 10.1016/S0896-6273(00)80911-3
   Mori S, 2002, ANN NEUROL, V51, P377, DOI 10.1002/ana.10137
   Tievsky AL, 1999, AM J NEURORADIOL, V20, P1491
   Frank LR, 2001, MAGNET RESON MED, V45, P935, DOI 10.1002/mrm.1125
   Mangin JF, 2002, NMR BIOMED, V15, P481, DOI 10.1002/nbm.780
   Horsfield MA, 2002, NMR BIOMED, V15, P570, DOI 10.1002/nbm.787
   Lin CP, 2001, NEUROIMAGE, V14, P1035, DOI 10.1006/nimg.2001.0882
   Wu O, 2001, STROKE, V32, P933
   Beaulieu C, 2002, NMR BIOMED, V15, P435, DOI 10.1002/nbm.782
   Pajevic S, 1999, MAGNET RESON MED, V42, P526, DOI 10.1002/(SICI)1522-2594(199909)42:3<526::AID-MRM15>3.0.CO;2-J
   Clark CA, 2000, MAGN RESON MED, V43, P133
   Werring DJ, 2000, J NEUROL NEUROSUR PS, V69, P269, DOI 10.1136/jnnp.69.2.269
   Conturo TE, 1999, P NATL ACAD SCI USA, V96, P10422, DOI 10.1073/pnas.96.18.10422
   Basser PJ, 2000, MAGNET RESON MED, V44, P625, DOI 10.1002/1522-2594(200010)44:4<625::AID-MRM17>3.0.CO;2-O
   Lim KO, 1999, ARCH GEN PSYCHIAT, V56, P367, DOI 10.1001/archpsyc.56.4.367
   BASSER PJ, 1994, J MAGN RESON SER B, V103, P247, DOI 10.1006/jmrb.1994.1037
   Pierpaoli C, 1996, RADIOLOGY, V201, P637
   BASSER JB, 1998, P INT SOC MAGN RES M, P1226
   Carpenter MB, 1976, HUMAN NEUROANATOMY
   Crosby E., 1962, CORRELATIVE ANATOMY
   DOUEK P, 1991, J COMPUT ASSIST TOMO, V15, P923, DOI 10.1097/00004728-199111000-00003
   ELLIS C, 1999, NEUROLOGY, V22, P1051
   Holodny AI, 2001, AM J NEURORADIOL, V22, P83
   LAZAR M, 2001, P INT SOC MAGN RES M, P506
   LAZAR M, 2000, P INT SOC MAGN RES M, P482
   LORI NF, 1999, P INT SOC MAGN RES M, P775
   Mori S, 2002, MAGNET RESON MED, V47, P215, DOI 10.1002/mrm.10074
   Mori S., 1998, P INT C FUNCT MAPP H
   Mukherjee P, 2000, RADIOLOGY, V215, P211
   NAKADA T, 1995, NEUROSCI RES, V22, P389, DOI 10.1016/0168-0102(95)00917-I
   Nieuwenhuys R, 1983, HUMAN CENTRAL NERVOU
   PARKER GJM, 2000, P 8 ANN M ISMRM DENV, P85
   Roberts W., 1989, MOL BIOL CELL
   Stieltjes B, 2001, NEUROIMAGE, V14, P723, DOI 10.1006/nimg.2001.0861
   TANNER JE, 1979, BIOPHYS J, V28, P107
   Tuch D, 2001, P 9 ANN M ISMRM GLAS, P502
   Tuch D.S., 2000, P 8 ANN M ISMRM DENV, P791
   Ulug AM, 1997, STROKE, V28, P483
   van Zijl PCM, 1994, NMR PHYSL BIOMEDICIN, P185
   WEDEEN V, IN PRESS NMR BIOMED
   Wedeen V., 2000, P 8 ANN M ISMRM DENV, P82
   Weinstein D., 1999, Proceedings Visualization '99 (Cat. No.99CB37067), DOI 10.1109/VISUAL.1999.809894
   WILLIAMS TH, 1997, HUMAN BRAIN DISSECTI
   ZHANG S, 2001, P INT SOC MAGN RES I, P505
NR 64
TC 1038
Z9 1070
U1 8
U2 73
PU JOHN WILEY & SONS LTD
PI W SUSSEX
PA BAFFINS LANE CHICHESTER, W SUSSEX PO19 1UD, ENGLAND
SN 0952-3480
J9 NMR BIOMED
JI NMR Biomed.
PD NOV-DEC
PY 2002
VL 15
IS 7-8
BP 468
EP 480
DI 10.1002/nbm.781
PG 13
WC Biophysics; Radiology, Nuclear Medicine & Medical Imaging; Spectroscopy
SC Biophysics; Radiology, Nuclear Medicine & Medical Imaging; Spectroscopy
GA 631KC
UT WOS:000180166100004
PM 12489096
ER

PT J
AU Radke, RJ
   Andra, S
   Al-Kofahi, O
   Roysam, B
AF Radke, RJ
   Andra, S
   Al-Kofahi, O
   Roysam, B
TI Image change detection algorithms: A systematic survey
SO IEEE TRANSACTIONS ON IMAGE PROCESSING
LA English
DT Review
DE background modeling; change detection; change mask; hypothesis testing;
   illumination invariance; mixture models; predictive models; shading
   model; significance testing
ID UNSUPERVISED CHANGE DETECTION; AUTOMATIC CHANGE DETECTION; DIGITAL
   CHANGE DETECTION; REMOTE-SENSING IMAGES; REAL-TIME TRACKING;
   MULTIPLE-SCLEROSIS; OPTICAL-FLOW; SEQUENCES; ILLUMINATION; SURVEILLANCE
AB Detecting regions of change in multiple images of the same scene taken at different times is of widespread interest due to a large number of applications in diverse disciplines, including remote sensing, surveillance, medical diagnosis and treatment, civil infrastructure, and underwater sensing. This paper presents a systematic survey of the common processing steps and core decision rules in modern change detection algorithms, including significance and hypothesis testing, predictive models, the shading model, and background modeling. We also discuss important preprocessing methods, approaches to enforcing the consistency of the change mask, and principles for evaluating and comparing the performance of change detection algorithms. It is hoped that our classification of algorithms into a relatively small number of categories will provide useful guidance to the algorithm designer.
C1 Rensselaer Polytech Inst, Dept Elect Comp & Syst Engn, Troy, NY 12180 USA.
RP Radke, RJ (reprint author), Rensselaer Polytech Inst, Dept Elect Comp & Syst Engn, Troy, NY 12180 USA.
EM rjradke@ecse.rpi.edu; andras@rpi.edu; alkofo@rpi.edu;
   roysam@ecse.rpi.edu
RI Radke, Richard/I-3289-2013
OI Radke, Richard/0000-0001-5064-7775
CR Aach T., 2001, Proceedings 2001 International Conference on Image Processing (Cat. No.01CH37205), DOI 10.1109/ICIP.2001.958200
   ANDRA S, 2004, MATLAB CHANGE DETECT
   Viola P, 1997, INT J COMPUT VISION, V24, P137, DOI 10.1023/A:1007958904918
   AACH T, 1993, SIGNAL PROCESS, V31, P165, DOI 10.1016/0165-1684(93)90063-G
   Durucan E, 2001, P IEEE, V89, P1368, DOI 10.1109/5.959336
   Fang CY, 2003, IEEE T NEURAL NETWOR, V14, P646, DOI 10.1109/TNN.2003.811353
   Bruzzone L, 2002, IEEE T IMAGE PROCESS, V11, P452, DOI 10.1109/TIP.2002.999678
   Huertas A, 2000, IMAGE VISION COMPUT, V18, P583, DOI 10.1016/S0262-8856(99)00063-3
   Bosc M, 2003, NEUROIMAGE, V20, P643, DOI 10.1016/S1053-8119(03)00406-3
   BARRON JL, 1994, INT J COMPUT VISION, V12, P43, DOI 10.1007/BF01420984
   Bruzzone L, 2000, IEEE T GEOSCI REMOTE, V38, P1171, DOI 10.1109/36.843009
   Can A, 2002, IEEE T PATTERN ANAL, V24, P347, DOI 10.1109/34.990136
   Negahdaripour S, 1998, IEEE T PATTERN ANAL, V20, P961, DOI 10.1109/34.713362
   Tan IL, 2002, J NEUROL, V249, P767, DOI 10.1007/s00415-002-0712-6
   Stow DA, 1999, INT J REMOTE SENS, V20, P2477, DOI 10.1080/014311699212137
   Bruzzone L, 1997, IEEE T GEOSCI REMOTE, V35, P858, DOI 10.1109/36.602528
   SKIFSTAD K, 1989, COMPUT VISION GRAPH, V46, P387, DOI 10.1016/0734-189X(89)90039-X
   ELFISHAWY AS, 1991, SIGNAL PROCESS, V23, P179, DOI 10.1016/0165-1684(91)90072-Q
   DEMPSTER AP, 1977, J ROY STAT SOC B MET, V39, P1
   Carvalho LMT, 2001, INT J REMOTE SENS, V22, P3871, DOI 10.1080/01431160110069836
   Wren CR, 1997, IEEE T PATTERN ANAL, V19, P780, DOI 10.1109/34.598236
   AACH T, 1995, SIGNAL PROCESS-IMAGE, V7, P147, DOI 10.1016/0923-5965(95)00003-F
   Touzi R, 2002, IEEE T GEOSCI REMOTE, V40, P2392, DOI 10.1109/TGRS.2002.803727
   TOWNSHEND JRG, 1992, IEEE T GEOSCI REMOTE, V30, P1054, DOI 10.1109/36.175340
   WHORFF JS, 1992, J EXP MAR BIOL ECOL, V160, P1, DOI 10.1016/0022-0981(92)90106-K
   RIGNOT EJM, 1993, IEEE T GEOSCI REMOTE, V31, P896, DOI 10.1109/36.239913
   Collins JB, 1996, REMOTE SENS ENVIRON, V56, P66, DOI 10.1016/0034-4257(95)00233-2
   ULSTAD MS, 1973, PATTERN RECOGN, V5, P323, DOI 10.1016/0031-3203(73)90024-1
   Bromiley PA, 2002, IMAGE VISION COMPUT, V20, P609, DOI 10.1016/S0262-8856(02)00050-1
   Carlotto MJ, 1997, IEEE T IMAGE PROCESS, V6, P189, DOI 10.1109/83.552106
   Hager GD, 1998, IEEE T PATTERN ANAL, V20, P1025, DOI 10.1109/34.722606
   Kasetkasem T, 2002, IEEE T GEOSCI REMOTE, V40, P1815, DOI 10.1109/TGRS.2002.802498
   Xie BL, 2004, IMAGE VISION COMPUT, V22, P117, DOI 10.1016/j.imavis.2003.07.003
   Elgammal A, 2002, P IEEE, V90, P1151, DOI 10.1109/JPROC.2002.801448
   Li LY, 2002, IEEE T IMAGE PROCESS, V11, P105, DOI 10.1109/83.982818
   Stewart CV, 2003, IEEE T MED IMAGING, V22, P1379, DOI 10.1109/TMI.2003.819276
   PAL NR, 1993, PATTERN RECOGN, V26, P1277, DOI 10.1016/0031-3203(93)90135-J
   JAIN ZS, 1995, IEEE T SYST MAN CYB, V25, P1340, DOI 10.1109/21.414528
   Stauffer C, 2000, IEEE T PATTERN ANAL, V22, P747, DOI 10.1109/34.868677
   Rey D, 2002, MED IMAGE ANAL, V6, P163, DOI 10.1016/S1361-8415(02)00056-7
   Collins RT, 2000, IEEE T PATTERN ANAL, V22, P745, DOI 10.1109/TPAMI.2000.868676
   Pizarro O, 2003, IEEE J OCEANIC ENG, V28, P651, DOI 10.1109/JOE.2003.819154
   Ren Y, 2003, PATTERN RECOGN LETT, V24, P183, DOI 10.1016/S0167-8655(02)00210-6
   Bruzzone L, 2003, IEEE T GEOSCI REMOTE, V41, P2455, DOI 10.1109/TGRS.2003.817268
   Dai XL, 1998, IEEE T GEOSCI REMOTE, V36, P1566
   Rosin PL, 2003, PATTERN RECOGN LETT, V24, P2345, DOI 10.1016/S0167-8655(03)00060-6
   Clifton C, 2003, APPL INTELL, V18, P215, DOI 10.1023/A:1021942526896
   Haritaoglu I, 2000, IEEE T PATTERN ANAL, V22, P809, DOI 10.1109/34.868683
   Yeung M, 1998, COMPUT VIS IMAGE UND, V71, P94, DOI 10.1006/cviu.1997.0628
   Black MJ, 2000, COMPUT VIS IMAGE UND, V78, P8, DOI 10.1006/cviu.1999.0825
   Ivanov Y, 2000, INT J COMPUT VISION, V37, P199, DOI 10.1023/A:1008107805263
   WANG JYA, 1994, IEEE T IMAGE PROCESS, V3, P625, DOI 10.1109/83.334981
   Lowe DG, 2004, INT J COMPUT VISION, V60, P91, DOI 10.1023/B:VISI.0000029664.99615.94
   Liu SC, 1998, IEEE T IMAGE PROCESS, V7, P1258, DOI 10.1109/83.709658
   Smits PC, 2000, IEEE T GEOSCI REMOTE, V38, P1484, DOI 10.1109/36.843048
   HSU YZ, 1984, COMPUT VISION GRAPH, V26, P73, DOI 10.1016/0734-189X(84)90131-2
   Anton H., 1994, ELEMENTARY LINEAR AL
   AYER S, 1995, P ICCV JUN
   BERGER JW, 2000, OPHTHALMOL, V107
   BESAG J, 1986, J ROY STAT SOC B MET, V48, P259
   BLAKE A, 1999, ACTIVE CONTOURS
   BROWN L, 1992, ACM COMPUT SURV, V24
   Cavallaro A., 2001, P SPIE VIS COMM IM P, P465
   Collins R., 2000, CMURITR0012
   Colwell J.E., 1981, P 15 INT S REM SENS, P839
   Coppin P. R., 1996, REMOTE SENSING REV, V13, P207, DOI DOI 10.1080/02757259609532305
   CRIST EP, 1984, IEEE T GEOSCI REMOTE, V22, P256, DOI 10.1109/TGRS.1984.350619
   Deer P., 2002, P 9 INT C INF PROC M, P187
   Di Stefano L., 2003, Proceedings IEEE Conference on Advanced Video and Signal Based Surveillance. AVSS 2003, DOI 10.1109/AVSS.2003.1217929
   Dumskyj M. J., 1996, CURRENT EYE RES, V15, P652
   DURUCAN E, 2001, P NSIP SEP
   EDGINTON D, 2003, P MTS IEEE OC C
   Zitova B, 2003, IMAGE VISION COMPUT, V21, P977, DOI 10.1016/S0262-8856(03)00137-9
   Forsyth D., 2003, COMPUTER VISION MODE
   FRITZSCHE KH, 2003, ANGIOGRAPHY PLAQUE I, P225
   FUKUDA K, 1989, TRENDS PHARM SCI S, V11, P4
   Fukuda S, 1998, INT J REMOTE SENS, V19, P507, DOI 10.1080/014311698216125
   GEMAN S, 1984, IEEE T PATTERN ANAL, V6, P721
   Gibbins D, 1996, THIRD IEEE WORKSHOP ON APPLICATIONS OF COMPUTER VISION - WACV '96, PROCEEDINGS, P22, DOI 10.1109/ACV.1996.571990
   GONG P, 1993, CANAD J REMOTE SENS, V19
   Gustafsson F., 2000, ADAPTIVE FILTERING C
   Hall O., 2003, INT J APPL EARTH OBS, V4, P311, DOI DOI 10.1016/S0303-2434(03)00010-
   Haralick RM, 1992, COMPUTER ROBOT VISIO, V1
   HOTER M, 1996, P INT C PATT REC, P249
   Hu J., 2001, P 6 INT C DOC AN REC, P129
   HUWER S, 2000, P VIS SURV
   Ibanez L., 2003, ITK SOFTWARE GUIDE I
   Jensen JR, 1996, INTRO DIGITAL IMAGE
   Kan WY, 1996, OPT ENG, V35, P1723, DOI 10.1117/1.600747
   Kanade T., 1998, P DARPA IM UND WORKS, VI, P3
   Kay S. M., 1993, FUNDAMENTALS STAT SI
   LANDIS E, 1999, J ENG MECH, V126, P599
   Latecki L. J., 2003, Proceedings IEEE Conference on Advanced Video and Signal Based Surveillance. AVSS 2003, DOI 10.1109/AVSS.2003.1217927
   LAVALLEE S, 1995, REGISTRATION COMPUTE
   Lebart K., 2000, P MTS IEEE OC 00 PRO, P337
   Leclerc YG, 2003, INT J COMPUT VISION, V51, P63, DOI 10.1023/A:1020940807324
   Lemieux L, 1998, Med Image Anal, V2, P227, DOI 10.1016/S1361-8415(98)80021-2
   Li S., 2001, MARKOV RANDOM FIELD
   LILLESTRAND RL, 1972, IEEE T COMPUT, VC 21, P654, DOI 10.1109/T-C.1972.223570
   Maintz J B, 1998, Med Image Anal, V2, P1, DOI 10.1016/S1361-8415(01)80026-8
   Malila W.A., 1980, P 6 ANN S MACH PROC, P326
   Mester R., 2001, Pattern Recognition. 23rd DAGM Symposium. Proceedings (Lecture Notes in Computer Science Vol.2191)
   MORISETTE JT, 1997, P 1997 IEEE INT GEOS, V4, P1769
   Nagy G., 2001, P VIS FORM, P759
   NIEMEYER I, 1999, P INT GEOSC REM SENS, P327
   Paragios N, 1999, SIGNAL PROCESS-IMAGE, V14, P277, DOI 10.1016/S0923-5965(98)00011-3
   PHONG BT, 1975, COMMUN ACM, V18, P311, DOI 10.1145/360825.360839
   Poor H. V., 1994, INTRO SIGNAL DETECTI
   QUEGAN S, 1997, P IGARSS AUG, P1041
   Rissanen J., 1987, ENCY STATISTICAL SCI, V5, P523
   RITTSCHER J, 2000, P 6 ECCV
   Rosin PL, 2002, COMPUT VIS IMAGE UND, V86, P79, DOI 10.1006/cviu.2002.0960
   SINGH A, 1989, INT J REMOTE SENS, V10, P989
   Stenger B., 2001, Proceedings Eighth IEEE International Conference on Computer Vision. ICCV 2001, DOI 10.1109/ICCV.2001.937532
   STRINGA E, 2000, P BRIT MACH VIS C
   Thirion JP, 1999, IEEE T MED IMAGING, V18, P429, DOI 10.1109/42.774170
   Thomas J.A., 1989, British Wildlife, V1, P2
   TOTH TAD, 2002, P 4 IEEE SW S IM AN, P3
   Toyama K., 1999, Proceedings of the Seventh IEEE International Conference on Computer Vision, DOI 10.1109/ICCV.1999.791228
   Watanabe S, 1998, INT C PATT RECOG, P1408, DOI 10.1109/ICPR.1998.711966
   Wells WM, 1997, INT J COMPUT VISION, V21, P63, DOI 10.1023/A:1007923522710
   YAKIMOVSKY Y, 1976, J ACM, V23, P599, DOI 10.1145/321978.321981
   Yamazawa I, 2001, DEV ECON, V39, P3, DOI 10.1111/j.1746-1049.2001.tb00892.x
   Yu HH, 1999, COMPUT VIS IMAGE UND, V75, P196, DOI 10.1006/cviu.1999.0773
   Zisserman A., 2000, MULTIPLE VIEW GEOMET
NR 125
TC 614
Z9 662
U1 11
U2 126
PU IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC
PI PISCATAWAY
PA 445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA
SN 1057-7149
EI 1941-0042
J9 IEEE T IMAGE PROCESS
JI IEEE Trans. Image Process.
PD MAR
PY 2005
VL 14
IS 3
BP 294
EP 307
DI 10.1109/TIP.2004.838698
PG 14
WC Computer Science, Artificial Intelligence; Engineering, Electrical &
   Electronic
SC Computer Science; Engineering
GA 898JZ
UT WOS:000227074400002
PM 15762326
ER

PT J
AU Provencher, SW
AF Provencher, SW
TI Automatic quantitation of localized in vivo H-1 spectra with LCModel
SO NMR IN BIOMEDICINE
LA English
DT Article
DE magnetic resonance spectroscopy; proton MRS; quantitation; LCModel;
   brain; in vivo
ID MAGNETIC-RESONANCE SPECTROSCOPY; MULTIPLE-SCLEROSIS LESIONS; PROTON MR
   SPECTROSCOPY; HUMAN BRAIN; IN-VIVO; METABOLITE CONCENTRATIONS; THERAPY;
   DEFICIENCY; EPILEPSY; DISEASE
AB The LCModel method analyzes an in vivo spectrum as a Linear Combination of Model in vitro spectra from individual metabolite solutions. Complete model spectra, rather than individual resonances, are used in order to incorporate maximum prior information into the analysis. A nearly model-free constrained regularization method automatically accounts for the baseline and lineshape in vivo without imposing a restrictive parameterized form on them. LCModel is automatic (non-interactive) with no subjective input. Approximately maximum-likelihood estimates of the metabolite concentrations and their uncertainties (Cramer-Rao lower bounds) are obtained. LCModel analyses of spectra from users with fields from 1.5 to 9.4 T and a wide range of sequences, particularly with short TE, are used here to illustrate the capabilities and limitations of LCModel and proton MRS. Copyright (C) 2001 John Wiley & Sons, Ltd.
C1 Max Planck Inst Biophys Chem, D-37070 Gottingen, Germany.
RP Provencher, SW (reprint author), 48 Chancery Lane, Oakville, ON L6J 5P6, Canada.
CR Pfeuffer J, 1999, J MAGN RESON, V141, P104, DOI 10.1006/jmre.1999.1895
   Choi CG, 1999, MAGNET RESON MED, V41, P204, DOI 10.1002/(SICI)1522-2594(199901)41:1<204::AID-MRM29>3.0.CO;2-7
   Rose SE, 1999, MAGN RESON IMAGING, V17, P291, DOI 10.1016/S0730-725X(98)00168-4
   PROVENCHER SW, 1982, COMPUT PHYS COMMUN, V27, P213, DOI 10.1016/0010-4655(82)90173-4
   Rubio-Gozalbo ME, 1999, MAGN RESON IMAGING, V17, P939, DOI 10.1016/S0730-725X(99)00002-8
   Schirmer T, 2000, NMR BIOMED, V13, P28, DOI 10.1002/(SICI)1099-1492(200002)13:1<28::AID-NBM606>3.0.CO;2-L
   Woermann FG, 1999, ANN NEUROL, V45, P369, DOI 10.1002/1531-8249(199903)45:3<369::AID-ANA13>3.0.CO;2-Q
   van der Knaap MS, 1999, ANN NEUROL, V46, P925, DOI 10.1002/1531-8249(199912)46:6<925::AID-ANA18>3.0.CO;2-J
   Pioro EP, 1999, NEUROLOGY, V53, P71
   Savic I, 2000, EPILEPSIA, V41, P290, DOI 10.1111/j.1528-1157.2000.tb00158.x
   Pouwels PJW, 1999, PEDIATR RES, V46, P474, DOI 10.1203/00006450-199910000-00019
   Pouwels PJW, 1998, MAGNET RESON MED, V39, P53, DOI 10.1002/mrm.1910390110
   Frahm J, 1996, MAGNET RESON MED, V35, P143, DOI 10.1002/mrm.1910350202
   van Walderveen MAA, 1999, ANN NEUROL, V46, P79, DOI 10.1002/1531-8249(199907)46:1<79::AID-ANA12>3.0.CO;2-9
   Rose SE, 2000, MAGN RESON IMAGING, V18, P95, DOI 10.1016/S0730-725X(99)00110-1
   Helms G, 2000, MAGNET RESON MED, V43, P102, DOI 10.1002/(SICI)1522-2594(200001)43:1<102::AID-MRM12>3.0.CO;2-I
   Nagatomo Y, 1995, NMR BIOMED, V8, P265, DOI 10.1002/nbm.1940080606
   Wilichowski E, 1999, NEUROPEDIATRICS, V30, P256, DOI 10.1055/s-2007-973500
   Helms G, 1999, MAGN RESON IMAGING, V17, P1211, DOI 10.1016/S0730-725X(99)00058-2
   Brex PA, 1999, J NEUROL SCI, V166, P16, DOI 10.1016/S0022-510X(99)00105-7
   CADY EB, 1997, J MAGN RESON ANAL, V3, P5
   Chong VFH, 1999, INT J RADIAT ONCOL, V45, P699, DOI 10.1016/S0360-3016(99)00236-9
   Ebert D, 1997, PSYCHIAT RES-NEUROIM, V74, P173, DOI 10.1016/S0925-4927(97)00016-4
   FRAHM J, 1997, ADV NEUROCH, V8, P329
   HOFMANN L, 1999, 7 SCI M INT SOC MAGN, P586
   Kraft E, 1999, J NEUROL, V246, P693, DOI 10.1007/s004150050434
   MCLEAN MA, 1998, 6 SCI M INT SOC MAGN, P626
   PROVENCHER SW, 1995, 3 ANN M SOC MAGN RES, P1952
   PROVENCHER SW, 1997, 5 SCI M INT SOC MAGN, P1411
   PROVENCHER SW, 1995, NEW PROSPECTS PSYCHI, P405
   PROVENCHER SW, 1993, MAGNET RESON MED, V30, P672, DOI 10.1002/mrm.1910300604
   SAILASUTA N, 1998, 6 SCI M INT SOC MAGN, P1842
   Speck O, 1996, ANTICANCER RES, V16, P1581
   Stockler S, 1996, LANCET, V348, P789, DOI 10.1016/S0140-6736(96)04116-5
   THIEL T, 1999, 7 SCI M INT SOC MAGN, P1473
   WANG Y, 1999, 7 SCI M INT SOC MAGN, P1429
   Wilken B, 1996, CHILD NERV SYST, V12, P626
NR 37
TC 601
Z9 611
U1 2
U2 15
PU JOHN WILEY & SONS LTD
PI W SUSSEX
PA BAFFINS LANE CHICHESTER, W SUSSEX PO19 1UD, ENGLAND
SN 0952-3480
J9 NMR BIOMED
JI NMR Biomed.
PD JUN
PY 2001
VL 14
IS 4
BP 260
EP 264
DI 10.1002/nbm.698
PG 5
WC Biophysics; Radiology, Nuclear Medicine & Medical Imaging; Spectroscopy
SC Biophysics; Radiology, Nuclear Medicine & Medical Imaging; Spectroscopy
GA 447AQ
UT WOS:000169546700005
PM 11410943
ER

PT J
AU Lips, P
AF Lips, P.
TI Vitamin D physiology
SO PROGRESS IN BIOPHYSICS & MOLECULAR BIOLOGY
LA English
DT Article; Proceedings Paper
CT Workshop of the International-Commission-on-Non-Ionizing
   Radiation-Protection
CY OCT 17-18, 2005
CL Munich, GERMANY
SP Int Commission Non-Ionizing Radiat Protect
DE vitamin D deficiency; bone mineralization; auto-immune disease; vitamin
   D; genomic and non-genomic effects; vitamin D-dependent rickets; vitamin
   D receptor
ID HYPOVITAMINOSIS-D; SECONDARY HYPERPARATHYROIDISM; AMSTERDAM LASA; D
   DEFICIENCY; CALCIUM
AB Vitamin D3 is synthesized in the skin during summer under the influence of ultraviolet light of the sun, or it is obtained from food, especially fatty fish. After hydroxylation in the liver into 25-hydroxyvitamin D (25(OH)D) and kidney into 1,25-dihydroxyvitamin D (1,25(OH)2D), the active metabolite can enter the cell, bind to the vitamin D-receptor and subsequently to a responsive gene such as that of calcium binding protein. After transcription and translation the protein is formed, e.g. osteocalcin or calcium binding protein. The calcium binding protein mediates calcium absorption from the gut. The production of 1,25(OH)2D is stimulated by parathyroid hormone (PTH) and decreased by calcium. Risk factors for vitamin D deficiency are premature birth, skin pigmentation, low sunshine exposure, obesity, malabsorption and advanced age. Risk groups are immigrants and the elderly. Vitamin D status is dependent upon sunshine exposure but within Europe, serum 25(OH)D levels are higher in Northern than in Southern European countries. Severe vitamin D deficiency causes rickets or osteomalacia, where the new bone, the osteoid, is not mineralized. Less severe vitamin D deficiency causes an increase of serum PTH leading to bone resorption, osteoporosis and fractures. A negative relationship exists between serum 25(OH)D and serum PTH. The threshold of serum 25(OH)D, where serum PTH starts to rise is about 75 nmol/l according to most surveys. Vitamin D supplementation to vitamin D-deficient elderly suppresses serum PTH, increases bone mineral density and may decrease fracture incidence especially in nursing home residents. The effects of 1,25(OH)2D and the vitamin D receptor have been investigated in patients with genetic defects of vitamin D metabolism and in knock-out mouse models. These experiments have demonstrated that for active calcium absorption, longitudinal bone growth and the activity of osteoblasts and osteoclasts both 1,25(OH)2D and the vitamin D receptor are essential. On the other side, bone mineralization can occur by high ambient calcium concentration, so by high doses of oral calcium or calcium infusion. The active metabolite 1,25(OH)2D has its effects through the vitamin D receptor leading to gene expression, e.g. the calcium binding protein or osteocalcin or through a plasma membrane receptor and second messengers such as cyclic AMP. The latter responses are very rapid and include the effects on the pancreas, vascular smooth muscle and monocytes. Muscle cells contain vitamin D receptor and several studies have demonstrated that serum 25(OH)D is related to physical performance. The active metabolite 1,25(OH)2D has an antiproliferative effect and downregulates inflammatory markers. Extrarenal synthesis of 1,25(OH)2D occurs under the influence of cytokines and is important for the paracrine regulation of cell differentiation and function. This may explain that vitamin D deficiency can play a role in the pathogenesis of auto-immune diseases such as multiple sclerosis and diabetes type 1, and cancer. In conclusion, the active metabolite 1,25(OH)2D has pleiotropic effects through the vitamin D receptor and vitamin D responsive elements of many genes and on the other side rapid non-genomic effects through a membrane receptor and second messengers. Active calcium absorption from the gut depends on adequate formation of 1,25(OH)2D and an intact vitamin D receptor. Bone mineralization mainly depends on ambient calcium concentration. Vitamin D metabolites may play a role in the prevention of auto-immune disease and cancer.
   (c) 2006 Elseier Ltd. All rights reserved.
C1 Vrije Univ Amsterdam, Med Ctr, Dept Endocrinol, NL-1007 MB Amsterdam, Netherlands.
RP Lips, P (reprint author), Vrije Univ Amsterdam, Med Ctr, Dept Endocrinol, POB 7057, NL-1007 MB Amsterdam, Netherlands.
EM p.lips@vumc.nl
CR Nagpal S, 2005, ENDOCR REV, V26, P662, DOI 10.1210/er.2004-0002
   Mathieu C, 2005, DIABETOLOGIA, V48, P1247, DOI 10.1007/s00125-005-1802-7
   Lips P, 2001, ENDOCR REV, V22, P477, DOI 10.1210/er.22.4.477
   Lips P, 2001, J CLIN ENDOCR METAB, V86, P1212, DOI 10.1210/jc.86.3.1212
   Bischoff-Ferrari HA, 2004, AM J CLIN NUTR, V80, P752
   Peterlik M, 2005, EUR J CLIN INVEST, V35, P290, DOI 10.1111/j.1365-2362.2005.01487.x
   Panda DK, 2004, J BIOL CHEM, V279, P16754, DOI 10.1074/jbc.M310271200
   Chiu KC, 2004, AM J CLIN NUTR, V79, P820
   Gannage-Yared MH, 2000, J BONE MINER RES, V15, P1856, DOI 10.1359/jbmr.2000.15.9.1856
   Bischoff-Ferrari HA, 2004, J BONE MINER RES, V19, P265, DOI 10.1359/jbmr.2004.19.2.265
   HOLICK MF, 1994, AM J CLIN NUTR, V60, P619
   Feldman D, 2005, VITAMIN D: VOLS 1 AND 2, 2ND EDITION, P1
   Grootjans-Geerts I, 2001, Ned Tijdschr Geneeskd, V145, P2057
   Lips P, 2005, BONE, V36, pS141
   vandenBemd GJCM, 1995, J STEROID BIOCHEM, V55, P337, DOI 10.1016/0960-0760(95)00218-9
   Wicherts IS, 2005, J BONE MINER RES, V20, pS35
NR 16
TC 411
Z9 431
U1 23
U2 103
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0079-6107
J9 PROG BIOPHYS MOL BIO
JI Prog. Biophys. Mol. Biol.
PD SEP
PY 2006
VL 92
IS 1
BP 4
EP 8
DI 10.1016/j.pbiomolbio.2006.02.016
PG 5
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA 060EW
UT WOS:000238786200002
PM 16563471
ER

PT J
AU Zijdenbos, AP
   Forghani, R
   Evans, AC
AF Zijdenbos, AP
   Forghani, R
   Evans, AC
TI Automatic "pipeline" analysis of 3-D MRI data for clinical trials:
   Application to multiple sclerosis
SO IEEE TRANSACTIONS ON MEDICAL IMAGING
LA English
DT Article
DE clinical trials; image segmentation; magnetic resonance imaging (MRI);
   multiple sclerosis (MS); tissue quantification
ID INTENSITY NONUNIFORMITY; HUMAN BRAIN; TISSUE CLASSIFICATION; IMAGES;
   SEGMENTATION; LESIONS; MODEL; ACTIVATION; SPACE; REGISTRATION
AB The quantitative analysis of magnetic resonance imaging (MRI) data has become increasingly important in both research and clinical studies aiming at human brain development, function, and pathology. Inevitably, the role of quantitative image analysis in the evaluation of drug therapy will increase, driven in part by requirements imposed by regulatory agencies. However, the prohibitive length of time involved and the significant intra- and inter-rater variability of the measurements obtained from manual analysis of large MRI databases represent major obstacles to the wider application of quantitative MRI analysis. We have developed a fully automatic "pipeline" image analysis framework and have successfully applied it to a number of large-scale, multi-center studies (more than 1000 MRI scans). This pipeline system is based on robust image processing algorithms, executed in a parallel, distributed fashion. This paper describes the application of this system to the automatic quantification of multiple sclerosis lesion load in MRI, in the context of a phase III clinical trial. The pipeline results were evaluated through an extensive validation study, revealing that the obtained lesion measurements are statistically indistinguishable from those obtained by trained human observers. Given that intra- and inter-rater measurement variability is eliminated by automatic analysis, this system enhances the ability to detect small treatment effects not readily detectable through conventional analysis techniques. While useful for clinical trial analysis in multiple sclerosis, this system holds widespread potential for applications in other neurological disorders, as well as for the study of neurobiology in general.
C1 McGill Univ, Montreal Neurol Inst, McConnell Brain Imaging Ctr, Montreal, PQ H3A 2B4, Canada.
RP Zijdenbos, AP (reprint author), McGill Univ, Montreal Neurol Inst, McConnell Brain Imaging Ctr, 3801 Univ St,WB-208, Montreal, PQ H3A 2B4, Canada.
EM alex@bic.mni.mcgill.ca
CR MacDonald D, 2000, NEUROIMAGE, V12, P340, DOI 10.1006/nimg.1999.0534
   Giedd JN, 1999, NAT NEUROSCI, V2, P861, DOI 10.1038/13158
   FOX PT, 1985, J COMPUT ASSIST TOMO, V9, P141, DOI 10.1097/00004728-198501000-00025
   KAMBER M, 1995, IEEE T MED IMAGING, V14, P442, DOI 10.1109/42.414608
   Worsley KJ, 1996, HUM BRAIN MAPP, V4, P58, DOI 10.1002/(SICI)1097-0193(1996)4:1&lt;58::AID-HBM4&gt;3.0.CO;2-O
   Van Leemput K, 2001, IEEE T MED IMAGING, V20, P677, DOI 10.1109/42.938237
   DICE LR, 1945, ECOLOGY, V26, P297, DOI 10.2307/1932409
   MEYER CR, 1995, IEEE T MED IMAGING, V14, P36, DOI 10.1109/42.370400
   Ashburner J, 1998, HUM BRAIN MAPP, V6, P348, DOI 10.1002/(SICI)1097-0193(1998)6:5/6<348::AID-HBM4>3.0.CO;2-P
   CHOI HS, 1991, IEEE T MED IMAGING, V10, P395, DOI 10.1109/42.97590
   MAZZIOTTA JC, 1995, NEUROIMAGE, V2, P89, DOI 10.1006/nimg.1995.1012
   Wells WM, 1996, IEEE T MED IMAGING, V15, P429, DOI 10.1109/42.511747
   Stokking R, 2000, NEUROIMAGE, V12, P726, DOI 10.1006/nimg.2000.0661
   PATY DW, 1993, NEUROLOGY, V43, P662
   GERIG G, 1992, IEEE T MED IMAGING, V11, P221, DOI 10.1109/42.141646
   Weiner HL, 1997, ANNU REV MED, V48, P341
   Pruessner JC, 2001, J NEUROSCI, V21, P194
   DAWANT BM, 1993, IEEE T MED IMAGING, V12, P770, DOI 10.1109/42.251128
   Evans A C, 1992, Neuroimage, V1, P43, DOI 10.1016/1053-8119(92)90006-9
   Van Leemput K, 1999, IEEE T MED IMAGING, V18, P885, DOI 10.1109/42.811268
   Collins DL, 1998, IEEE T MED IMAGING, V17, P463, DOI 10.1109/42.712135
   Sled JG, 1998, IEEE T MED IMAGING, V17, P653, DOI 10.1109/42.730409
   DeCarli C, 1996, JMRI-J MAGN RESON IM, V6, P519, DOI 10.1002/jmri.1880060316
   Sled JG, 1998, IEEE T MED IMAGING, V17, P87, DOI 10.1109/42.668698
   FLEISS JL, 1971, PSYCHOL BULL, V76, P378, DOI 10.1037/h0031619
   Giedd JN, 1996, CEREB CORTEX, V6, P551, DOI 10.1093/cercor/6.4.551
   ORMEROD IEC, 1987, BRAIN, V110, P1579, DOI 10.1093/brain/110.6.1579
   BARTOLI RM, 1983, REV ICIDCA, V17, P3
   BRUMMER ME, 1993, IEEE T MED IMAGING, V12, P153, DOI 10.1109/42.232244
   CHARIL A, 2000, 6 ANN M ORG HUM BRAN
   COLLIGNON A, 1995, COMP IMAG VIS, V3, P263
   COLLINS DL, 1994, J COMPUT ASSIST TOMO, V18, P192
   Evans A. C., 1996, P343
   Evans AC, 1997, ANN NEUROL, V41, P125, DOI 10.1002/ana.410410123
   EVANS AC, 1994, NATO ADV SCI INST SE, V264, P263
   Filippi M, 1998, J NEUROL NEUROSUR PS, V64, pS88
   Frackowiak R, 1997, HUMAN BRAIN FUNCTION
   Friston KJ, 1995, HUM BRAIN MAPP, V3, P165, DOI 10.1002/hbm.460030303
   Henkelman RM, 1987, REV MAGN RESON MED, V2, P1
   KOLLOKIAN V, 1996, THESIS CONCORDIA U M
   Kwan RKS, 1999, IEEE T MED IMAGING, V18, P1085, DOI 10.1109/42.816072
   Mitchell JR, 1996, MED PHYS, V23, P115, DOI 10.1118/1.597689
   NARAYANA PA, 1995, MAGNET RESON MED, V33, P396, DOI 10.1002/mrm.1910330312
   NEELIN P, 1998, 4 INT C FUNCT MAPP H
   OZKAN M, 1993, IEEE T MED IMAGING, V12, P534, DOI 10.1109/42.241881
   Paus T, 1999, SCIENCE, V283, P1908, DOI 10.1126/science.283.5409.1908
   PERONA P, 1990, IEEE T PATTERN ANAL, V12, P629, DOI 10.1109/34.56205
   ROSENFIELD GH, 1986, PHOTOGRAMM ENG REM S, V52, P223
   SCHAPER KA, 2001, 7 ANN M ORG HUM BRAI
   SIMMONS A, 1994, MAGNET RESON MED, V32, P121, DOI 10.1002/mrm.1910320117
   Sled JG, 1997, P 15 INT C INF PROC, P459
   Talairach J, 1988, COPLANAR STEREOTAXIC
   Toga AW, 1996, BRAIN MAPPING METHOD
   WICKS DAG, 1993, MAGN RESON IMAGING, V11, P183, DOI 10.1016/0730-725X(93)90023-7
   WORSLEY KJ, 1992, J CEREBR BLOOD F MET, V12, P900
   ZIJDENBOS AP, 1994, IEEE T MED IMAGING, V13, P716, DOI 10.1109/42.363096
   ZIJDENBOS AP, 1994, COMPUT MED IMAG GRAP, V18, P11, DOI 10.1016/0895-6111(94)90057-4
   ZIJDENBOS AP, 1995, P 9 INT S EXH COMP A, P216
NR 58
TC 377
Z9 378
U1 0
U2 9
PU IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC
PI PISCATAWAY
PA 445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA
SN 0278-0062
J9 IEEE T MED IMAGING
JI IEEE Trans. Med. Imaging
PD OCT
PY 2002
VL 21
IS 10
BP 1280
EP 1291
DI 10.1109/TMI.2002.806283
PG 12
WC Computer Science, Interdisciplinary Applications; Engineering,
   Biomedical; Engineering, Electrical & Electronic; Imaging Science &
   Photographic Technology; Radiology, Nuclear Medicine & Medical Imaging
SC Computer Science; Engineering; Imaging Science & Photographic
   Technology; Radiology, Nuclear Medicine & Medical Imaging
GA 641VW
UT WOS:000180768600009
PM 12585710
ER

PT J
AU Wilson, AS
   Power, BE
   Molloy, PL
AF Wilson, Ann S.
   Power, Barbara E.
   Molloy, Peter L.
TI DNA hypomethylation and human diseases
SO BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER
LA English
DT Review
DE DNA hypomethylation; global demethylation; cancer; biomarker;
   transposable element; repeat sequence
ID DNMT1 PROTEIN EXPRESSION; HUMAN GENETIC-DISEASE; PERICENTROMERIC
   SATELLITE REGIONS; HUMAN ENDOGENOUS RETROVIRUS; SPORADIC
   COLORECTAL-CANCER; CPG ISLAND METHYLATION; DE-NOVO METHYLATION; MALE
   GERM-CELLS; BREAST-CANCER; ICF SYNDROME
AB Changes in human DNA methylation patterns are an important feature of cancer development and progression and a potential role in other conditions such as atherosclerosis and autoimmune diseases (e.g., multiple sclerosis and lupus) is being recognised. The cancer genome is frequently characterised by hypermethylation of specific genes concurrently with an overall decrease in the level of 5 methyl cytosine. This hypomethylation of the genome largely affects the intergenic and intronic regions of the DNA, particularly repeat sequences and transposable elements, and is believed to result in chromosomal instability and increased mutation events. This review examines our understanding of the patterns of cancer-associated hypomethylation, and how recent advances in understanding of chromatin biology may help elucidate the mechanisms underlying repeat sequence demethylation. It also considers how global demethylation of repeat sequences including transposable elements and the site-specific hypomethylation of certain genes might contribute to the deleterious effects that ultimately result in the initiation and progression of cancer and other diseases. The use of hypomethylation of interspersed repeat sequences and genes as potential biomarkers in the early detection of tumors and their prognostic use in monitoring disease progression are also examined. Crown Copyright (c) 2006 Published by Elsevier B.V. All rights reserved.
C1 Preventat Hlth Natl Res Flagship, N Ryde, NSW 1670, Australia.
   CSIRO, Mol & Hlth Technol, N Ryde, NSW 1670, Australia.
   CSIRO, Mol & Hlth Technol, Parkville, Vic 3052, Australia.
RP Molloy, PL (reprint author), Preventat Hlth Natl Res Flagship, POB 184, N Ryde, NSW 1670, Australia.
EM Peter.Molloy@csiro.au
RI Molloy, Peter/H-7931-2013; 
OI Molloy, Peter/0000-0002-7788-3417; Power, Barbara/0000-0002-4182-3375
CR Akcakanat A, 2006, INT J CANCER, V118, P123, DOI 10.1002/ijc.21219
   Bourc'his D, 2004, NATURE, V431, P96, DOI 10.1038/nature02886
   Yang AS, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh032
   Toyota M, 2000, P NATL ACAD SCI USA, V97, P710, DOI 10.1073/pnas.97.2.710
   Peters AHFM, 2001, CELL, V107, P323, DOI 10.1016/S0092-8674(01)00542-6
   Wei W, 2001, MOL CELL BIOL, V21, P1429, DOI 10.1128/MCB.21.4.1429-1439.2001
   SMIT AFA, 1993, NUCLEIC ACIDS RES, V21, P1863, DOI 10.1093/nar/21.8.1863
   Hata K, 2006, MOL REPROD DEV, V73, P116, DOI 10.1002/mrd.20387
   Rohrer J, 1999, CLIN IMMUNOL, V90, P28, DOI 10.1006/clim.1998.4629
   Grunau C, 2005, GENE CHROMOSOME CANC, V43, P11, DOI 10.1002/gcc.20155
   Florl AL, 2004, BRIT J CANCER, V91, P985, DOI 10.1038/sj.bjc.6602030
   Kaplan MJ, 2004, J IMMUNOL, V172, P3652
   Whitelaw E, 2001, NAT GENET, V27, P361, DOI 10.1038/86850
   Lavie L, 2005, J VIROL, V79, P876, DOI 10.1128/JVI.79.2.876-883.2005
   MORGAN GT, 1995, J MOL BIOL, V254, P1, DOI 10.1006/jmbi.1995.0593
   Esnault C, 2000, NAT GENET, V24, P363
   Jackson-Grusby L, 2001, NAT GENET, V27, P31, DOI 10.1038/83730
   Xiao J, 2005, J GASTROENTEROL, V40, P716, DOI 10.1007/s00535-005-1615-y
   Saito Y, 2002, P NATL ACAD SCI USA, V99, P10060, DOI 10.1073/pnas.152121799
   Ehrlich M, 2002, ONCOGENE, V21, P5400, DOI 10.1038/sj.onc.1205651
   Takai D, 2000, JPN J CLIN ONCOL, V30, P306, DOI 10.1093/jjco/hyd079
   Morris K, 2005, CELL MOL LIFE SCI, V62, P3057, DOI 10.1007/s00018-005-5182-4
   Bruniquel D, 2003, NAT IMMUNOL, V4, P235, DOI 10.1039/ni887
   Suzuki K, 2006, CANCER CELL, V9, P199, DOI 10.1016/j.ccr.2006.02.016
   Nishiyama R, 2005, MOL CANCER RES, V3, P617, DOI 10.1158/1541-7786.MCR-05-0146
   Qu GZ, 1999, MUTAT RES-FUND MOL M, V423, P91, DOI 10.1016/S0027-5107(98)00229-2
   DeBaun MR, 1998, J PEDIATR-US, V132, P398, DOI 10.1016/S0022-3476(98)70008-3
   Dewannieux M, 2003, NAT GENET, V35, P41, DOI 10.1038/ng1223
   Kobayashi K, 1998, NATURE, V394, P388
   Yoder JA, 1997, TRENDS GENET, V13, P335, DOI 10.1016/S0168-9525(97)01181-5
   Dodge JE, 2005, J BIOL CHEM, V280, P17986, DOI 10.1074/jbc.M413246200
   Takai D, 2001, HUM MOL GENET, V10, P2619, DOI 10.1093/hmg/10.23.2619
   Hassan KMA, 2001, HUM GENET, V109, P452
   Cui HM, 2002, CANCER RES, V62, P6442
   Kazazian HH, 2004, SCIENCE, V303, P1626, DOI 10.1126/science.1089670
   Yang AS, 2006, CANCER RES, V66, P5495, DOI 10.1158/0008-5472.CAN-05-2385
   Schulz WA, 2002, GENE CHROMOSOME CANC, V35, P58, DOI 10.1002/gcc.10092
   De Marzo AM, 1999, CANCER RES, V59, P3855
   Bariol C, 2003, AM J PATHOL, V162, P1361, DOI 10.1016/S0002-9440(10)63932-6
   Santos-Rosa H, 2005, EUR J CANCER, V41, P2381, DOI 10.1016/j.ejca.2005.08.010
   Karpf AR, 2005, CANCER RES, V65, P8635, DOI 10.1158/0008-5472
   Ostertag EM, 2001, ANNU REV GENET, V35, P501, DOI 10.1146/annurev.genet.35.102401.091032
   Santourlidis S, 1999, PROSTATE, V39, P166
   Goldberg B, 2000, IMMUNOL LETT, V73, P13, DOI 10.1016/S0165-2478(00)00191-7
   Sato N, 2003, CANCER RES, V63, P4158
   Deng C, 2001, ARTHRITIS RHEUM, V44, P397, DOI 10.1002/1529-0131(200102)44:2<397::AID-ANR59>3.0.CO;2-N
   Brouha B, 2003, P NATL ACAD SCI USA, V100, P5280, DOI 10.1073/pnas.0831042100
   Richardson B, 2003, CLIN IMMUNOL, V109, P72, DOI 10.1016/S1521-6616(03)00206-7
   Murphy SK, 2006, MOL CANCER RES, V4, P283, DOI 10.1158/1541-7786.MCR-05-0138
   FEINBERG AP, 1983, BIOCHEM BIOPH RES CO, V111, P47, DOI 10.1016/S0006-291X(83)80115-6
   Girault I, 2003, CLIN CANCER RES, V9, P4415
   Brothman AR, 2005, CANCER GENET CYTOGEN, V156, P31, DOI 10.1016/j.cancergencyto.2004.04.004
   Hata K, 1997, GENE, V189, P227, DOI 10.1016/S0378-1119(96)00856-6
   Eads CA, 1999, CANCER RES, V59, P2302
   Roman-Gomez J, 2005, ONCOGENE, V24, P7213, DOI 10.1038/sj.onc.1208866
   Weisenberger DJ, 2005, NUCLEIC ACIDS RES, V33, P6823, DOI 10.1093/nar/gki987
   Imamura T, 2004, BIOCHEM BIOPH RES CO, V322, P593, DOI 10.1016/j.bbrc.2004.07.159
   Holm TM, 2005, CANCER CELL, V8, P275, DOI 10.1016/j.ccr.2005.09.007
   FEINBERG AP, 1988, CANCER RES, V48, P1159
   Akcakanat A, 2004, CANCER CHEMOTH PHARM, V54, P95, DOI 10.1007/s00280-004-0768-3
   Fruhwald MC, 2002, MOL GENET METAB, V75, P1, DOI 10.1006/mgme.2001.3265
   Nakagawa K, 2005, CLIN CANCER RES, V11, P5496, DOI 10.1158/1078-0432.CCR-05-0216
   Tsuda H, 2002, AM J PATHOL, V161, P859, DOI 10.1016/S0002-9440(10)64246-0
   Chen JM, 2005, HUM GENET, V117, P411, DOI 10.1007/s00439-005-1321-0
   Bacher CP, 2006, NAT CELL BIOL, V8, P293, DOI 10.1038/ncb1365
   Rodenhiser D, 2006, CAN MED ASSOC J, V174, P341, DOI 10.1503/cmaj.050774
   Li SF, 2003, GYNECOL ONCOL, V90, P123, DOI 10.1016/S0090-8258(03)00194-X
   Esteller M, 2002, J PATHOL, V196, P1, DOI 10.1002/path.1024
   Ehrlich M, 2002, ONCOGENE, V21, P6694, DOI 10.1038/sj.onc.1205890
   Deng GR, 2006, INT J CANCER, V118, P2999, DOI 10.1002/ijc.21740
   Maison C, 2002, NAT GENET, V30, P329, DOI 10.1038/ng843
   Nishigaki M, 2005, CANCER RES, V65, P2115, DOI 10.1158/0008-5472.CAN-04-3340
   Nakagawa T, 2005, J UROLOGY, V173, P1767, DOI 10.1097/01.ju.0000154632.11824.4d
   Morgan HD, 2005, HUM MOL GENET, V14, pR47, DOI 10.1093/hmg/ddi114
   Fazzari MJ, 2004, NAT REV GENET, V5, P446, DOI 10.1038/nrg1349
   Nishiyama R, 2005, CANCER BIOL THER, V4, P440
   Klose RJ, 2006, TRENDS BIOCHEM SCI, V31, P89, DOI 10.1016/j.tibs.2005.12.008
   Fraga MF, 2005, NAT GENET, V37, P391, DOI 10.1038/ng1531
   Bird A, 2002, GENE DEV, V16, P6, DOI 10.1101/gad.947102
   van Overveld PGM, 2005, ANN NEUROL, V58, P569, DOI 10.1002/ana.20625
   Jaenisch R, 2003, NAT GENET, V33, P245, DOI 10.1038/ng1089
   Liu HY, 2005, CANCER RES, V65, P7635, DOI 10.1158/0008-5472.CAN-05-1089
   Avner P, 2001, NAT REV GENET, V2, P59, DOI 10.1038/35047580
   Shen LL, 2005, J NATL CANCER I, V97, P1330, DOI 10.1093/jnci/dji275
   Peng DF, 2005, CANCER SCI, V96, P403, DOI 10.1111/j.1349-7006.2005.00071.x
   Fossa A, 2004, PROSTATE, V59, P440, DOI 10.1002/pros.20025
   Chedin F, 2002, P NATL ACAD SCI USA, V99, P16916, DOI 10.1073/pnas.262443999
   Yamada Y, 2005, P NATL ACAD SCI USA, V102, P13580, DOI 10.1073/pnas.0506612102
   Xie ZH, 2006, HUM MOL GENET, V15, P1375, DOI 10.1093/hmg/ddl059
   Frigola J, 2006, NAT GENET, V38, P540, DOI 10.1038/ng1781
   Reik W, 2001, SCIENCE, V293, P1089, DOI 10.1126/science.1063443
   Eden A, 2003, SCIENCE, V300, P455, DOI 10.1126/science.1083557
   Jones PA, 2002, NAT REV GENET, V3, P415, DOI 10.1038/nrg816
   Suter CM, 2004, INT J COLORECTAL DIS, V19, P95, DOI 10.1007/s00384-003-0539-3
   Ehrlich M, 2005, BIOCHEMISTRY-MOSCOW+, V70, P568, DOI 10.1007/s10541-005-0150-z
   Tycko B, 2000, J CLIN INVEST, V105, P245, DOI 10.1172/JCI9319
   Hackanson B, 2005, EXPERT OPIN THER TAR, V9, P45, DOI 10.1517/14728222.9.1.45
   Lewis A, 2006, CYTOGENET GENOME RES, V113, P81, DOI 10.1159/000090818
   Baylin SB, 2000, J NATL CANCER I, V92, P1460, DOI 10.1093/jnci/92.18.1460
   Neidhart M, 2000, ARTHRITIS RHEUM, V43, P2634, DOI 10.1002/1529-0131(200012)43:12<2634::AID-ANR3>3.0.CO;2-1
   Hoffmann MJ, 2005, BIOCHEM CELL BIOL, V83, P296, DOI 10.1139/005-036
   Matsuzaki K, 2005, CLIN CANCER RES, V11, P8564, DOI 10.1158/1708-0432.CCR-05-0859
   Bestor TH, 2000, HUM MOL GENET, V9, P2395, DOI 10.1093/hmg/9.16.2395
   Mahillon J, 1998, MICROBIOL MOL BIOL R, V62, P725
   Bannister AJ, 2005, NATURE, V436, P1103, DOI 10.1038/nature04048
   Agoston AT, 2005, J BIOL CHEM, V280, P18302, DOI 10.1074/jbc.M501675200
   Koturbash I, 2005, BIOCHEM BIOPH RES CO, V337, P526, DOI 10.1016/j.bbrc.2005.09.084
   Perron H, 1997, P NATL ACAD SCI USA, V94, P7583, DOI 10.1073/pnas.94.14.7583
   Kremenskoy M, 2003, BIOCHEM BIOPH RES CO, V311, P884, DOI 10.1016/j.bbrc.2003.10.078
   Hata K, 2002, DEVELOPMENT, V129, P1983
   Lin CH, 2001, CANCER RES, V61, P4238
   Kim M, 2004, NUCLEIC ACIDS RES, V32, P5742, DOI 10.1093/nar/gkh912
   Florl AR, 1999, BRIT J CANCER, V80, P1312, DOI 10.1038/sj.bjc.6690524
   Kanai Y, 2001, INT J CANCER, V91, P205, DOI 10.1002/1097-0215(200002)9999:9999<::AID-IJC1040>3.0.CO;2-2
   Rentzsch C, 2003, CLIN CANCER RES, V9, P4376
   Robertson HM, 1997, GENE, V205, P219, DOI 10.1016/S0378-1119(97)00471-X
   Okano M, 1999, CELL, V99, P247, DOI 10.1016/S0092-8674(00)81656-6
   Etoh T, 2004, AM J PATHOL, V164, P689, DOI 10.1016/S0002-9440(10)63156-2
   Widschwendter M, 2004, CANCER RES, V64, P4472, DOI 10.1158/0008-5472.CAN-04-0238
   Santos F, 2002, DEV BIOL, V241, P172, DOI 10.1006/dbio.2001.0501
   Ulaner GA, 2003, HUM MOL GENET, V12, P535, DOI 10.1093/hmg/ddg034
   Weber M, 2005, NAT GENET, V37, P853, DOI 10.1038/ng1598
   Sims JK, 2006, J BIOL CHEM, V281, P12760, DOI 10.1074/jbc.M513462200
   Tufarelli C, 2003, NAT GENET, V34, P157, DOI 10.1038/ng1157
   Fujisawa K, 2005, LAB INVEST, V85, P214, DOI 10.1038/labinvest.3700214
   Frigola J, 2005, HUM MOL GENET, V14, P319, DOI 10.1093/hmg/ddi028
   Cloos PAC, 2006, NATURE, V442, P307, DOI 10.1038/nature04837
   Gu ZL, 2000, GENE, V259, P81, DOI 10.1016/S0378-1119(00)00434-0
   Ehrlich M, 2006, ONCOGENE, V25, P2636, DOI 10.1038/sj.onc.1209145
   Santini V, 2001, ANN INTERN MED, V134, P573
   Ehrlich M, 2003, CLIN IMMUNOL, V109, P17, DOI 10.1016/S1521-6616(03)00201-8
   Chalitchagorn K, 2004, ONCOGENE, V23, P8841, DOI 10.1038/sj.onc.1208137
   Oshimo Y, 2003, INT J ONCOL, V23, P1663
   Yoon BJ, 2002, NAT GENET, V30, P92, DOI 10.1038/ng795
   Tamura G, 2006, WORLD J GASTROENTERO, V12, P192
   Gilbert N, 2005, MOL CELL BIOL, V25, P7780, DOI 10.1128/MCB.25.17.7780-7795.2005
   Feltus FA, 2003, P NATL ACAD SCI USA, V100, P12253, DOI 10.1073/pnas.2037852100
   Couillard J, 2006, BIOCHEM BIOPH RES CO, V342, P1233, DOI 10.1016/j.bbrc.2006.02.068
   Paredes J, 2005, CLIN CANCER RES, V11, P5869, DOI 10.1158/1078-0432.CCR-05-0059
   Nichol K, 2002, GENOME RES, V12, P1246, DOI 10.1101/gr.74502
   Chen ZX, 2005, J CELL BIOCHEM, V95, P902, DOI 10.1002/jcb.20447
   Malik K, 2000, BRIT J CANCER, V83, P1583, DOI 10.1054/bjoc.2000.1549
   Chen JM, 2005, HUM MUTAT, V25, P207, DOI 10.1002/humu.20133
   Burdo TH, 2004, DNA CELL BIOL, V23, P261, DOI 10.1089/104454904773819842
   Costa FF, 2005, GENE, V357, P83, DOI 10.1016/j.gene.2005.06.019
   Martienssen RA, 2005, TRENDS GENET, V21, P450, DOI 10.1016/j.tig.2005.06.005
   Cui HM, 2003, SCIENCE, V299, P1753, DOI 10.1126/science.1080902
   Jeffery L, 2004, J BIOL CHEM, V279, P49479, DOI 10.1074/jbc.M409070200
   Tryndyak VP, 2006, CANCER BIOL THER, V5, P65
   Ehrlich M, 2003, CANCER GENET CYTOGEN, V141, P97, DOI 10.1016/S0165-4608(02)00668-4
   FEINBERG AP, 1983, NATURE, V301, P89, DOI 10.1038/301089a0
   Karlsson H, 2001, P NATL ACAD SCI USA, V98, P4634, DOI 10.1073/pnas.061021998
   Galm O, 2006, BLOOD REV, V20, P1, DOI 10.1016/j.blre.2005.01.006
   Sandovici I, 2005, HUM MOL GENET, V14, P2135, DOI 10.1093/hmg/ddi218
   Wong N, 2001, AM J PATHOL, V159, P465, DOI 10.1016/S0002-9440(10)61718-X
   Tuck-Muller CM, 2000, CYTOGENET CELL GENET, V89, P121, DOI 10.1159/000015590
   Sato N, 2004, ONCOGENE, V23, P1531, DOI 10.1038/sj.onc.1207269
   Feinberg AP, 2006, NAT REV GENET, V7, P21, DOI 10.1038/nrg1748
   Delaval K, 2006, BIOESSAYS, V28, P453, DOI 10.1002/bies.20407
   Bernstein E, 2005, GENE DEV, V19, P1635, DOI 10.1101/gad.1324305
   Kondo Y, 2004, CANCER METAST REV, V23, P29, DOI 10.1023/A:1025806911782
   Nakagawa T, 2005, J UROLOGY, V173, P243, DOI 10.1097/01.ju.0000141577.98902.49
   Feinberg AP, 2004, NAT REV CANCER, V4, P143, DOI 10.1038/nrc1279
   Vilain A, 2000, CYTOGENET CELL GENET, V90, P93, DOI 10.1159/000015641
   Aoyama T, 2004, J BIOL CHEM, V279, P28789, DOI 10.1074/jbc.M401273200
   Baylin Stephen B, 2005, Nat Clin Pract Oncol, V2 Suppl 1, pS4, DOI 10.1038/ncponc0354
   Belgnaoui SM, 2006, CANCER CELL INT, V6, DOI 10.1186/1475-2867-6-13
   BESTOR TH, 1994, CURR OPIN CELL BIOL, V6, P380, DOI 10.1016/0955-0674(94)90030-2
   Bettstetter M, 2005, J PATHOL, V205, P606, DOI 10.1002/path.1732
   Casau AE, 1999, J VIROL, V73, P9976
   Costa FF, 2006, CANCER GENET CYTOGEN, V165, P135, DOI 10.1016/j.cancergencyto.2005.07.023
   DE SC, 1996, P NATL ACAD SCI USA, V93, P7149
   Dean Wendy, 2005, Birth Defects Res C Embryo Today, V75, P98, DOI 10.1002/bdrc.20037
   de Vos D, 2005, SEMIN ONCOL, V32, P437, DOI 10.1053/j.seminoncol.2005.07.025
   EHRLICH M, 1982, NUCLEIC ACIDS RES, V10, P2709, DOI 10.1093/nar/10.8.2709
   El-Osta A, 2003, BIOESSAYS, V25, P1071, DOI 10.1002/bies.10345
   Feinberg AP, 2005, CANCER CELL, V8, P267, DOI 10.1016/j.ccr.2005.09.014
   Fremont M, 1997, NUCLEIC ACIDS RES, V25, P2375, DOI 10.1093/nar/25.12.2375
   Itano O, 2002, ONCOGENE, V21, P789, DOI 10.1038/sj.onc.1205124
   Gaudet F, 2003, SCIENCE, V300, P489, DOI 10.1126/science.1083558
   James SJ, 2003, J NUTR, V133, p3740S
   JAMES SR, 2006, ONCOGENE
   Kaneda A, 2004, CANCER SCI, V95, P58, DOI 10.1111/j.1349-7006.2004.tb03171.x
   Kim TH, 2004, MOL CELLS, V18, P87
   Kubicek S, 2006, Ernst Schering Res Found Workshop, P1
   Lee JM, 2000, AIDS RES HUM RETROV, V16, P2055, DOI 10.1089/088922200750054792
   Ma YH, 2005, J CELL SCI, V118, P1607, DOI 10.1242/jcs.02291
   Mak J, 2005, RETROVIROLOGY, V2, DOI 10.1186/1742-4690-2-35
   Menendez L, 2004, MOL CANCER, V3, DOI 10.1186/1476-4598-3-12
   NEUHAUSEN A, 2006, CANC BIOL THER, V5
   Patzke S, 2002, VIROLOGY, V303, P164, DOI 10.1006/viro.2002.1615
   Pini JT, 2004, ONCOL RES, V14, P399
   Piotrowski A, 2006, GENE CHROMOSOME CANC, V45, P656, DOI 10.1002/gcc.20331
   Raptis Stavroula, 2006, EXS, P303
   Richardson BC, 2002, J NUTR, V132, p2401S
   Royo H, 2006, CYTOGENET GENOME RES, V113, P99, DOI 10.1159/000090820
   Salem AH, 2003, J MOL BIOL, V326, P1127, DOI 10.1016/S0022-2836(03)00032-9
   Samani NJ, 1996, J AM COLL CARDIOL, V28, P338, DOI 10.1016/0735-1097(96)00139-8
   Scanlan Matthew J, 2004, Cancer Immun, V4, P1
   Schofield PN, 2001, TOXICOL LETT, V120, P151, DOI 10.1016/S0378-4274(01)00294-6
   Steinhoff C., 2003, MGG Molecular Genetics and Genomics, V270, P394
   Strichman-Almashanu LZ, 2002, GENOME RES, V12, P543, DOI 10.1101/gr.224102
   Tammela Jonathan, 2004, Cancer Immun, V4, P10
   Teugels Erik, 2005, Hum Mutat, V26, P284, DOI 10.1002/humu.9366
   Wang XY, 1997, CYTOKINES CELL MOL T, V3, P3
   Wang Yu, 2004, Cancer Immun, V4, P11
   Wohrle D, 2001, AM J HUM GENET, V69, P504, DOI 10.1086/322739
NR 207
TC 373
Z9 404
U1 9
U2 47
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0304-419X
J9 BBA-REV CANCER
JI Biochim. Biophys. Acta-Rev. Cancer
PD JAN
PY 2007
VL 1775
IS 1
BP 138
EP 162
DI 10.1016/j.bbcan.2006.08.007
PG 25
WC Biochemistry & Molecular Biology; Biophysics; Oncology
SC Biochemistry & Molecular Biology; Biophysics; Oncology
GA 123TD
UT WOS:000243317700008
PM 17045745
ER

PT J
AU Vovk, U
   Pernus, F
   Likar, B
AF Vovk, Uros
   Pernus, Franjo
   Likar, Bostjan
TI A review of methods for correction of intensity inhomogeneity in MRI
SO IEEE TRANSACTIONS ON MEDICAL IMAGING
LA English
DT Review
DE bias field; intensity inhomogeneity; intensity nonuniformity; magnetic
   resonance images (MRI); segmentation; shading
ID MAGNETIC-RESONANCE IMAGES; BIAS FIELD CORRECTION; MULTIPLE-SCLEROSIS
   LESIONS; C-MEANS ALGORITHM; AUTOMATIC CORRECTION; NONUNIFORMITY
   CORRECTION; TISSUE CLASSIFICATION; RADIOFREQUENCY INHOMOGENEITY;
   RETROSPECTIVE CORRECTION; RF COILS
AB Medical image acquisition devices provide a vast amount of anatomical and functional information, which facilitate and improve diagnosis and patient treatment, especially when supported by modern quantitative image analysis methods. However, modality specific image artifacts, such as the phenomena of intensity inhomogeneity in magnetic resonance images (MRI), are still prominent and can adversely affect quantitative image analysis. In this paper, numerous methods that have been developed to reduce or eliminate intensity inhomogeneities in MRI are reviewed. First, the methods are classified according to the inhomogeneity correction strategy. Next, different qualitative and quantitative evaluation approaches are reviewed. Third, 60 relevant publications are categorized according to several features and analyzed so as to reveal major trends, popularity, evaluation strategies and applications. Finally, key evaluation issues and future development of the inhomogeneity correction field, supported by the results of the analysis, are discussed.
C1 Univ Ljubljana, Fac Elect Engn, Ljubljana 1000, Slovenia.
RP Likar, B (reprint author), Univ Ljubljana, Fac Elect Engn, Trzaska 25, Ljubljana 1000, Slovenia.
EM bostjan.likar@fe.uni-lj.si
CR AHMED MN, 1999, IEEE INT C COMP VIS
   Ibrahim TS, 2005, IEEE T BIO-MED ENG, V52, P1278, DOI 10.1109/TBME.2005.847564
   Likar B, 2001, IEEE T MED IMAGING, V20, P1398, DOI 10.1109/42.974934
   Luo JH, 2005, IEEE T MED IMAGING, V24, P1067, DOI 10.1109/TMI.2005.852066
   Gispert JD, 2004, HUM BRAIN MAPP, V22, P133, DOI 10.1002/hbm.20013
   Collewet G, 2002, MAGN RESON IMAGING, V20, P365, DOI 10.1016/S0730-725X(02)00502-7
   Zhang YY, 2001, IEEE T MED IMAGING, V20, P45, DOI 10.1109/42.906424
   Vokurka EA, 1999, JMRI-J MAGN RESON IM, V10, P550, DOI 10.1002/(SICI)1522-2586(199910)10:4<550::AID-JMRI8>3.0.CO;2-Q
   MCVEIGH ER, 1986, MED PHYS, V13, P806, DOI 10.1118/1.595967
   BEZDEK JC, 1993, MED PHYS, V20, P1033, DOI 10.1118/1.597000
   Ibrahim TS, 2005, MAGNET RESON MED, V54, P683, DOI 10.1002/mrm.20596
   Vovk U, 2006, NEUROIMAGE, V32, P54, DOI 10.1016/j.neuroimage.2006.03.020
   TINCHER M, 1993, IEEE T MED IMAGING, V12, P361, DOI 10.1109/42.232267
   Rajapakse JC, 1998, IMAGE VISION COMPUT, V16, P165, DOI 10.1016/S0262-8856(97)00067-X
   Van Leemput K, 2001, IEEE T MED IMAGING, V20, P677, DOI 10.1109/42.938237
   Keiper MD, 1998, AM J NEURORADIOL, V19, P1489
   Belaroussi B, 2006, MED IMAGE ANAL, V10, P234, DOI 10.1016/j.media.2005.09.004
   MEYER CR, 1995, IEEE T MED IMAGING, V14, P1, DOI 10.1109/42.370397
   Vokurka EA, 2001, J MAGN RESON IMAGING, V14, P540, DOI 10.1002/jmri.1217
   Rajapakse JC, 1997, IEEE T MED IMAGING, V16, P176, DOI 10.1109/42.563663
   Tomazevic D, 2002, J MICROSC-OXFORD, V208, P212, DOI 10.1046/j.1365-2818.2002.01079.x
   NARAYANA PA, 1988, MAGN RESON IMAGING, V6, P271, DOI 10.1016/0730-725X(88)90401-8
   Ashburner J, 2005, NEUROIMAGE, V26, P839, DOI 10.1016/j.neuroimage.2005.02.018
   Pruessmann KP, 1999, MAGNET RESON MED, V42, P952, DOI 10.1002/(SICI)1522-2594(199911)42:5<952::AID-MRM16>3.0.CO;2-S
   Wells WM, 1996, IEEE T MED IMAGING, V15, P429, DOI 10.1109/42.511747
   Li X, 2005, MED PHYS, V32, P2337, DOI 10.1118/1.1944912
   Fischl B, 2004, NEUROIMAGE, V23, pS69, DOI 10.1016/j.neuroimage.2004.07.016
   Chiou JY, 2003, IEEE T MED IMAGING, V22, P200, DOI 10.1109/TMI.2002.808362
   BREY WW, 1988, MED PHYS, V15, P241, DOI 10.1118/1.596255
   Pham DL, 1999, PATTERN RECOGN LETT, V20, P57, DOI 10.1016/S0167-8655(98)00121-4
   Liew AWC, 2003, IEEE T MED IMAGING, V22, P1063, DOI 10.1109/TMI.2003.816956
   Lai SH, 2003, MAGN RESON IMAGING, V21, P121, DOI 10.1016/S0730-725X(02)00637-9
   AXEL L, 1987, AM J ROENTGENOL, V148, P418
   Arnold JB, 2001, NEUROIMAGE, V13, P931, DOI 10.1006/nimg.2001.0756
   Johnston B, 1996, IEEE T MED IMAGING, V15, P154, DOI 10.1109/42.491417
   Milles J, 2004, P SOC PHOTO-OPT INS, V5370, P734, DOI 10.1117/12.532325
   DAWANT BM, 1993, IEEE T MED IMAGING, V12, P770, DOI 10.1109/42.251128
   Sijbers J, 1998, IEEE T MED IMAGING, V17, P357, DOI 10.1109/42.712125
   Ahmed MN, 2002, IEEE T MED IMAGING, V21, P193, DOI 10.1109/42.996338
   Van Leemput K, 1999, IEEE T MED IMAGING, V18, P897, DOI 10.1109/42.811270
   Van Leemput K, 1999, IEEE T MED IMAGING, V18, P885, DOI 10.1109/42.811268
   Styner M, 2000, IEEE T MED IMAGING, V19, P153, DOI 10.1109/42.845174
   Guillemaud R, 1997, IEEE T MED IMAGING, V16, P238, DOI 10.1109/42.585758
   Collins DL, 1998, IEEE T MED IMAGING, V17, P463, DOI 10.1109/42.712135
   Sled JG, 1998, IEEE T MED IMAGING, V17, P653, DOI 10.1109/42.730409
   Velthuizen RP, 1998, MED PHYS, V25, P1655, DOI 10.1118/1.598357
   Zhou LQ, 2001, COMPUT MED IMAG GRAP, V25, P379, DOI 10.1016/S0895-6111(01)00006-4
   Pham DL, 1999, IEEE T MED IMAGING, V18, P737, DOI 10.1109/42.802752
   Vovk U, 2004, PHYS MED BIOL, V49, P4119, DOI 10.1088/0031-9155/49/17/020
   Brinkmann BH, 1998, IEEE T MED IMAGING, V17, P161, DOI 10.1109/42.700729
   Sled JG, 1998, IEEE T MED IMAGING, V17, P87, DOI 10.1109/42.668698
   Shattuck DW, 2001, NEUROIMAGE, V13, P856, DOI 10.1006/nimg.2000.0730
   Lewis EB, 2004, NEUROIMAGE, V23, P75, DOI 10.1016/j.neuroimage.2004.04.030
   Alecci M, 2001, MAGNET RESON MED, V46, P379, DOI 10.1002/mrm.1201
   Studholme C, 2004, IEEE T MED IMAGING, V23, P99, DOI 10.1109/TMI.2003.820029
   CONDON BR, 1987, BRIT J RADIOL, V60, P83
   Andersen AH, 2002, J NEUROSCI METH, V122, P13, DOI 10.1016/S0165-0270(02)00273-X
   Cohen MS, 2000, HUM BRAIN MAPP, V10, P204, DOI 10.1002/1097-0193(200008)10:4<204::AID-HBM60>3.0.CO;2-2
   Likar B, 2000, J MICROSC-OXFORD, V197, P285
   Mihara H, 1998, MAGN RESON MATER PHY, V7, P115
   Ashburner J, 2000, NEUROIMAGE, V11, P805, DOI 10.1006/nimg.2000.0582
   BANSAL R, 2004, MED IM COMP COMP ASS
   Benoit-Cattin H, 2005, J MAGN RESON, V173, P97, DOI 10.1016/j.jmr.2004.09.027
   Brechbuhler C., 1996, P 4 INT C VIS BIOM C, P141, DOI [10.1007/BFb0046948, DOI 10.1007/BFB0046948]
   Chen ZG, 2004, MAGN RESON IMAGING, V22, P835, DOI 10.1016/j.mri.2004.01.062
   Cocosco C. A., 1997, NEUROIMAGE, V5, P425
   Derganc J, 2002, P SOC PHOTO-OPT INS, V4684, P391, DOI 10.1117/12.467181
   Fan Ayres, 2003, Inf Process Med Imaging, V18, P148
   Lai S H, 1999, Med Image Anal, V3, P409, DOI 10.1016/S1361-8415(99)80033-4
   GERIG G, 2003, 6 INT C MED IM COMP
   GISPERT JD, 2003, 2003 INT C IM PROC I
   HASELGROVE J, 1986, Magnetic Resonance Imaging, V4, P469, DOI 10.1016/0730-725X(86)90024-X
   Hernandez J. A., 2004, 5 INT S BIOL MED DAT
   JAIN RC, 1991, CVGIP-IMAG UNDERSTAN, V53, P112, DOI 10.1016/1049-9660(91)90009-E
   KIM S, 2003, APRS WORKSH DIG IM C
   Koivula A, 1997, MAGN RESON IMAGING, V15, P1167, DOI 10.1016/S0730-725X(97)00177-X
   LEARNEDMILLER EG, 2004, NEUR INF PROC SYST C
   Liang Z. P., 1999, PRINCIPLES MAGNETIC
   LIKAR B, 2000, 3 INT C MED IM COMP
   Likar B, 2002, P SOC PHOTO-OPT INS, V4684, P1531, DOI 10.1117/12.467120
   MANGIN JF, 2000, IEEE WORKSH MATH MET
   Montillo A, 2003, P SOC PHOTO-OPT INS, V5032, P1025, DOI 10.1117/12.483555
   NARAYANA PA, 1995, MAGNET RESON MED, V33, P396, DOI 10.1002/mrm.1910330312
   Prima S., 2001, P MED IM COMP COMP A, V2208, P811
   Russ J. C., 1995, IMAGE PROCESSING HDB
   SIMMONS A, 1994, MAGNET RESON MED, V32, P121, DOI 10.1002/mrm.1910320117
   SOLANAS E, 2001, 4 INT MED IM COMP CO
   Thomas DL, 2005, MAGN RESON MED, V53, P1452, DOI 10.1002/mrm.20482
   Uematsu H, 2003, EUR J RADIOL, V47, P161, DOI 10.1016/S0720-048X(02)00195-X
   Vemuri P., 2005, INF PROC MED IM 19 I
   Viola P., 1995, THESIS MIT CAMBRIDGE
   WICKS DAG, 1993, MAGN RESON IMAGING, V11, P183, DOI 10.1016/0730-725X(93)90023-7
   YAN MXH, 1995, P INF PROC MED IM IP, V20, P12
   Zhu CZ, 2003, NEUROIMAGE, V18, P685, DOI 10.1016/S1053-8119(03)00006-5
   ZHUGE Y, 2002, P SPIE MED IM 2002 I, V4686, P1103
NR 95
TC 282
Z9 318
U1 7
U2 44
PU IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC
PI PISCATAWAY
PA 445 HOES LANE, PISCATAWAY, NJ 08855 USA
SN 0278-0062
J9 IEEE T MED IMAGING
JI IEEE Trans. Med. Imaging
PD MAR
PY 2007
VL 26
IS 3
BP 405
EP 421
DI 10.1109/TMI.2006.891486
PG 17
WC Computer Science, Interdisciplinary Applications; Engineering,
   Biomedical; Engineering, Electrical & Electronic; Imaging Science &
   Photographic Technology; Radiology, Nuclear Medicine & Medical Imaging
SC Computer Science; Engineering; Imaging Science & Photographic
   Technology; Radiology, Nuclear Medicine & Medical Imaging
GA 143MM
UT WOS:000244726300012
PM 17354645
ER

PT J
AU Van Leemput, K
   Maes, F
   Vandermeulen, D
   Colchester, A
   Suetens, P
AF Van Leemput, K
   Maes, F
   Vandermeulen, D
   Colchester, A
   Suetens, P
TI Automated segmentation of multiple sclerosis lesions by model outlier
   detection
SO IEEE TRANSACTIONS ON MEDICAL IMAGING
LA English
DT Article
DE digital brain atlas; MRI; multiple sclerosis; tissue classification
ID MAGNETIC-RESONANCE IMAGES; QUANTITATIVE FOLLOW-UP; MR-IMAGES; ADAPTIVE
   SEGMENTATION; BIAS FIELD; BRAIN; QUANTIFICATION; INFORMATION;
   VALIDATION; ALGORITHM
AB This paper presents a fully automated algorithm for segmentation of multiple sclerosis (MS) lesions from multispectral magnetic resonance (MR) images. The method performs intensity-based tissue classification using a stochastic model for normal brain images and simultaneously detects MS lesions as outliers that are not well explained by the model. It corrects for MR field inhomogeneities, estimates tissue-specific intensity models from the data itself, and incorporates contextual information in the classification using a Markov random field. The results of the automated method are compared with lesion delineations by human experts, showing a high total lesion load correlation. When the degree of spatial correspondence between segmentations is taken into account, considerable disagreement is found, both between expert segmentations, and between expert and automatic measurements.
C1 Univ Hosp Gasthuisberg, Fac Med, Radiol ESAT PSI, Med Image Comp, B-3000 Louvain, Belgium.
   Univ Hosp Gasthuisberg, Fac Engn, Radiol ESAT PSI, B-3000 Louvain, Belgium.
   Univ Kent, Elect Engn Lab, Neurosci Med Image Anal Grp, Canterbury CT2 7NT, Kent, England.
RP Van Leemput, K (reprint author), Univ Hosp Gasthuisberg, Fac Med, Radiol ESAT PSI, Med Image Comp, Herestr 49, B-3000 Louvain, Belgium.
RI Van Leemput, Koen/A-9197-2009; Maes, Frederik/I-7572-2013
OI Van Leemput, Koen/0000-0001-6466-5309; Maes,
   Frederik/0000-0003-0027-1479
CR Ising E, 1925, Z PHYS, V31, P253, DOI 10.1007/BF02980577
   Maes F, 1997, IEEE T MED IMAGING, V16, P187, DOI 10.1109/42.563664
   Guttmann CRG, 1999, JMRI-J MAGN RESON IM, V9, P509, DOI 10.1002/(SICI)1522-2586(199904)9:4<509::AID-JMRI2>3.0.CO;2-S
   Udupa JK, 1997, IEEE T MED IMAGING, V16, P598, DOI 10.1109/42.640750
   Kikinis R, 1999, J MAGN RESON IMAGING, V9, P519
   KAMBER M, 1995, IEEE T MED IMAGING, V14, P442, DOI 10.1109/42.414608
   KURTZKE JF, 1983, NEUROLOGY, V33, P1444
   DEMPSTER AP, 1977, J ROY STAT SOC B MET, V39, P1
   DICE LR, 1945, ECOLOGY, V26, P297, DOI 10.2307/1932409
   Zijdenbos A, 1998, LECT NOTES COMPUT SC, V1496, P439
   Dave RN, 1997, IEEE T FUZZY SYST, V5, P270, DOI 10.1109/91.580801
   Thirion JP, 1996, PROC CVPR IEEE, P245, DOI 10.1109/CVPR.1996.517081
   Wells WM, 1996, IEEE T MED IMAGING, V15, P429, DOI 10.1109/42.511747
   PATY DW, 1993, NEUROLOGY, V43, P662
   [Anonymous], MATL
   Schroeter P, 1998, IEEE T MED IMAGING, V17, P172, DOI 10.1109/42.700730
   Johnston B, 1996, IEEE T MED IMAGING, V15, P154, DOI 10.1109/42.491417
   Van Leemput K, 1999, IEEE T MED IMAGING, V18, P897, DOI 10.1109/42.811270
   Van Leemput K, 1999, IEEE T MED IMAGING, V18, P885, DOI 10.1109/42.811268
   Guillemaud R, 1997, IEEE T MED IMAGING, V16, P238, DOI 10.1109/42.585758
   Wilson DL, 1999, IEEE T MED IMAGING, V18, P938, DOI 10.1109/42.811277
   Zhuang XH, 1996, IEEE T IMAGE PROCESS, V5, P1293, DOI 10.1109/83.535841
   Ashburner J., STAT PARAMETRIC MAPP
   Bello F, 1998, LECT NOTES COMPUT SC, V1496, P964
   *BIOMORPH, 1996, EUBIOMED2 BIOMORPH
   Chung ACS, 1999, LECT NOTES COMPUT SC, V1679, P82
   Evans A. C., 1993, P IEEE NUCL SCI S ME, P1813
   Evans AC, 1997, ANN NEUROL, V41, P125, DOI 10.1002/ana.410410123
   Filippi M, 1995, BRAIN, V118, P1601, DOI 10.1093/brain/118.6.1601
   Gerig G, 1998, LECT NOTES COMPUT SC, V1496, P469
   Hoaglin D. C., 1983, WILEY SERIES PROBABI
   Huber P.J., 1981, WILEY SERIES PROBABI
   JOHNSTON B, 1994, P SOC PHOTO-OPT INS, V2167, P28, DOI 10.1117/12.175075
   Mclachlan G. J., 1998, LECT NOTES COMPUTER, P658
   METCALF D, 1992, P 14 ANN INT C IEEE, V3, P945
   Rey D, 1999, LECT NOTES COMPUT SC, V1613, P154
   Thirion JP, 1999, IEEE T MED IMAGING, V18, P429, DOI 10.1109/42.774170
   Warfield S, 1995, J Image Guid Surg, V1, P326, DOI 10.1002/(SICI)1522-712X(1995)1:6<326::AID-IGS4>3.0.CO;2-C
   Zijdenbos A, 1996, LECT NOTES COMPUT SC, V1131, P439
   ZIJDENBOS AP, 1994, IEEE T MED IMAGING, V13, P716, DOI 10.1109/42.363096
NR 40
TC 255
Z9 255
U1 4
U2 15
PU IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC
PI NEW YORK
PA 345 E 47TH ST, NEW YORK, NY 10017-2394 USA
SN 0278-0062
J9 IEEE T MED IMAGING
JI IEEE Trans. Med. Imaging
PD AUG
PY 2001
VL 20
IS 8
BP 677
EP 688
DI 10.1109/42.938237
PG 12
WC Computer Science, Interdisciplinary Applications; Engineering,
   Biomedical; Engineering, Electrical & Electronic; Imaging Science &
   Photographic Technology; Radiology, Nuclear Medicine & Medical Imaging
SC Computer Science; Engineering; Imaging Science & Photographic
   Technology; Radiology, Nuclear Medicine & Medical Imaging
GA 460QM
UT WOS:000170320100001
PM 11513020
ER

PT J
AU Horsfield, MA
   Jones, DK
AF Horsfield, MA
   Jones, DK
TI Applications of diffusion-weighted and diffusion tensor MRI to white
   matter diseases - a review
SO NMR IN BIOMEDICINE
LA English
DT Review
DE diffusion; tensor; MRI; DTI; white matter; disease
ID PROGRESSIVE MULTIPLE-SCLEROSIS; CREUTZFELDT-JAKOB-DISEASE;
   MAGNETIC-RESONANCE; ALZHEIMERS-DISEASE; WATER DIFFUSION;
   CORPUS-CALLOSUM; HUMAN BRAIN; LESIONS; DAMAGE; ANISOTROPY
AB This paper reviews the current applications of diffusion-weighted and diffusion tensor MRI in diseases of the brain white matter. The contribution that diffusion-weighted imaging has made to our understanding of white matter diseases is critically appraised. The quantitative nature of diffusion MRI is one of its major attractions; however, this is offset by the more advanced hardware required to collect diffusion-weighted images reliably, and the more complex processing to produce quantitative parametric diffusion images. With the now common availability of scanners equipped to perform echo-planar imaging, the acquisition of diffusion tensor images is sure to become more widespread and routine. Copyright (C) 2002 John Wiley Sons, Ltd.
C1 Univ Leicester, Leicester Royal Infirm, Dept Med Phys, Leicester LE1 5WW, Leics, England.
   Inst Psychiat, Old Age Psychiat Sect, London SE5 8AF, England.
RP Horsfield, MA (reprint author), Univ Leicester, Leicester Royal Infirm, Dept Med Phys, Leicester LE1 5WW, Leics, England.
RI Jones, Derek/D-1460-2009; Horsfield, Mark/C-6569-2013; 
OI Horsfield, Mark/0000-0002-0815-6697; Jones, Derek/0000-0003-4409-8049
CR Filippi M, 2000, ARCH NEUROL-CHICAGO, V57, P1017, DOI 10.1001/archneur.57.7.1017
   Nusbaum AO, 2000, AM J ROENTGENOL, V175, P821
   Pierpaoli C, 2001, NEUROIMAGE, V13, P1174, DOI 10.1006/nimg.2001.0765
   Rocca MA, 2000, NEUROLOGY, V55, P882
   Hanyu H, 1998, J NEUROL SCI, V156, P195, DOI 10.1016/S0022-510X(98)00043-4
   LEBIHAN D, 1986, RADIOLOGY, V161, P401
   Rose SE, 2000, J NEUROL NEUROSUR PS, V69, P528, DOI 10.1136/jnnp.69.4.528
   Filippi CG, 2001, AM J NEURORADIOL, V22, P277
   Guo AC, 2001, RADIOLOGY, V218, P809
   BRUN A, 1986, ANN NEUROL, V19, P253, DOI 10.1002/ana.410190306
   Chabriat H, 1999, STROKE, V30, P2637
   Pierpaoli C, 1996, MAGNET RESON MED, V36, P893, DOI 10.1002/mrm.1910360612
   Werring DJ, 1999, NEUROLOGY, V52, P1626
   Mori S, 1999, ANN NEUROL, V45, P265, DOI 10.1002/1531-8249(199902)45:2<265::AID-ANA21>3.0.CO;2-3
   HENKELMAN RM, 1994, MAGNET RESON MED, V32, P592, DOI 10.1002/mrm.1910320508
   Werring DJ, 2000, BRAIN, V123, P1667, DOI 10.1093/brain/123.8.1667
   CHRISTIANSEN P, 1993, ACTA NEUROL SCAND, V87, P195
   Bahn MM, 1999, ARCH NEUROL-CHICAGO, V56, P577, DOI 10.1001/archneur.56.5.577
   HACHINSKI VC, 1987, ARCH NEUROL-CHICAGO, V44, P21
   HILLEL AD, 1989, NEUROEPIDEMIOLOGY, V8, P142, DOI 10.1159/000110176
   Cercignani M, 2000, NEUROLOGY, V54, P1139
   Hanyu H, 1999, J NEUROL SCI, V167, P37, DOI 10.1016/S0022-510X(99)00135-5
   Jones DK, 1999, STROKE, V30, P393
   Horsfield MA, 1996, MAGN RESON MED, V36, P393, DOI 10.1002/mrm.1910360310
   Hampel H, 1998, ARCH NEUROL-CHICAGO, V55, P193, DOI 10.1001/archneur.55.2.193
   Pomara N, 2001, PSYCHIAT RES-NEUROIM, V106, P15, DOI 10.1016/S0925-4927(00)00082-2
   Conturo TE, 1999, P NATL ACAD SCI USA, V96, P10422, DOI 10.1073/pnas.96.18.10422
   LARSSON HBW, 1992, MAGN RESON IMAGING, V10, P7, DOI 10.1016/0730-725X(92)90367-9
   Ellis CM, 1999, NEUROLOGY, V53, P1051
   Bammer R, 2000, MAGNET RESON MED, V44, P583, DOI 10.1002/1522-2594(200010)44:4<583::AID-MRM12>3.0.CO;2-O
   Pantoni L, 1997, STROKE, V28, P652
   Pierpaoli C, 1996, RADIOLOGY, V201, P637
   BROWN MM, 1995, LACUNAR OTHER SUBCOR
   Scanderberg AC, 2000, AM J NEURORADIOL, V21, P862
   CHABRIAT H, 1999, STROKE, V30, pP62
   Droogan AG, 1999, MAGN RESON IMAGING, V17, P653, DOI 10.1016/S0730-725X(99)00011-9
   Ito R, 2001, NEUROLOGY, V56, P544
   Kropp S, 2000, NERVENARZT, V71, P91, DOI 10.1007/s001150070001
   Le Bihan D, 1991, Magn Reson Q, V7, P1
   MANKA C, 1999, RADIOLOGY P, V213, P1471
   Nusbaum AO, 2000, NEUROLOGY, V54, P1421
   SCHAUMBURG HH, 1975, ARCH NEUROL-CHICAGO, V32, P577
   Segawa F, 1994, No To Shinkei, V46, P835
   VONMEERWALL E, 1981, J CHEM PHYS, V74, P6956, DOI 10.1063/1.441059
   WU RH, 1998, P 6 ANN M INT SOC MA, P1249
NR 45
TC 231
Z9 237
U1 0
U2 16
PU JOHN WILEY & SONS LTD
PI W SUSSEX
PA BAFFINS LANE CHICHESTER, W SUSSEX PO19 1UD, ENGLAND
SN 0952-3480
J9 NMR BIOMED
JI NMR Biomed.
PD NOV-DEC
PY 2002
VL 15
IS 7-8
BP 570
EP 577
DI 10.1002/nbm.787
PG 8
WC Biophysics; Radiology, Nuclear Medicine & Medical Imaging; Spectroscopy
SC Biophysics; Radiology, Nuclear Medicine & Medical Imaging; Spectroscopy
GA 631KC
UT WOS:000180166100011
PM 12489103
ER

PT J
AU Weiss, N
   Miller, F
   Cazaubon, S
   Couraud, PO
AF Weiss, Nicolas
   Miller, Florence
   Cazaubon, Sylvie
   Couraud, Pierre-Olivier
TI The blood-brain barrier in brain homeostasis and neurological diseases
SO BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES
LA English
DT Review
DE Blood-brain barrier; Tight-junction; Neurological disease; Drug
   delivery; Brain endothelium
ID CENTRAL-NERVOUS-SYSTEM; EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS;
   EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS; INTERCELLULAR-ADHESION
   MOLECULE-1; MICROVASCULAR ENDOTHELIAL-CELLS; CEREBRAL-ARTERY OCCLUSION;
   NEURAL PRECURSOR CELLS; MATRIX METALLOPROTEINASES CONTRIBUTE;
   PLASMINOGEN-ACTIVATOR CROSSES; HUMAN GLIOBLASTOMA-MULTIFORME
AB Brain endothelial cells are unique among endothelial cells in that they express apical junctional complexes, including tight junctions, which quite resemble epithelial tight junctions both structurally and functionally. They form the blood-brain-barrier (BBB) which strictly controls the exchanges between the blood and the brain compartments by limiting passive diffusion of blood-borne solutes while actively transporting nutrients to the brain. Accumulating experimental and clinical evidence indicate that BBB dysfunctions are associated with a number of serious CNS diseases with important social impacts, such as multiple sclerosis, stroke, brain tumors, epilepsy or Alzheimer's disease. This review will focus on the implication of brain endothelial tight junctions in BBB architecture and physiology, will discuss the consequences of BBB dysfunction in these CNS diseases and will present some therapeutic strategies for drug delivery to the brain across the BBB. (C) 2008 Elsevier B.V. All rights reserved
C1 [Couraud, Pierre-Olivier] Univ Paris 05, INSERM, CNRS, UMR 8104,Inst Cochin,U567, F-75014 Paris, France.
RP Couraud, PO (reprint author), Univ Paris 05, INSERM, CNRS, UMR 8104,Inst Cochin,U567, 22 Rue Mechain, F-75014 Paris, France.
EM pierre-olivier.couraud@inserm.fr
CR ABRAHAMSON DR, 1986, J PATHOL, V149, P257, DOI 10.1002/path.1711490402
   Doulet N, 2006, J CELL BIOL, V173, P627, DOI 10.1083/jcb.200507128
   Chandler S, 1997, J NEUROIMMUNOL, V72, P155, DOI 10.1016/S0165-5728(96)00179-8
   Lopez-Atalaya JP, 2007, STROKE, V38, P1036, DOI 10.1161/01.STR.0000258100.04923.84
   Engelhardt B, 1997, BLOOD, V90, P4459
   Martel CL, 1996, NEUROSCI LETT, V206, P157, DOI 10.1016/S0304-3940(96)12462-9
   Biernacki K, 2005, ARCH NEUROL-CHICAGO, V62, P563, DOI 10.1001/archneur.62.4.563
   Taddei A, 2008, NAT CELL BIOL, V10, P923, DOI 10.1038/ncb1752
   Perriere N, 2007, BRAIN RES, V1150, P1, DOI 10.1016/j.brainres.2007.02.091
   Meairs S, 2007, PROG BIOPHYS MOL BIO, V93, P354, DOI 10.1016/j.pbiomolbio.2006.07.019
   Kuroda S, 1997, CLIN NEUROSCI, V4, P199
   Bo L, 1996, J NEUROPATH EXP NEUR, V55, P1060, DOI 10.1097/00005072-199655100-00006
   Nassif X, 2002, TRENDS MICROBIOL, V10, P227, DOI 10.1016/S0966-842X(02)02349-1
   Lipinski CA, 2001, ADV DRUG DELIVER REV, V46, P3, DOI 10.1016/S0169-409X(00)00129-0
   Gilbertson RJ, 2007, NAT REV CANCER, V7, P733, DOI 10.1038/nrc2246
   Weber C, 2007, NAT REV IMMUNOL, V7, P467, DOI 10.1038/nri2096
   Bannerman DD, 1999, LAB INVEST, V79, P1181
   Mazzini L, 2008, J NEUROL SCI, V265, P78, DOI 10.1016/j.jns.2007.05.016
   MEYER J, 1990, BRAIN RES, V514, P305, DOI 10.1016/0006-8993(90)91425-G
   Begley DJ, 2004, CURR PHARM DESIGN, V10, P1295, DOI 10.2174/1381612043384844
   Lindahl P, 1997, SCIENCE, V277, P242, DOI 10.1126/science.277.5323.242
   Belayev L, 1996, BRAIN RES, V739, P88, DOI 10.1016/S0006-8993(96)00815-3
   Hirase T, 2001, J BIOL CHEM, V276, P10423, DOI 10.1074/jbc.M007136200
   Stanness KA, 1999, NEUROREPORT, V10, P3725, DOI 10.1097/00001756-199912160-00001
   Loscher W, 2005, NAT REV NEUROSCI, V6, P591, DOI 10.1038/nrn1728
   Asahi M, 2001, J NEUROSCI, V21, P7724
   Yong VW, 2005, NAT REV NEUROSCI, V6, P931, DOI 10.1038/nrn1807
   Fabis MJ, 2007, P NATL ACAD SCI USA, V104, P5656, DOI 10.1073/pnas.0701252104
   Teifel M, 1996, EXP CELL RES, V228, P50, DOI 10.1006/excr.1996.0298
   Schreibelt G, 2007, FASEB J, V21, P3666, DOI 10.1096/fj.07-8329com
   Viegas P, 2006, J CELL SCI, V119, P4634, DOI 10.1242/jcs.03222
   Hawkins BT, 2005, PHARMACOL REV, V57, P173, DOI 10.1124/pr.57.2.4
   de Lange ECM, 2004, ADV DRUG DELIVER REV, V56, P1793, DOI 10.1016/j.addr.2004.07.009
   Paul R, 1998, ANN NEUROL, V44, P592, DOI 10.1002/ana.410440404
   Benchenane K, 2005, CIRCULATION, V111, P2241, DOI 10.1161/01.CIR.0000163542.48611.A2
   Petty MA, 2002, PROG NEUROBIOL, V68, P311, DOI 10.1016/S0301-0082(02)00128-4
   Lou JN, 1999, LAB INVEST, V79, P1015
   Zhang Y, 2001, J NEUROCHEM, V76, P1597, DOI 10.1046/j.1471-4159.2001.00222.x
   Pluchino S, 2003, NATURE, V422, P688, DOI 10.1038/nature01552
   Morgan L, 2007, NEUROSCIENCE, V147, P664, DOI 10.1016/j.neuroscience.2007.04.051
   Laschinger M, 2000, J NEUROIMMUNOL, V102, P32, DOI 10.1016/S0165-5728(99)00156-3
   MULDOON LL, 1995, AM J PATHOL, V147, P1840
   Furuse M, 1998, J CELL BIOL, V141, P1539, DOI 10.1083/jcb.141.7.1539
   Hori S, 2004, J NEUROCHEM, V89, P503, DOI 10.1111/j.1471-4159.2004.02343.x
   Persidsky Y, 2006, J NEUROIMMUNE PHARM, V1, P223, DOI 10.1007/s11481-006-9025-3
   Vitry S, 2001, MOL CELL NEUROSCI, V17, P983, DOI 10.1006/mcne.2001.0987
   Conant K, 1999, ANN NEUROL, V46, P391, DOI 10.1002/1531-8249(199909)46:3<391::AID-ANA15>3.0.CO;2-0
   Sagare A, 2007, NAT MED, V13, P1029, DOI 10.1038/nm1635
   Kebir H, 2007, NAT MED, V13, P1173, DOI 10.1038/nm1651
   Wielinga PR, 2003, J BIOL CHEM, V278, P17664, DOI 10.1074/jbc.M212723200
   del Zoppo GJ, 2003, J CEREBR BLOOD F MET, V23, P879, DOI 10.1097/01.WCB.0000078322.96027.78
   Wolburg H, 2005, ACTA NEUROPATHOL, V109, P181, DOI 10.1007/s00401-004-0928-x
   Asheuer M, 2004, P NATL ACAD SCI USA, V101, P3557, DOI 10.1073/pnas.0306431101
   Demeule M, 2002, J NEUROCHEM, V83, P924, DOI 10.1046/j.1471-4159.2002.01201.x
   Dejana E, 2006, NAT CELL BIOL, V8, P105, DOI 10.1038/ncb0206-105
   Desai BS, 2007, CELL TRANSPLANT, V16, P285
   Kinoshita M, 2006, P NATL ACAD SCI USA, V103, P11719, DOI 10.1073/pnas.0604318103
   ZHANG RL, 1994, NEUROLOGY, V44, P1747
   Kim KS, 2003, NAT REV NEUROSCI, V4, P376, DOI 10.1038/nrn1103
   Wolburg H, 2001, NEUROSCI LETT, V307, P77, DOI 10.1016/S0304-3940(01)01927-9
   Liebner S, 2000, ACTA NEUROPATHOL, V100, P323
   Jou TS, 1998, J CELL BIOL, V142, P101, DOI 10.1083/jcb.142.1.101
   PELUSO R, 1985, VIROLOGY, V147, P231, DOI 10.1016/0042-6822(85)90246-6
   Marcondes MCG, 2001, J IMMUNOL, V167, P5429
   Blasig IE, 2001, MICROVASC RES, V62, P114, DOI 10.1006/mvre.2001.2318
   Planas AM, 2006, BIOCHEM SOC T, V34, P1267
   Dirnagl U, 1999, TRENDS NEUROSCI, V22, P391, DOI 10.1016/S0166-2236(99)01401-0
   Ifergan I, 2008, BRAIN, V131, P785, DOI 10.1093/brain/awm295
   Engelhardt B, 2004, EUR J IMMUNOL, V34, P2955, DOI 10.1002/eji.200425327
   Santaguida S, 2006, BRAIN RES, V1109, P1, DOI 10.1016/j.brainres.2006.06.027
   Kim RB, 1998, J CLIN INVEST, V101, P289, DOI 10.1172/JCI1269
   Miklossy J, 2006, EXP NEUROL, V197, P275, DOI 10.1016/j.expneurol.2005.10.034
   Dziegielewska KM, 2001, MICROSC RES TECHNIQ, V52, P5, DOI 10.1002/1097-0029(20010101)52:1<5::AID-JEMT3>3.3.CO;2-A
   Hesselgesser J, 1998, CURR BIOL, V8, P595, DOI 10.1016/S0960-9822(98)70230-1
   Yamamoto M, 2008, AM J PATHOL, V172, P521, DOI 10.2353/ajpath.2008.070076
   Zozulya A, 2008, BRAIN RES, V1189, P1, DOI 10.1016/j.brainres.2007.10.099
   Nitta T, 2003, J CELL BIOL, V161, P653, DOI 10.1083/jcb.200302070
   Tsukita S, 2001, NAT REV MOL CELL BIO, V2, P285, DOI 10.1038/35067088
   Waubant E, 2006, DIS MARKERS, V22, P235
   DOREDUFFY P, 1993, ADV EXP MED BIOL, V331, P243
   ROUX F, 1994, J CELL PHYSIOL, V159, P101, DOI 10.1002/jcp.1041590114
   Soppimath KS, 2001, J CONTROL RELEASE, V75, P331, DOI 10.1016/S0168-3659(01)00404-7
   PERLMUTTER LS, 1990, BRAIN RES BULL, V24, P677, DOI 10.1016/0361-9230(90)90007-M
   Antonetti DA, 1999, J BIOL CHEM, V274, P23463, DOI 10.1074/jbc.274.33.23463
   Jain RK, 2007, NAT REV NEUROSCI, V8, P610, DOI 10.1038/nrn2175
   Tsukita S, 1999, TRENDS CELL BIOL, V9, P268, DOI 10.1016/S0962-8924(99)01578-0
   PARDRIDGE WM, 1985, J NEUROCHEM, V44, P1771, DOI 10.1111/j.1471-4159.1985.tb07167.x
   Pluchino S, 2005, NATURE, V436, P266, DOI 10.1038/nature03889
   Miller DH, 2003, NEW ENGL J MED, V348, P15, DOI 10.1056/NEJMoa020696
   Sakakibara A, 1997, J CELL BIOL, V137, P1393, DOI 10.1083/jcb.137.6.1393
   Heneka MT, 2007, J NEUROIMMUNOL, V184, P69, DOI 10.1016/j.jneuroim.2006.11.017
   ABRAHAM MH, 1994, J PHARM SCI, V83, P1257, DOI 10.1002/jps.2600830915
   Alonso MM, 2007, CANCER RES, V67, P11499, DOI 10.1158/0008-5472.CAN-07-5312
   McKinley MJ, 2003, ADV ANAT EMBRYOL CEL, V172, P1
   Cayrol R, 2008, NAT IMMUNOL, V9, P137, DOI 10.1038/ni1551
   Rigau V, 2007, BRAIN, V130, P1942, DOI 10.1093/brain/awm118
   Furuya K, 2001, STROKE, V32, P2665, DOI 10.1161/hs3211.098535
   Papadopoulos MC, 2001, NEUROPATH APPL NEURO, V27, P384, DOI 10.1046/j.0305-1846.2001.00341.x
   Martin-Padura I, 1998, J CELL BIOL, V142, P117, DOI 10.1083/jcb.142.1.117
   Cucullo L, 2008, J CEREBR BLOOD F MET, V28, P312, DOI 10.1038/sj.jcbfm.9600525
   Morita K, 1999, J CELL BIOL, V147, P185, DOI 10.1083/jcb.147.1.185
   Carman CV, 2004, J CELL BIOL, V167, P377, DOI 10.1083/jcb.200404129
   ZLOKOVIC BV, 1990, BIOCHIM BIOPHYS ACTA, V1025, P191, DOI 10.1016/0005-2736(90)90097-8
   Opdenakker G, 2003, LANCET NEUROL, V2, P747, DOI 10.1016/S1474-4422(03)00587-8
   Floris S, 2004, BRAIN, V127, P616, DOI 10.1093/brain/awh068
   Aschner M, 2006, METH MOL B, V341, P1
   Montaner J, 2001, STROKE, V32, P2762, DOI 10.1161/hs1201.99512
   MUSTAFA MM, 1989, J PEDIATR-US, V115, P208, DOI 10.1016/S0022-3476(89)80067-8
   Benchenane K, 2004, TRENDS NEUROSCI, V27, P155, DOI 10.1016/j.tins.2003.12.011
   Deane R, 2004, NEURON, V43, P333, DOI 10.1016/j.neuron.2004.07.017
   Leib SL, 2000, INFECT IMMUN, V68, P615, DOI 10.1128/IAI.68.2.615-620.2000
   Kroll RA, 1998, NEUROSURGERY, V42, P1083, DOI 10.1097/00006123-199805000-00082
   Pardridge WM, 1999, ADV DRUG DELIVER REV, V36, P299, DOI 10.1016/S0169-409X(98)00087-8
   Leppert D, 2000, CLIN INFECT DIS, V31, P80, DOI 10.1086/313922
   Selkoe DJ, 2001, NEURON, V32, P177, DOI 10.1016/S0896-6273(01)00475-5
   Carman CV, 2008, CURR OPIN CELL BIOL, V20, P533, DOI 10.1016/j.ceb.2008.05.007
   Shibata M, 2000, J CLIN INVEST, V106, P1489, DOI 10.1172/JCI10498
   Bickel U, 2001, ADV DRUG DELIVER REV, V46, P247, DOI 10.1016/S0169-409X(00)00139-3
   Banks WA, 2001, J VIROL, V75, P4681, DOI 10.1128/JVI.75.10.4681-4691.2001
   JANZER RC, 1987, NATURE, V325, P253, DOI 10.1038/325253a0
   Balda MS, 1996, J CELL BIOL, V134, P1031, DOI 10.1083/jcb.134.4.1031
   Zlokovic BV, 1996, P NATL ACAD SCI USA, V93, P4229, DOI 10.1073/pnas.93.9.4229
   HAMANN GF, 1995, STROKE, V26, P2120
   Zlokovic BV, 1996, LIFE SCI, V59, P1483, DOI 10.1016/0024-3205(96)00310-4
   Afonso PV, 2007, J IMMUNOL, V179, P2576
   Folkins C, 2007, CANCER RES, V67, P3560, DOI 10.1158/0008-5472.CAN-06-4238
   Zlokovic BV, 2005, TRENDS NEUROSCI, V28, P202, DOI 10.1016/j.tins.2005.02.001
   de Boer AG, 2003, ANNU REV PHARMACOL, V43, P629, DOI 10.1146/annurev.pharmtox.43.100901.140204
   Togo T, 2002, J NEUROIMMUNOL, V124, P83, DOI 10.1016/S0165-5728(01)00496-9
   Roux F, 2005, CELL MOL NEUROBIOL, V25, P41, DOI 10.1007/s10571-004-1376-9
   Cerletti A, 2000, J DRUG TARGET, V8, P435, DOI 10.3109/10611860008997919
   Brocke S, 1999, P NATL ACAD SCI USA, V96, P6896, DOI 10.1073/pnas.96.12.6896
   Akiyama Y, 2001, EXP NEUROL, V167, P27, DOI 10.1006/exnr.2000.7539
   Prados MD, 2003, NEURO-ONCOLOGY, V5, P96, DOI 10.1215/15228517-5-2-96
   Abbott NJ, 2006, NAT REV NEUROSCI, V7, P41, DOI 10.1038/nrn1824
   Zysk G, 2001, INFECT IMMUN, V69, P845, DOI 10.1128/IAI.69.2.845-852.2001
   Zlokovic BV, 2008, NEURON, V57, P178, DOI 10.1016/j.neuron.2008.01.003
   Wong AST, 2003, J CELL BIOL, V161, P1191, DOI 10.1083/jcb.200212033
   Millan J, 2006, NAT CELL BIOL, V8, P113, DOI 10.1038/ncb1356
   Bentz GL, 2006, J VIROL, V80, P11539, DOI 10.1128/JVI.01016-06
   Rosenberg GA, 1998, STROKE, V29, P2189
   Coisne C, 2005, LAB INVEST, V85, P734, DOI 10.1038/labinvest.3700281
   Polman CH, 2006, NEW ENGL J MED, V354, P899, DOI 10.1056/NEJMoa044397
   Engelhardt B, 2005, TRENDS IMMUNOL, V26, P485, DOI 10.1016/j.it.2005.07.004
   Markowitz CE, 2007, NEUROLOGY, V68, pS8, DOI 10.1212/01.wnl.0000277703.74115.d2
   Claudio L, 1996, ACTA NEUROPATHOL, V91, P6
   Romero IA, 2000, J VIROL, V74, P6021, DOI 10.1128/JVI.74.13.6021-6030.2000
   Li B, 2006, FEBS LETT, V580, P4252, DOI 10.1016/j.febslet.2006.06.056
   Lee JP, 2007, NAT MED, V13, P439, DOI 10.1038/nm1548
   Lindsberg PJ, 1996, CIRCULATION, V94, P939
   Cecchelli R, 1999, ADV DRUG DELIVER REV, V36, P165, DOI 10.1016/S0169-409X(98)00083-0
   PARDRIDGE WM, 1995, P NATL ACAD SCI USA, V92, P5592, DOI 10.1073/pnas.92.12.5592
   Carman CV, 2003, J IMMUNOL, V171, P6135
   Wang W, 2001, AM J PHYSIOL-HEART C, V280, pH434
   Greenwood J, 2003, J IMMUNOL, V171, P2099
   Kean RB, 2000, J IMMUNOL, V165, P6511
   Berzin TM, 2000, NEUROBIOL AGING, V21, P349, DOI 10.1016/S0197-4580(00)00121-4
   Guillemot L, 2008, BBA-BIOMEMBRANES, V1778, P601, DOI 10.1016/j.bbamem.2007.09.032
   Thomas SA, 2004, CURR PHARM DESIGN, V10, P1313, DOI 10.2174/1381612043384835
   Goya RL, 2008, J NEUROL SCI, V265, P32, DOI 10.1016/j.jns.2007.09.006
   Petry KG, 2007, NEUROTHERAPEUTICS, V4, P434, DOI 10.1016/j.nurt.2007.05.005
   Hynynen K, 1999, IEEE T ULTRASON FERR, V46, P752, DOI 10.1109/58.764862
   Deane R, 2003, NAT MED, V9, P907, DOI 10.1038/nm890
   Lee SW, 2003, NAT MED, V9, P900, DOI 10.1038/nm889
   Lee BC, 2004, MOL CANCER RES, V2, P327
   Frohman EM, 2006, NEW ENGL J MED, V354, P942, DOI 10.1056/NEJMra052130
   Ostermann G, 2002, NAT IMMUNOL, V3, P151, DOI 10.1038/ni755
   Nakagawa S, 2007, CELL MOL NEUROBIOL, V27, P687, DOI 10.1007/s10571-007-9195-4
   KUROIWA T, 1985, ACTA NEUROPATHOL, V68, P122
   Lee TH, 2003, J BIOL CHEM, V278, P5277, DOI 10.1074/jbc.M210063200
   HAASE AT, 1986, NATURE, V322, P130, DOI 10.1038/322130a0
   LEVANONY H, 1992, J CELL BIOL, V119, P1117, DOI 10.1083/jcb.119.5.1117
   Buckwalter MS, 2006, J NEUROSCI, V26, P11437, DOI 10.1523/JNEUROSCI.2436-06.2006
   Gavard J, 2006, NAT CELL BIOL, V8, P1223, DOI 10.1038/ncb1486
   Ancuta P, 2003, J EXP MED, V197, P1701, DOI 10.1084/jem.20022156
   Wolburg H, 2002, VASC PHARMACOL, V38, P323, DOI 10.1016/S1537-1891(02)00200-8
   Lee MA, 1999, BRAIN, V122, P191, DOI 10.1093/brain/122.2.191
   Adamson P, 1999, J IMMUNOL, V162, P2964
   Rampon C, 2008, STEM CELLS, V26, P1673, DOI 10.1634/stemcells.2008-0122
   Persidsky Y, 2006, BLOOD, V107, P4770, DOI 10.1182/blood-2005-11-4721
   Schinkel AH, 1997, P NATL ACAD SCI USA, V94, P4028, DOI 10.1073/pnas.94.8.4028
   Miller SD, 2007, ANN NY ACAD SCI, V1103, P179, DOI 10.1196/annals.1394.023
   Kirk J, 2003, J PATHOL, V201, P319, DOI 10.1002/path.1434
   Persidsky Y, 1997, J IMMUNOL, V158, P3499
   Town T, 2005, NEUROMOL MED, V7, P255, DOI 10.1385/NMM:7:3:255
   Hintzen RQ, 2002, MULT SCLER, V8, P155, DOI 10.1191/1352458502ms789oa
   Koziara JM, 2006, J NANOSCI NANOTECHNO, V6, P2712, DOI 10.1166/jnn.2006.441
   Sheikov N, 2004, ULTRASOUND MED BIOL, V30, P979, DOI 10.1016/j.ultrasmedbio.2004.04.010
   PLATE KH, 1992, NATURE, V359, P845, DOI 10.1038/359845a0
   Weksler BB, 2005, FASEB J, V19, P1872
   Wosik K, 2007, J NEUROSCI, V27, P9032, DOI 10.1523/JNEUROSCI.2088-07.2007
   Peppiatt CM, 2006, NATURE, V443, P700, DOI 10.1038/nature05193
   Assemat E, 2008, BBA-BIOMEMBRANES, V1778, P614, DOI 10.1016/j.bbamem.2007.08.029
   Garberg P, 2005, TOXICOL IN VITRO, V19, P299, DOI 10.1016/j.tiv.2004.06.011
   Carman CV, 2007, IMMUNITY, V26, P784, DOI 10.1016/j.immuni.2007.04.015
   Wolburg H, 2003, ACTA NEUROPATHOL, V105, P586, DOI 10.1007/s00401-003-0688-z
   Alexandrov AV, 2008, STROKE, V39, P1464, DOI 10.1161/STROKEAHA.107.505727
   SOBEL RA, 1990, AM J PATHOL, V136, P1309
   Aronowski J, 1997, J CEREBR BLOOD F MET, V17, P1048
   Betti M, 2006, ANN ONCOL, V17, P235
   Brightman M W, 1992, NIDA Res Monogr, V120, P87
   Chavakis T, 2003, THROMB HAEMOSTASIS, V89, P13
   Decleves X, 2006, CURR CANCER DRUG TAR, V6, P433, DOI 10.2174/156800906777723930
   DURIEUTRAUTMANN O, 1991, IN VITRO CELL DEV B, V27, P771
   Sherman DG, 2001, NEUROLOGY, V57, P1428
   Erdlenbruch B, 2005, J DRUG TARGET, V13, P143, DOI 10.1080/10611860400029085
   Farrall A. J., 2007, NEUROBIOL AGING
   Fischer-Smith T, 2001, J NEUROVIROL, V7, P528
   Fisher LJ, 1997, NEUROBIOL DIS, V4, P1, DOI 10.1006/nbdi.1997.0137
   Freedman MS, 2007, J NEUROL SCI, V259, P85, DOI 10.1016/j.jns.2006.10.023
   Giraudon P, 1998, NEUROLOGY, V50, P1920
   Giri R, 2000, AM J PHYSIOL-CELL PH, V279, pC1772
   HICKEY WF, 1991, J NEUROSCI RES, V28, P254, DOI 10.1002/jnr.490280213
   Ichiyama T, 1997, CLIN INFECT DIS, V25, P328
   Jahnke Kristoph, 2006, Neurosurg Focus, V21, pE11
   Kroll RA, 1998, NEUROSURGERY, V42, P1099
   LASSMANN H, 1983, PROG BRAIN RES, V59, P305
   Lazarini F, 2003, GLIA, V42, P139, DOI 10.1002/glia.10139
   Marchetti D, 2003, PATHOL ONCOL RES, V9, P147
   Minagar A, 2003, MULT SCLER, V9, P235, DOI 10.1191/1352458503ms916oa
   MURAKAMI N, 1990, J PHYSIOL-LONDON, V428, P299
   Mycko MP, 1998, ANN NEUROL, V44, P70, DOI 10.1002/ana.410440113
   Nicholas M Kelly, 2007, Expert Rev Anticancer Ther, V7, pS23, DOI 10.1586/14737140.7.12s.S23
   Noseworthy JH, 2000, NEW ENGL J MED, V343, P938, DOI 10.1056/NEJM200009283431307
   OPPENHEIMERMARKS N, 1991, J IMMUNOL, V147, P2913
   PARDRIDGE WM, 1987, METABOLISM, V36, P892, DOI 10.1016/0026-0495(87)90099-0
   PRESTON JE, 1989, J PHYSIOL-LONDON, V408, P31
   RAYMOND JJ, 1986, CAN J NEUROL SCI, V13, P214
   Rubin Lee L., 1992, Current Opinion in Cell Biology, V4, P830, DOI 10.1016/0955-0674(92)90107-N
   Sehgal A, 1998, J SURG ONCOL, V69, P99, DOI 10.1002/(SICI)1096-9098(199810)69:2<99::AID-JSO10>3.0.CO;2-M
   Soriano SG, 1996, ANN NEUROL, V39, P618, DOI 10.1002/ana.410390511
   Stuertz K, 1998, J CLIN MICROBIOL, V36, P2346
   Trojano M, 2000, J NEUROVIROL, V6, pS47
   Tsuji Akira, 2005, NeuroRx, V2, P54, DOI 10.1007/BF03206642
   van der Worp HB, 2007, NEW ENGL J MED, V357, P572, DOI 10.1056/NEJMcp072057
   Verbeek MM, 1996, ACTA NEUROPATHOL, V91, P608
   Visted T, 2003, FRONT BIOSCI, V8, pE289, DOI 10.2741/1026
   Washington CB, 2000, DRUG METAB DISPOS, V28, P1058
   Westmoreland SV, 1998, AM J PATHOL, V152, P659
   Xu CR, 2002, J BIOMOL STRUCT DYN, V19, P789
   Yang FY, 2007, ULTRASOUND MED BIOL, V33, P1421, DOI 10.1016/j.ultrasmedbio.2007.04.006
   YEDNOCK TA, 1992, NATURE, V356, P63, DOI 10.1038/356063a0
   ZHANG RL, 1995, BRAIN RES, V682, P182, DOI 10.1016/0006-8993(95)00346-R
   ZLOKOVIC BV, 1989, J NEUROCHEM, V53, P1333, DOI 10.1111/j.1471-4159.1989.tb08522.x
NR 244
TC 193
Z9 204
U1 1
U2 34
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0005-2736
J9 BBA-BIOMEMBRANES
JI Biochim. Biophys. Acta-Biomembr.
PD APR
PY 2009
VL 1788
IS 4
BP 842
EP 857
DI 10.1016/j.bbamem.2008.10.022
PG 16
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA 438RH
UT WOS:000265572600011
PM 19061857
ER

PT J
AU Chevalier-Larsen, E
   Holzbaur, ELF
AF Chevalier-Larsen, Erica
   Holzbaur, Erika L. F.
TI Axonal transport and neurodegenerative disease
SO BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
LA English
DT Review
DE axonal transport; ALS; kinesin; cytoplasmic dynein; molecular motors;
   cytoskeleton
ID KINESIN HEAVY-CHAIN; MARIE-TOOTH-DISEASE; HEREDITARY SPASTIC PARAPLEGIA;
   MOTOR-NEURON-DISEASE; BULBAR MUSCULAR-ATROPHY;
   AMYOTROPHIC-LATERAL-SCLEROSIS; NEUROFILAMENT-LIGHT GENE; CYTOPLASMIC
   DYNEIN MOTOR; ACTIN-RELATED PROTEIN; NERVE GROWTH-FACTOR
AB Neurons have extensive processes and communication between those processes and the cell body is crucial to neuronal function and survival. Thus, neurons are uniquely dependent on microtubule based transport. Growing evidence supports the idea that deficits in axonal transport contribute to pathogenesis in multiple neurodegenerative diseases. We describe the motor, cytoskeletal, and adaptor proteins involved in axonal transport and their interactions. Data linking disruption of axonal transport to diseases such as ALS are discussed. Finally, we explore the pathways that may cause neuronal dysfunction and death. (c) 2006 Elsevier B.V. All rights reserved.
C1 Univ Penn, Sch Med, Philadelphia, PA 19104 USA.
RP Holzbaur, ELF (reprint author), Univ Penn, Sch Med, Philadelphia, PA 19104 USA.
EM holzbaur@mail.med.upenn.edu
CR Evans KJ, 2005, J CELL BIOL, V168, P599, DOI 10.1083/jcb.20409058
   Walczak CE, 1996, CELL, V84, P37, DOI 10.1016/S0092-8674(00)80991-5
   Verhey KJ, 1998, J CELL BIOL, V143, P1053, DOI 10.1083/jcb.143.4.1053
   Puls I, 2005, ANN NEUROL, V57, P687, DOI 10.1002/ana.20468
   Bhattacharyya A, 2002, J NEUROBIOL, V51, P302, DOI 10.1002/neu.10062
   Perlson E, 2005, NEURON, V45, P715, DOI 10.1016/j.neuron.2005.01.023
   MORRIS RL, 1993, J CELL SCI, V104, P917
   Rossoll W, 2003, J CELL BIOL, V163, P801, DOI 10.1083/jcb.200304128
   VALE RD, 1985, CELL, V42, P39, DOI 10.1016/S0092-8674(85)80099-4
   Lee WCM, 2004, P NATL ACAD SCI USA, V101, P3224, DOI 10.1073/pnas.0400243101
   Johnston JA, 2002, CELL MOTIL CYTOSKEL, V53, P26, DOI 10.1002/cm.10057
   Xia CH, 2003, J CELL BIOL, V161, P55, DOI 10.1083/jcb.200301026
   Takeda S, 2000, J CELL BIOL, V148, P1255, DOI 10.1083/jcb.148.6.1255
   Piper M, 2004, ANNU REV CELL DEV BI, V20, P505, DOI 10.1146/annurev.cellbio.20.010403.111764
   De Jonghe P, 2001, ANN NEUROL, V49, P245, DOI 10.1002/1531-8249(20010201)49:2<245::AID-ANA45>3.0.CO;2-A
   Jordens I, 2001, CURR BIOL, V11, P1680, DOI 10.1016/S0960-9822(01)00531-0
   Yamada K, 2004, INVEST OPHTH VIS SCI, V45, P2218, DOI 10.1167/iovs.03-1413
   Yang ZH, 2001, MOL CELL BIOL, V21, P5306, DOI 10.1128/MCB.21.16.5306-5311.2001
   Hurd DD, 1996, GENETICS, V144, P1075
   Ye HH, 2003, NEURON, V39, P57, DOI 10.1016/S0896-6273(03)00266-6
   Nguyen PV, 1997, J NEUROPHYSIOL, V78, P281
   FABRICIUS C, 1993, J NEUROCYTOL, V22, P941, DOI 10.1007/BF01218352
   Ligon LA, 2005, NEUROREPORT, V16, P533, DOI 10.1097/00001756-200504250-00002
   Burkhardt JK, 1997, J CELL BIOL, V139, P469, DOI 10.1083/jcb.139.2.469
   Peretti D, 2000, J CELL BIOL, V149, P141, DOI 10.1083/jcb.149.1.141
   Deacon SW, 2003, J CELL BIOL, V160, P297, DOI 10.1083/jcb.200210066
   Su QN, 2004, NAT CELL BIOL, V6, P941, DOI 10.1038/ncb1169
   Fischer LR, 2004, EXP NEUROL, V185, P232, DOI 10.1016/j.expneurol.2003.10.004
   HARTE PJ, 1983, DEV BIOL, V99, P88, DOI 10.1016/0012-1606(83)90256-7
   Wagner OI, 2003, J NEUROSCI, V23, P9046
   Samso M, 2004, J MOL BIOL, V340, P1059, DOI 10.1016/j.jmb.2004.05.063
   He Y, 2005, J CELL BIOL, V168, P697, DOI 10.1083/jcb.200407191
   Roy S, 2000, J NEUROSCI, V20, P6849
   Tanaka Y, 1998, CELL, V93, P1147, DOI 10.1016/S0092-8674(00)81459-2
   Zhang B, 1997, J CELL BIOL, V139, P1307, DOI 10.1083/jcb.139.5.1307
   Siddiqui SS, 2002, TRAFFIC, V3, P20, DOI 10.1034/j.1600-0854.2002.30104.x
   Evgrafov OV, 2004, NAT GENET, V36, P602, DOI 10.1038/ng1354
   Engelender S, 1997, HUM MOL GENET, V6, P2205, DOI 10.1093/hmg/6.13.2205
   Puls I, 2003, NAT GENET, V33, P455, DOI 10.1038/ng1123
   Zhao C, 2001, CELL, V105, P587, DOI 10.1016/S0092-8674(01)00363-4
   Munch C, 2005, ANN NEUROL, V58, P777, DOI 10.1002/ana.20631
   Li H, 2000, NAT GENET, V25, P385
   Nagano F, 1998, J BIOL CHEM, V273, P30065, DOI 10.1074/jbc.273.46.30065
   Sapp E, 1999, J NEUROPATH EXP NEUR, V58, P165, DOI 10.1097/00005072-199902000-00006
   Deneka M, 2003, CRIT REV BIOCHEM MOL, V38, P121, DOI 10.1080/713609214
   McDermott CJ, 2003, ANN NEUROL, V54, P748, DOI 10.1002/ana.10757
   Lawrence CJ, 2004, J CELL BIOL, V167, P19, DOI 10.1083/jcb.200408113
   Gunawardena S, 2003, NEURON, V40, P25, DOI 10.1016/S0896-6273(03)00594-4
   Parvari R, 2002, NAT GENET, V32, P448, DOI 10.1038/ng1012
   Williamson TL, 1999, NAT NEUROSCI, V2, P50
   HOLZBAUR ELF, 1991, NATURE, V351, P579, DOI 10.1038/351579a0
   Brown A, 2005, MOL BIOL CELL, V16, P4243, DOI 10.1091/mbc.E05-02-0141
   Fichera M, 2004, NEUROLOGY, V63, P1108
   Levy JR, 2006, J CELL BIOL, V172, P733, DOI 10.1083/jcb.200511068
   Yamada K, 2003, NAT GENET, V35, P318, DOI 10.1038/ng1261
   Gauthier LR, 2004, CELL, V118, P127, DOI 10.1016/j.cell.2004.06.018
   Setou M, 2002, NATURE, V417, P83, DOI 10.1038/nature743
   Ligon LA, 2001, NAT CELL BIOL, V3, P913, DOI 10.1038/ncb1001-913
   Lo Giudice M, 2006, ARCH NEUROL-CHICAGO, V63, P284, DOI 10.1001/archneur.63.2.284
   PASCHAL BM, 1987, J CELL BIOL, V105, P1273, DOI 10.1083/jcb.105.3.1273
   Mersiyanova IV, 2000, AM J HUM GENET, V67, P37, DOI 10.1086/302962
   Hirokawa N, 2004, CURR OPIN NEUROBIOL, V14, P564, DOI 10.1016/j.conb.2004.08.011
   Seabra MC, 2004, TRAFFIC, V5, P393, DOI 10.1111/j.1398-9219.2004.00190.x
   Manfredi G, 2005, MITOCHONDRION, V5, P77, DOI 10.1016/j.mito.2005.01.002
   Zhang HLL, 2003, J NEUROSCI, V23, P6627
   Welte MA, 2004, CURR BIOL, V14, pR525, DOI 10.1016/j.cub.2004.06.045
   Trettel F, 2000, HUM MOL GENET, V9, P2799, DOI 10.1093/hmg/9.19.2799
   Piccioni F, 2001, BRAIN RES BULL, V56, P215, DOI 10.1016/S0361-9230(01)00652-9
   Yildiz A, 2004, SCIENCE, V303, P676, DOI 10.1126/science.1093753
   XU ZS, 1993, CELL, V73, P23, DOI 10.1016/0092-8674(93)90157-L
   Campbell KS, 1998, J IMMUNOL, V161, P1728
   Szebenyi G, 2003, NEURON, V40, P41, DOI 10.1016/S0896-6273(03)00569-5
   Wong RWC, 2002, P NATL ACAD SCI USA, V99, P14500, DOI 10.1073/pnas.222371099
   LaMonte BH, 2002, NEURON, V34, P715, DOI 10.1016/S0896-6273(02)00696-7
   Taylor JP, 2003, HUM MOL GENET, V12, P749, DOI 10.1093/hmg/ddg074
   Miki H, 2005, TRENDS CELL BIOL, V15, P467, DOI 10.1016/j.tcb.2005.07.006
   Wang ZH, 1995, BIOPHYS J, V69, P2011
   Gee MA, 1997, NATURE, V390, P636
   WATERMANSTORER CM, 1995, P NATL ACAD SCI USA, V92, P1634, DOI 10.1073/pnas.92.5.1634
   Yang ZH, 2001, MOL CELL BIOL, V21, P765, DOI 10.1128/MCB.21.3.765-770.2001
   Ackerley S, 2006, HUM MOL GENET, V15, P347, DOI 10.1093/hmg/ddi452
   Bommel H, 2002, J CELL BIOL, V159, P563, DOI 10.1083/jcb.200208001
   NANGAKU M, 1994, CELL, V79, P1209, DOI 10.1016/0092-8674(94)90012-4
   Holleran EA, 1996, J CELL BIOL, V135, P1815, DOI 10.1083/jcb.135.6.1815
   Vale RD, 1996, NATURE, V380, P451, DOI 10.1038/380451a0
   Matanis T, 2002, NAT CELL BIOL, V4, P986, DOI 10.1038/ncb891
   Cai Q, 2005, J CELL BIOL, V170, P959, DOI 10.1083/jcb.200506042
   Tai AW, 1999, CELL, V97, P877, DOI 10.1016/S0092-8674(00)80800-4
   DiFiglia M, 1997, SCIENCE, V277, P1990, DOI 10.1126/science.277.5334.1990
   Stokin GB, 2005, SCIENCE, V307, P1282, DOI 10.1126/science.1105681
   GAREN SH, 1983, DEV BIOL, V96, P445, DOI 10.1016/0012-1606(83)90182-3
   Liu Q, 2004, CELL MOL LIFE SCI, V61, P3057, DOI 10.1007/s00018-004-4268-8
   Martin N, 2002, NAT GENET, V32, P443, DOI 10.1038/ng1016
   SCHAFER DA, 1994, J CELL BIOL, V126, P403, DOI 10.1083/jcb.126.2.403
   COTE F, 1993, CELL, V73, P35, DOI 10.1016/0092-8674(93)90158-M
   Pfister KK, 2005, J CELL BIOL, V171, P411, DOI 10.1083/jcb.200508078
   MacInnis BL, 2002, SCIENCE, V295, P1536, DOI 10.1126/science.1064913
   BRADY ST, 1990, P NATL ACAD SCI USA, V87, P1061, DOI 10.1073/pnas.87.3.1061
   Hollenbeck PJ, 2005, J CELL SCI, V118, P5411, DOI 10.1242/jcs.02745
   Stock MF, 1999, J BIOL CHEM, V274, P14617, DOI 10.1074/jbc.274.21.14617
   HALL DH, 1991, CELL, V65, P837, DOI 10.1016/0092-8674(91)90391-B
   Byrd DT, 2001, NEURON, V32, P787, DOI 10.1016/S0896-6273(01)00532-3
   Ravikumar B, 2005, NAT GENET, V37, P771, DOI 10.1038/ng1591
   King SR, 1996, ENDOCR RES, V22, P505
   Cavalli V, 2005, J CELL BIOL, V168, P775, DOI 10.1083/jcb.200410136
   Shah JV, 2000, MOL BIOL CELL, V11, P3495
   KENNEDY WR, 1968, NEUROLOGY, V18, P671
   Gunawardena S, 2001, NEURON, V32, P389, DOI 10.1016/S0896-6273(01)00496-2
   Blangy A, 1997, J BIOL CHEM, V272, P19418, DOI 10.1074/jbc.272.31.19418
   Chada SR, 2004, CURR BIOL, V14, P1272, DOI 10.1016/j.cub.2004.07.027
   Ligon LA, 2004, J BIOL CHEM, V279, P19201, DOI 10.1074/jbc.M313472200
   Reid E, 2002, AM J HUM GENET, V71, P1189, DOI 10.1086/344210
   Pigino G, 2003, J NEUROSCI, V23, P4499
   Nakajima K, 2002, MOL CELL BIOL, V22, P866
   Wang L, 2000, NAT CELL BIOL, V2, P137
   Homma N, 2003, CELL, V114, P229, DOI 10.1016/S0092-8674(03)00522-1
   Gross SP, 2002, J CELL BIOL, V156, P715, DOI 10.1083/jcb.200109047
   Li H, 2001, J NEUROSCI, V21, P8473
   KARKI S, 1995, J BIOL CHEM, V270, P28806
   Muresan V, 2001, MOL CELL, V7, P173, DOI 10.1016/S1097-2765(01)00165-4
   Hafezparast M, 2003, SCIENCE, V300, P808, DOI 10.1126/science.1083129
   Yang ZH, 2001, MOL CELL BIOL, V21, P2463, DOI 10.1128/MCB.21.7.2463-2466.2001
   Heerssen HM, 2004, NAT NEUROSCI, V7, P596, DOI 10.1038/nn1242
   Klopfenstein DR, 2004, MOL BIOL CELL, V15, P3729, DOI 10.1091/mbc.E04-04-0326
   Trotta N, 2004, CURR BIOL, V14, P1135, DOI 10.1016/j.cub.2004.06.058
   Kieran D, 2005, J CELL BIOL, V169, P561, DOI 10.1083/jcb.200501085
   Kawaguchi Y, 2003, CELL, V115, P727, DOI 10.1016/S0092-8674(03)00939-5
   Horiuchi D, 2005, CURR BIOL, V15, P2137, DOI 10.1016/j.cub.2005.10.047
   Holleran EA, 2001, J BIOL CHEM, V276, P36598, DOI 10.1074/jbc.M104838200
   Martin M, 1999, MOL BIOL CELL, V10, P3717
   Stowers RS, 2002, NEURON, V36, P1063, DOI 10.1016/S0896-6273(02)01094-2
   Koushika SP, 2004, J NEUROSCI, V24, P3907, DOI 10.1523/JNEUROSCI.5039-03.2004
   Ling SC, 2004, P NATL ACAD SCI USA, V101, P17428, DOI 10.1073/pnas.0408114101
   Kural C, 2005, SCIENCE, V308, P1469, DOI 10.1126/science.1108408
   Perez-Olle R, 2005, J NEUROCHEM, V93, P861, DOI 10.1111/j.1471-4159.2005.03095.x
   SAXTON WM, 1991, CELL, V64, P1093, DOI 10.1016/0092-8674(91)90264-Y
   Kanai Y, 2004, NEURON, V43, P513, DOI 10.1016/j.neuron.2004.07.022
   WatermanStorer CM, 1997, P NATL ACAD SCI USA, V94, P12180, DOI 10.1073/pnas.94.22.12180
   VAUGHAN KT, 1995, J CELL BIOL, V131, P1507, DOI 10.1083/jcb.131.6.1507
   Munch C, 2004, NEUROLOGY, V63, P724
   King SJ, 2000, NAT CELL BIOL, V2, P20
   Ligon LA, 2000, J COMP NEUROL, V427, P351, DOI 10.1002/1096-9861(20001120)427:3<351::AID-CNE3>3.0.CO;2-R
   Kamal A, 2000, CURR OPIN CELL BIOL, V12, P503, DOI 10.1016/S0955-0674(00)00123-X
   Harada A, 1998, J CELL BIOL, V141, P51, DOI 10.1083/jcb.141.1.51
   Hazan J, 1999, NAT GENET, V23, P296, DOI 10.1038/15472
   Bindokas VP, 1998, J NEUROSCI, V18, P4570
   Bassell GJ, 2006, EMBO REP, V7, P31, DOI 10.1038/sj.embor.7400616
   Holzbaur ELF, 2004, TRENDS CELL BIOL, V14, P233, DOI 10.1016/j.tcb.2004.03.009
   Karki S, 1997, J BIOL CHEM, V272, P5887
   LA SA, 1991, NATURE, V352, P77
   Ma S, 2002, J CELL SCI, V115, P1453
   MCDONALD HB, 1990, CELL, V63, P1159, DOI 10.1016/0092-8674(90)90412-8
   OTSUKA AJ, 1991, NEURON, V6, P113, DOI 10.1016/0896-6273(91)90126-K
   PILLING AD, 2006, MOL BIOL CELL
   ROSS JL, 2006, IN PRESS NAT CELL BI
   Tiab Leila, 2004, Ophthalmic Genet, V25, P241, DOI 10.1080/13816810490902828
   Wagner OI, 2004, MOL BIOL CELL, V15, P5092, DOI 10.1091/mbc.E04-05-0401
   Yano H., 2001, J NEUROSCI, V21, P125
   Zhou HM, 2001, J NEUROSCI, V21, P3749
   Zoghbi HY, 2000, ANNU REV NEUROSCI, V23, P217, DOI 10.1146/annurev.neuro.23.1.217
NR 160
TC 193
Z9 198
U1 0
U2 16
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0925-4439
J9 BBA-MOL BASIS DIS
JI Biochim. Biophys. Acta-Mol. Basis Dis.
PD NOV-DEC
PY 2006
VL 1762
IS 11-12
BP 1094
EP 1108
DI 10.1016/j.bbadis.2006.04.002
PG 15
WC Biochemistry & Molecular Biology; Biophysics; Cell Biology
SC Biochemistry & Molecular Biology; Biophysics; Cell Biology
GA 118FB
UT WOS:000242926600012
PM 16730956
ER

PT J
AU Schenck, JF
   Zimmerman, EA
AF Schenck, JF
   Zimmerman, EA
TI High-field magnetic resonance imaging of brain iron: birth of a
   biomarker?
SO NMR IN BIOMEDICINE
LA English
DT Review
DE magnetic resonance imaging; high field imaging; brain iron; biomarkers;
   Alzheimer's disease; Parkinson's disease; ferritin; hemosiderin
ID HALLERVORDEN-SPATZ-SYNDROME; CENTRAL-NERVOUS-SYSTEM; RESTLESS LEGS
   SYNDROME; REDOX-ACTIVE IRON; KINASE-ASSOCIATED NEURODEGENERATION;
   INTERECHO TIME-DEPENDENCE; HUMAN SUBSTANTIA-NIGRA; RAT CEREBRAL-CORTEX;
   ALZHEIMERS-DISEASE; PARKINSONS-DISEASE
AB The brain has an unusually high concentration of iron, which is distributed in an unusual pattern unlike that in any other organ. The physiological role of this iron and the reasons for this pattern of distribution are not yet understood. There is increasing evidence that several neurodegenerative diseases are associated with altered brain iron metabolism. Understanding these dysmetabolic conditions may provide important information for their diagnosis and treatment. For many years the iron distribution in the human brain could be studied effectively only under postmortem conditions. This situation was changed dramatically by the finding that T-2-weighted MR imaging at high field strength (initially 1.5 T) appears to demonstrate the pattern of iron distribution in normal brains and that this imaging technique can detect changes in brain iron concentrations associated with disease states. Up to the present time this imaging capability has been utilized in many research applications but it has not yet been widely applied in the routine diagnosis and management of neurodegenerative disorders. However, recent advances in the basic science of brain iron metabolism, the clinical understanding of neurodegenerative diseases and in MRI technology, particularly in the availability of clinical scanners operating at the higher field strength of 3 T, suggest that iron-dependent MR imaging may soon provide biomarkers capable of characterizing the presence and progression of important neurological disorders. Such biomarkers may be of crucial assistance in the development and utilization of effective new therapies for Alzheimer's and Parkinson's diseases, multiple sclerosis and other iron-related CNS disorders which are difficult to diagnose and treat. Copyright (C) 2004 John Wiley Sons, Ltd.
C1 Gen Elect Global Res, Schenectady, NY 12309 USA.
   Albany Med Coll, Dept Neurol, Albany, NY USA.
RP Schenck, JF (reprint author), Gen Elect Global Res, Bldg K1-NMR,1 Res Dr, Schenectady, NY 12309 USA.
EM schenck@research.ge.com
CR ADAK S, 2004, INT SOC MAGNRES MED
   Allkemper T, 2004, EUR RADIOL, V14, P1000, DOI 10.1007/s00330-004-2241-4
   ANDREWS SC, 1987, BIOCHEM J, V245, P439
   ANDREWS SC, 1992, J INORG BIOCHEM, V47, P161, DOI 10.1016/0162-0134(92)84062-R
   Bradbury MWB, 1997, J NEUROCHEM, V69, P443
   Dhenain M, 1997, NEUROBIOL AGING, V18, P517, DOI 10.1016/S0197-4580(97)00105-X
   Pulliam JF, 2003, AM J MED GENET B, V119B, P48, DOI 10.1002/ajmg.b.10069
   Ong WY, 2004, ANN NY ACAD SCI, V1012, P51, DOI 10.1196/annals.1306.005
   Zhou B, 2001, NAT GENET, V28, P345, DOI 10.1038/ng572
   Lovell MA, 1998, J NEUROL SCI, V158, P47, DOI 10.1016/S0022-510X(98)00092-6
   Ye FQ, 1996, MOVEMENT DISORD, V11, P243, DOI 10.1002/mds.870110305
   Sipe JC, 2002, DEV NEUROSCI-BASEL, V24, P188, DOI 10.1159/000065701
   CONNOR JR, 1995, J COMP NEUROL, V355, P111, DOI 10.1002/cne.903550112
   Cabantchik ZI, 2002, ADV EXP MED BIOL, V509, P55
   Lozoff B, 1996, J PEDIATR-US, V129, P382, DOI 10.1016/S0022-3476(96)70070-7
   Loreal O, 2002, J HEPATOL, V36, P851, DOI 10.1016/S0168-8278(02)00042-9
   Koeppen AH, 1995, J NEUROL SCI, V134, P1, DOI 10.1016/0022-510X(95)00202-D
   Scahill RI, 2003, ARCH NEUROL-CHICAGO, V60, P989, DOI 10.1001/archneur.60.7.989
   KOENIG SH, 1984, MAGNET RESON MED, V1, P478, DOI 10.1002/mrm.1910010407
   Atamna H, 2004, AGEING RES REV, V3, P303, DOI 10.1016/j.arr.2004.02.002
   Todorich BM, 2004, ANN NY ACAD SCI, V1012, P171, DOI 10.1196/annals.1306.014
   MIROWITZ SA, 1992, RADIOLOGY, V185, P535
   Bishop GM, 2003, J NEUROSCI RES, V73, P316, DOI 10.1002/jnr.10661
   Gunter JL, 2003, J MAGN RESON IMAGING, V18, P16, DOI 10.1002/jmri.10325
   Qian ZM, 2001, TRENDS MOL MED, V7, P103, DOI 10.1016/S1471-4914(00)01910-9
   Rouault TA, 2001, NAT GENET, V28, P299, DOI 10.1038/91036
   Johnson MA, 2004, ANN NY ACAD SCI, V1012, P282, DOI 10.1196/annals.1306.023
   Klunk WE, 1998, NEUROBIOL AGING, V19, P145, DOI 10.1016/S0197-4580(98)00013-X
   Malecki EA, 1999, NEUROTOXICOLOGY, V20, P647
   Dobson J, 2001, FEBS LETT, V496, P1, DOI 10.1016/S0014-5793(01)02386-9
   Pautler RG, 1998, MAGNET RESON MED, V40, P740, DOI 10.1002/mrm.1910400515
   Jensen JH, 2000, MAGN RESON MED, V44, P144, DOI 10.1002/1522-2594(200007)44:1<144::AID-MRM21>3.0.CO;2-O
   MORRIS CM, 1994, NEURODEGENERATION, V3, P277
   Ritchie CW, 2003, ARCH NEUROL-CHICAGO, V60, P1685, DOI 10.1001/archneur.60.12.1685
   Dhenain M, 2002, NMR BIOMED, V15, P197, DOI 10.1002/nbm.760
   Bouras C, 1997, EUR NEUROL, V38, P53, DOI 10.1159/000112903
   MCLACHLAN DRC, 1991, LANCET, V337, P1304, DOI 10.1016/0140-6736(91)92978-B
   Huang XD, 2004, ANN NY ACAD SCI, V1012, P153, DOI 10.1196/annals.1306.012
   Fox NC, 2000, ARCH NEUROL-CHICAGO, V57, P339, DOI 10.1001/archneur.57.3.339
   Whitwell JL, 2004, DEMENT GERIATR COGN, V17, P307, DOI 10.1159/000077160
   HALLGREN B, 1958, J NEUROCHEM, V3, P41, DOI 10.1111/j.1471-4159.1958.tb12607.x
   KOEPPEN AH, 1988, J NEUROPATH EXP NEUR, V47, P249, DOI 10.1097/00005072-198805000-00005
   Hampel H, 2004, J NEURAL TRANSM, V111, P247, DOI 10.1007/s00702-003-0065-z
   Cowley JM, 2000, J STRUCT BIOL, V131, P210, DOI 10.1006/jsbi.2000.4292
   PUJOL J, 1992, ARCH NEUROL-CHICAGO, V49, P711
   STPIERRE TG, 1988, BIOCHIM BIOPHYS ACTA, V952, P158, DOI 10.1016/0167-4838(88)90111-2
   Whittall KP, 1999, MAGNET RESON MED, V41, P1255, DOI 10.1002/(SICI)1522-2594(199906)41:6<1255::AID-MRM23>3.0.CO;2-I
   VYMAZAL J, 1992, MAGNET RESON MED, V27, P368, DOI 10.1002/mrm.1910270218
   Halliwell B, 2001, DRUG AGING, V18, P685, DOI 10.2165/00002512-200118090-00004
   CRAELIUS W, 1982, ARCH PATHOL LAB MED, V106, P397
   GRUNDKEIQBAL I, 1990, ACTA NEUROPATHOL, V81, P105
   Rao R, 2003, J NUTR, V133, P3215
   Zecca L, 2003, J NEURAL TRANSM-SUPP, P145
   GOOD PF, 1992, BRAIN RES, V593, P343, DOI 10.1016/0006-8993(92)91334-B
   Drysdale J, 2002, BLOOD CELL MOL DIS, V29, P376, DOI 10.1006/bcmd.2002.0577
   Klunk WE, 2004, ANN NEUROL, V55, P306, DOI 10.1002/ana.20009
   O'Brien JT, 2001, NEUROLOGY, V56, P1386
   Schenck JF, 1996, MED PHYS, V23, P815, DOI 10.1118/1.597854
   LEVINE SM, 1990, J NEUROSCI RES, V26, P508, DOI 10.1002/jnr.490260415
   Berger K, 2002, J NEUROL, V249, P1195, DOI 10.1007/s00415-002-0805-2
   RICHARDSON JS, 1993, ANN NY ACAD SCI, V695, P73, DOI 10.1111/j.1749-6632.1993.tb23031.x
   Schenck JF, 1995, J NEUROL SCI, V134, P10, DOI 10.1016/0022-510X(95)00203-E
   Killiany RJ, 2000, ANN NEUROL, V47, P430, DOI 10.1002/1531-8249(200004)47:4<430::AID-ANA5>3.0.CO;2-I
   Ye FQ, 1996, MAGNET RESON MED, V36, P153, DOI 10.1002/mrm.1910360124
   SAVOIARDO M, 1991, J NEUROL NEUROSUR PS, V54, P888, DOI 10.1136/jnnp.54.10.888
   Hautot D, 2003, P ROY SOC B-BIOL SCI, V270, pS62, DOI 10.1098/rsbl.2003.0012
   Wu LJC, 2004, BRAIN RES, V1001, P108, DOI 10.1016/j.brainres.2003.10.066
   Krieger J, 2001, SLEEP MED REV, V5, P277, DOI 10.1053/smrv.2001.0156
   Smith MA, 1997, P NATL ACAD SCI USA, V94, P9866, DOI 10.1073/pnas.94.18.9866
   St Pierre TG, 1998, BBA-MOL BASIS DIS, V1407, P51, DOI 10.1016/S0925-4439(98)00026-X
   Kakhlon O, 2002, FREE RADICAL BIO MED, V33, P1037, DOI 10.1016/S0891-5849(02)01006-7
   Beard J, 2003, J NUTR, V133, P1174
   DRAYER BP, 1987, ANN NEUROL, V22, P546, DOI 10.1002/ana.410220418
   Rottkamp CA, 2001, FREE RADICAL BIO MED, V30, P447, DOI 10.1016/S0891-5849(00)00494-9
   Frank RA, 2003, NEUROBIOL AGING, V24, P521, DOI 10.1016/S0197-4580(03)00002-2
   Rae TD, 1999, SCIENCE, V284, P805, DOI 10.1126/science.284.5415.805
   Ogg RJ, 1999, MAGN RESON IMAGING, V17, P1141, DOI 10.1016/S0730-725X(99)00017-X
   Jensen JH, 2000, MAGNET RESON MED, V43, P226, DOI 10.1002/(SICI)1522-2594(200002)43:2<226::AID-MRM9>3.0.CO;2-P
   Ostrerova-Golts N, 2000, J NEUROSCI, V20, P6048
   Michaelis L, 1943, J BIOL CHEM, V148, P463
   Gelman N, 1999, RADIOLOGY, V210, P759
   Double KL, 2003, BIOCHEM PHARMACOL, V66, P489, DOI 10.1016/S0006-2952(03)00293-4
   Dubiel SM, 1999, EUR BIOPHYS J BIOPHY, V28, P263, DOI 10.1007/s002490050208
   Ye FQ, 1996, MAGN RESON MED, V35, P285, DOI 10.1002/mrm.1910350304
   Grabill C, 2003, BRAIN RES, V971, P95, DOI 10.1016/S0006-8993(03)02366-7
   SETHI KD, 1988, ANN NEUROL, V24, P692, DOI 10.1002/ana.410240519
   MASSOVER WH, 1993, MICRON, V24, P389, DOI 10.1016/0968-4328(93)90005-L
   Miyajima H, 2003, NEUROPATHOLOGY, V23, P345, DOI 10.1046/j.1440-1789.2003.00521.x
   Reichenbach JR, 1997, JMRI-J MAGN RESON IM, V7, P266, DOI 10.1002/jmri.1880070203
   Konagaya M, 2004, J NEUROL SCI, V218, P85, DOI 10.1016/j.jns.2003.11.007
   GELMAN BB, 1995, J NEUROPATH EXP NEUR, V54, P477, DOI 10.1097/00005072-199507000-00001
   Gotz ME, 2004, ANN NY ACAD SCI, V1012, P193, DOI 10.1196/annals.1306.017
   CONNOR JR, 1992, J NEUROSCI RES, V31, P75, DOI 10.1002/jnr.490310111
   Fox NC, 2004, LANCET, V363, P392, DOI 10.1016/S0140-6736(04)15441-X
   CHEN JC, 1989, RADIOLOGY, V173, P521
   Brooks RA, 1998, MAGN RESON MED, V40, P227, DOI 10.1002/mrm.1910400208
   Rogers JT, 2002, J BIOL CHEM, V277, P45518, DOI 10.1074/jbc.M207435200
   Connor JR, 2003, NEUROLOGY, V61, P304
   Patwardhan MB, 2004, RADIOLOGY, V231, P73, DOI 10.1148/radiol.2311021620
   Koeppen AH, 2003, J NEUROL SCI, V207, P95, DOI 10.1016/S0022-510X(02)00429-X
   Bartzokis G, 1999, ARCH NEUROL-CHICAGO, V56, P569, DOI 10.1001/archneur.56.5.569
   HILL JM, 1984, NEUROSCIENCE, V11, P595, DOI 10.1016/0306-4522(84)90046-0
   Schenck JF, 2003, J NEUROL SCI, V207, P99, DOI 10.1016/S0022-510X(02)00431-8
   Barnes CM, 2002, P NATL ACAD SCI USA, V99, P5195, DOI 10.1073/pnas.032089399
   Fox NC, 1996, BRAIN, V119, P2001, DOI 10.1093/brain/119.6.2001
   Curtis ARJ, 2001, NAT GENET, V28, P350, DOI 10.1038/ng571
   Moos T, 2004, ANN NY ACAD SCI, V1012, P14, DOI 10.1196/annals.1306.002
   Berg D, 2001, J NEUROCHEM, V79, P225, DOI 10.1046/j.1471-4159.2001.00608.x
   YABLONSKIY DA, 1994, MAGNET RESON MED, V32, P749, DOI 10.1002/mrm.1910320610
   PERL DP, 1992, ANN NEUROL, V32, pS76, DOI 10.1002/ana.410320713
   Kaur D, 2003, NEURON, V37, P899, DOI 10.1016/S0896-6273(03)00126-0
   GOOD PF, 1992, ANN NEUROL, V31, P286, DOI 10.1002/ana.410310310
   Jack CR, 2004, NEUROLOGY, V62, P591
   BROOKS DJ, 1989, J NEUROL NEUROSUR PS, V52, P108, DOI 10.1136/jnnp.52.1.108
   FRANCOIS C, 1981, BRAIN RES, V215, P317, DOI 10.1016/0006-8993(81)90510-2
   Schipper HM, 2004, AGEING RES REV, V3, P265, DOI 10.1016/j.arr.2004.02.001
   DRAYER B, 1986, AM J ROENTGENOL, V147, P103
   Deibel MA, 1996, J NEUROL SCI, V143, P137, DOI 10.1016/S0022-510X(96)00203-1
   Aisen P, 1999, CURR OPIN CHEM BIOL, V3, P200, DOI 10.1016/S1367-5931(99)80033-7
   BIZZI A, 1990, RADIOLOGY, V177, P59
   Harris ZL, 1999, P NATL ACAD SCI USA, V96, P10812, DOI 10.1073/pnas.96.19.10812
   Hilditch-Maguire P, 2000, HUM MOL GENET, V9, P2789, DOI 10.1093/hmg/9.19.2789
   Wixom R L, 1980, Int Rev Exp Pathol, V22, P193
   Zecca L, 2003, TRENDS NEUROSCI, V26, P578, DOI 10.1016/j.tins.2003.08.009
   LAWSON DM, 1989, FEBS LETT, V254, P207, DOI 10.1016/0014-5793(89)81040-3
   Miyajima H, 2003, BIOMETALS, V16, P205, DOI 10.1023/A:1020775101654
   Frank R, 2003, NAT REV DRUG DISCOV, V2, P566, DOI 10.1038/nrd1130
   Gilissen EP, 1998, AM J PRIMATOL, V45, P291, DOI 10.1002/(SICI)1098-2345(1998)45:3<291::AID-AJP5>3.0.CO;2-R
   Bulteau AL, 2004, SCIENCE, V305, P242, DOI 10.1126/science.1098991
   Zhou JY, 2001, MAGNET RESON MED, V46, P401, DOI 10.1002/mrm.1204
   Williams RJP, 2003, INORG CHIM ACTA, V356, P27, DOI 10.1016/S0020-1693(03)00471-7
   Schuff N, 1998, RADIOLOGY, V207, P91
   Andrews NC, 1999, NEW ENGL J MED, V341, P1986, DOI 10.1056/NEJM199912233412607
   Kaur D, 2004, AGEING RES REV, V3, P327, DOI 10.1016/j.arr.2004.01.003
   Hayflick SJ, 2003, CURR OPIN PEDIATR, V15, P572, DOI 10.1097/00008480-200312000-00005
   KOEPPEN AHW, 1971, J NEUROPATH EXP NEUR, V30, P448, DOI 10.1097/00005072-197107000-00010
   Alsop DC, 2000, ANN NEUROL, V47, P93, DOI 10.1002/1531-8249(200001)47:1<93::AID-ANA15>3.0.CO;2-8
   CHEN JC, 1993, AM J NEURORADIOL, V14, P275
   Castellani RJ, 2004, AGEING RES REV, V3, P319, DOI 10.1016/j.arr.2004.01.002
   Honda K, 2004, ANN NY ACAD SCI, V1012, P179, DOI 10.1196/annals.1306.015
   MORRIS CM, 1992, ACTA ANAT, V144, P235
   Yoon T, 2004, J BIOL CHEM, V279, P25943, DOI 10.1074/jbc.C400107200
   ORDIDGE RJ, 1994, MAGNET RESON MED, V32, P335, DOI 10.1002/mrm.1910320309
   Bush AI, 2003, TRENDS NEUROSCI, V26, P207, DOI 10.1016/S0166-2236(03)00067-5
   Jack CR, 2003, NEUROLOGY, V60, P253
   LeVine SM, 2004, ANN NY ACAD SCI, V1012, P252, DOI 10.1196/annals.1306.021
   Castelnau PA, 1998, J NEUROPATH EXP NEUR, V57, P268, DOI 10.1097/00005072-199803000-00008
   Atlas SW, 2002, MAGNETIC RESONANCE I, P773
   Bakshi R, 2002, ARCH NEUROL-CHICAGO, V59, P62, DOI 10.1001/archneur.59.1.62
   Bartzokis G, 2000, ARCH GEN PSYCHIAT, V57, P47, DOI 10.1001/archpsyc.57.1.47
   Beard J, 2003, J NUTR, V133, p1468S
   Bertini I., 1994, BIOINORGANIC CHEM
   Bishop GM, 2002, DEV NEUROSCI-BASEL, V24, P184, DOI 10.1159/000065696
   Bishop GM, 2004, J NEURAL TRANSM, V111, P159, DOI 10.1007/s00702-003-0098-3
   Boulby PA, 2003, QUANTITATIVE MRI OF THE BRAIN: MEASURING CHANGES CAUSED BY DISEASE, P143, DOI 10.1002/0470869526.ch6
   Brooks RA, 2002, MAGNET RESON MED, V47, P388, DOI 10.1002/mrm.10064
   Bulte JWM, 1998, ACAD RADIOL, V5, pS137, DOI 10.1016/S1076-6332(98)80084-6
   BULTE JW, 1998, ACAD RADIOL S, V5, pS145
   Burdette SC, 2003, P NATL ACAD SCI USA, V100, P3605, DOI 10.1073/pnas.0637711100
   Chakos M H, 1998, Magn Reson Imaging Clin N Am, V6, P155
   CHASTEEN ND, 1998, IRON TRANSPORT STORA, P479
   COHEN G, 1994, ANN NEUROL, V36, P333, DOI 10.1002/ana.410360302
   Cole GM, 2003, NEURON, V37, P889, DOI 10.1016/S0896-6273(03)00160-0
   Connor J. R., 2001, Journal of Alzheimer's Disease, V3, P471
   Connor JR, 1997, METALS OXIDATIVE DAM
   Cornell R.M., 2003, IRON OXIDES STRUCTUR
   Crichton R., 2001, INORGANIC BIOCH IRON
   Dexter DT, 1992, ANN NEUROL, V32, P94
   Dobson J, 2004, ANN NY ACAD SCI, V1012, P183, DOI 10.1196/annals.1306.016
   DRAYER BP, 1989, RADIOLOGY, V173, P311
   Erb GL, 1996, DEV BRAIN RES, V93, P120, DOI 10.1016/0165-3806(96)00020-X
   FIEHRING M, 1959, Z INN MED, V14, P787
   Frankel R.B., 1991, IRON BIOMINERALS
   Gakh O, 2002, BIOCHEMISTRY-US, V41, P6798, DOI 10.1021/bi025566+
   GOODMAN L, 1953, J NERV MENT DIS, V118, P97, DOI 10.1097/00005053-195308000-00001
   Gossuin Y, 2002, MAGNET RESON MED, V48, P959, DOI 10.1002/mrm.10316
   Gutteridge J. M. C., 1992, ANN NEUROL S, V32, pS16
   GUTTMAN M, 2002, PARKINSONS DIS DIAGN, P259
   Halliwell B., 1999, FREE RADICALS BIOL M
   HARRISON PM, 1998, IRON TRANSPORT STORA, P435
   Hatanaka Y, 2003, INTERNAL MED, V42, P599, DOI 10.2169/internalmedicine.42.599
   Hayflick SJ, 2003, NEW ENGL J MED, V348, P33, DOI 10.1056/NEJMoa020817
   Hill J. M., 1988, BRAIN IRON NEUROCHEM, P1
   HILL JM, 1982, BIOCH PHYSL IRON, P599
   IANCU TC, 1992, ELECTRON MICROSC REV, V5, P209, DOI 10.1016/0892-0354(92)90011-E
   JELLINGER K, 1990, J NEURAL TRANSM-PARK, V2, P327, DOI 10.1007/BF02252926
   Jensen JH, 2001, MAGN RESON MED, V46, P159, DOI 10.1002/mrm.1171
   Jensen JH, 2002, MAGNET RESON MED, V47, P1131, DOI 10.1002/mrm.10170
   Kantarci K, 2002, DEMENT GERIATR COGN, V14, P198, DOI 10.1159/000066021
   Kienzl E, 1999, LIFE SCI, V65, P1973, DOI 10.1016/S0024-3205(99)00458-0
   Klintworth GK, 1969, P 2 INT C NEUR GEN N, P589
   KLINTWORTH GK, 1973, HUNTINGTONS CHOREA 1, P353
   KOENIG SH, 1995, MAGNET RESON MED, V34, P227, DOI 10.1002/mrm.1910340214
   KUCHARCZYK W, 1994, AM J NEURORADIOL, V15, P1795
   Levenson CW, 2004, AGEING RES REV, V3, P251, DOI 10.1016/j.arr.2004.03.001
   LEVINE SM, 2004, REDOX ACTIVE METALS
   Lippard S. J., 1994, PRINCIPLES BIOINORGA
   LOZOFF B, 1991, NEW ENGL J MED, V325, P687, DOI 10.1056/NEJM199109053251004
   MAKLOUF SA, 1997, PHYS REV B, V55, P14717
   Mann S., 1989, BIOMINERALIZATION CH
   MAREK K, 2002, PARKINSONS DIS DIAGN, P251
   Markesbery WR, 1995, NEURODEGENERATION, V4, P383, DOI 10.1006/neur.1995.0046
   Minoshima S, 2003, NEUROIMAG CLIN N AM, V13, P769, DOI 10.1016/S1052-5149(03)00099-6
   Miszkziel KA, 1997, MAGN RESON IMAGING, V15, P1113, DOI 10.1016/S0730-725X(97)00089-1
   MORRIS CM, 1994, NEURODEGENERATION, V3, P267
   MULLIGAN M, 1986, INT J BIOCHEM, V18, P791, DOI 10.1016/0020-711X(86)90055-8
   OCONNELL M, 1986, BIOCHEM J, V234, P727
   Owen AD, 1997, J NEURAL TRANSM-SUPP, P167
   Perls M, 1867, VIRCHOW ARCH A, V39, P42
   Perry George, 2002, Journal of Biomedicine & Biotechnology, V2, P120, DOI 10.1155/S1110724302203010
   Ponka P, 2004, ANN NY ACAD SCI, V1012, P267, DOI 10.1196/annals.1306.022
   Ponka P, 1999, Kidney Int Suppl, V69, pS2
   POWELL AK, 1998, IRON TRANSPORT STORA, P515
   Prasher VP, 1998, INT J GERIATR PSYCH, V13, P818, DOI 10.1002/(SICI)1099-1166(1998110)13:11<818::AID-GPS864>3.0.CO;2-K
   PRESS DZ, 2004, NEUROBIOL AGING, V25, P378
   Puccio H, 2002, CURR OPIN GENET DEV, V12, P272, DOI 10.1016/S0959-437X(02)00298-8
   Richardson DR, 2004, ANN NY ACAD SCI, V1012, P326, DOI 10.1196/annals.1306.026
   RICHARDSON JS, 1992, ANN NY ACAD SCI, V648, P326, DOI 10.1111/j.1749-6632.1992.tb24570.x
   Riederer P., 1993, IRON CENTRAL NERVOUS
   Robinson S., 1995, ALZ RES, V1, P191
   SAVOIARDO M, 1993, AM J NEURORADIOL, V14, P155
   SCHENCK JF, 1989, ABSTRACTS SOC MAGNET, P9
   Schipper HM, 2004, ANN NY ACAD SCI, V1012, P342, DOI 10.1196/annals.1306.027
   Schuff N, 2003, NEUROLOGY, V61, P358
   Shachar Dorit Ben, 2004, Neuropharmacology, V46, P254, DOI 10.1016/j.neuropharm.2003.09.005
   Shevell M, 2003, NEW ENGL J MED, V348, P3, DOI 10.1056/NEJMp020158
   Sigel Astrid, 1998, IRON TRANSPORT STORA
   Silva J. J. R. F. D., 2001, BIOL CHEM ELEMENTS I
   Spatz H, 1922, Z GESAMTE NEUROL PSY, V77, P261, DOI 10.1007/BF02865844
   St Pierre TG, 1989, BIOMINERALIZATION CH, P295
   SUNDERMANN A, 1961, Z ALTERNSFORSCHUNG, V15, P97
   Testa U., 2002, PROTEINS IRON METABO
   Tofts P, 2003, QUANTITATIVE MRI OF THE BRAIN: MEASURING CHANGES CAUSED BY DISEASE, pXV
   Vymazal J, 1998, J INORG BIOCHEM, V71, P153, DOI 10.1016/S0162-0134(98)10047-8
   WARD RJ, 1994, EUR J BIOCHEM, V225, P187, DOI 10.1111/j.1432-1033.1994.00187.x
   Williams R. J. P., 1996, NATURAL SELECTION CH
   Yang QX, 1999, J MAGN RESON, V141, P1, DOI 10.1006/jmre.1999.1900
   Yang QX, 1998, MAGNET RESON MED, V39, P402, DOI 10.1002/mrm.1910390310
   Yoshida S, 2001, J SYNCHROTRON RADIAT, V8, P998, DOI 10.1107/S0909049500017726
   YOUDIM MBH, 1988, MT SINAI J MED, V55, P97
   YOUDIM MBH, 1988, BRAIN IRON NEUROCHEM
   Zimmerman EA, 2003, ANN NEUROL, V54, pS68
   Zywicke HA, 2002, ANN NEUROL, V52, P102, DOI 10.1002/ana.10216
NR 243
TC 171
Z9 175
U1 1
U2 12
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0952-3480
J9 NMR BIOMED
JI NMR Biomed.
PD NOV
PY 2004
VL 17
IS 7
BP 433
EP 445
DI 10.1002/nbm.922
PG 15
WC Biophysics; Radiology, Nuclear Medicine & Medical Imaging; Spectroscopy
SC Biophysics; Radiology, Nuclear Medicine & Medical Imaging; Spectroscopy
GA 874EA
UT WOS:000225332500003
PM 15523705
ER

PT J
AU Cocosco, CA
   Zijdenbos, AP
   Evans, AC
AF Cocosco, CA
   Zijdenbos, AP
   Evans, AC
TI A fully automatic and robust brain MRI tissue classification method
SO MEDICAL IMAGE ANALYSIS
LA English
DT Article; Proceedings Paper
CT 5th International Conference on Medical Image Computing and
   Computer-Assisted Intervention
CY SEP 25-28, 2002
CL TOKYO, JAPAN
DE automatic brain MRI classification; automatic brain tissue segmentation;
   morphological variability insensitivity; pruning; non-parametric method
ID MAGNETIC-RESONANCE IMAGES; NONPARAMETRIC REGRESSION; MULTIPLE-SCLEROSIS;
   BIAS FIELD; SEGMENTATION; MODEL; REGISTRATION; QUANTIFICATION;
   SCHIZOPHRENIA; VALIDATION
AB A novel. fully automatic, adaptive, robust procedure for brain tissue classification from 3D magnetic resonance head images (MRI) is described in this paper. The procedure is adaptive in that it customizes a training set, by using a 'pruning' strategy, such that the classification is robust against anatomical variability and pathology. Starting from a set of samples generated from prior tissue probability maps (a 'model') in a standard, brain-based coordinate system ('stereotaxic space'), the method first reduces the fraction of incorrectly labeled samples in this set by using a minimum spanning tree graph-theoretic approach. Then, the corrected set of samples is used by a supervised kNN classifier for classifying the entire 3D image. The classification procedure is robust against variability in the image quality through a non-parametric implementation: no assumptions are made about the tissue intensity distributions. The performance of this brain tissue classification procedure is demonstrated through quantitative and qualitative validation experiments on both simulated MRI data (10 subjects) and real MRI data (43 subjects). A significant improvement in output quality was observed on subjects who exhibit morphological deviations from the model due to aging and pathology. (C) 2003 Elsevier B.V. All rights reserved.
C1 McGill Univ, Montreal Neurol Inst, McConnell Brain Imaging Ctr, Montreal, PQ H3A 2B4, Canada.
RP Cocosco, CA (reprint author), Philips Res Labs, Div Syst Technol, Roentgenstr 24-26, D-22335 Hamburg, Germany.
EM crisco@bic.mni.mcgill.ca
CR Albertson M. O., 1988, DISCRETE MATH ALGORI
   MacDonald D, 2000, NEUROIMAGE, V12, P340, DOI 10.1006/nimg.1999.0534
   Zijdenbos AP, 2002, IEEE T MED IMAGING, V21, P1280, DOI 10.1109/TMI.2002.806283
   DECARLI C, 1992, J COMPUT ASSIST TOMO, V16, P274, DOI 10.1097/00004728-199203000-00018
   KAMBER M, 1995, IEEE T MED IMAGING, V14, P442, DOI 10.1109/42.414608
   Van Leemput K, 2003, IEEE T MED IMAGING, V22, P105, DOI 10.1109/TMI.2002.806587
   Rajapakse JC, 1997, IEEE T MED IMAGING, V16, P176, DOI 10.1109/42.563663
   Zijdenbos A, 1998, LECT NOTES COMPUT SC, V1496, P439
   Held K, 1997, IEEE T MED IMAGING, V16, P878, DOI 10.1109/42.650883
   Wright IC, 1995, NEUROIMAGE, V2, P244, DOI 10.1006/nimg.1995.1032
   CHOI HS, 1991, IEEE T MED IMAGING, V10, P395, DOI 10.1109/42.97590
   DEVROYE L, 1981, ANN STAT, V9, P1310, DOI 10.1214/aos/1176345647
   Wells WM, 1996, IEEE T MED IMAGING, V15, P429, DOI 10.1109/42.511747
   Stokking R, 2000, NEUROIMAGE, V12, P726, DOI 10.1006/nimg.2000.0661
   Schroeter P, 1998, IEEE T MED IMAGING, V17, P172, DOI 10.1109/42.700730
   ENAS GG, 1986, COMPUT MATH APPL-A, V12, P235, DOI 10.1016/0898-1221(86)90076-3
   Collins DL, 1997, INT J PATTERN RECOGN, V11, P1271, DOI 10.1142/S0218001497000597
   Smith RB, 2002, NEUROREHABILITATION, V17, P3
   Van Leemput K, 1999, IEEE T MED IMAGING, V18, P897, DOI 10.1109/42.811270
   Van Leemput K, 1999, IEEE T MED IMAGING, V18, P885, DOI 10.1109/42.811268
   Guillemaud R, 1997, IEEE T MED IMAGING, V16, P238, DOI 10.1109/42.585758
   Collins DL, 1998, IEEE T MED IMAGING, V17, P463, DOI 10.1109/42.712135
   Sled JG, 1998, IEEE T MED IMAGING, V17, P653, DOI 10.1109/42.730409
   Pham DL, 1999, IEEE T MED IMAGING, V18, P737, DOI 10.1109/42.802752
   Sled JG, 1998, IEEE T MED IMAGING, V17, P87, DOI 10.1109/42.668698
   STONE CJ, 1977, ANN STAT, V5, P595, DOI 10.1214/aos/1176343886
   Jones SE, 2000, HUM BRAIN MAPP, V11, P12, DOI 10.1002/1097-0193(200009)11:1<12::AID-HBM20>3.0.CO;2-K
   Warfield SK, 2000, MED IMAGE ANAL, V4, P43, DOI 10.1016/S1361-8415(00)00003-7
   Rapoport JL, 1999, ARCH GEN PSYCHIAT, V56, P649, DOI 10.1001/archpsyc.56.7.649
   Arya S, 1998, J ACM, V45, P891, DOI 10.1145/293347.293348
   Arya S., 1993, P DCC 93 DAT COMPR C, P381, DOI 10.1109/DCC.1993.253111
   Ashburner J, 2000, NEUROIMAGE, V11, P805, DOI 10.1006/nimg.2000.0582
   ASHBURNER J, 2000, THESIS U COLLEGE LON
   CLARKE LP, 1993, MAGN RESON IMAGING, V11, P95, DOI 10.1016/0730-725X(93)90417-C
   Cocosco C.A., 1997, NEUROIMAGE, V5, pS425
   COHEN J, 1960, EDUC PSYCHOL MEAS, V20, P37, DOI 10.1177/001316446002000104
   Collins D.L., 2001, LNCS, V2082, P141
   COLLINS DL, 1994, J COMPUT ASSIST TOMO, V18, P192
   Cormen T. H., 1990, INTRO ALGORITHMS
   D'Agostino E., 2002, LNCS
   Duda R.O., 2001, PATTERN CLASSIFICATI
   Fischl B., 2000, P NATL ACAD SCI USA, V97, P11044, DOI DOI 10.1073/PNAS.200033797
   Hahn HK, 2000, LECT NOTES COMPUT SC, V1935, P134
   Justice RK, 1997, P SOC PHOTO-OPT INS, V3034, P900, DOI 10.1117/12.274179
   KABANI N, 1997, P SOC NEUR ANN M NEW
   Kabani N.J., 1998, NEUROIMAGE, V7
   Kandel ER, 2000, PRINCIPLES NEURAL SC
   KOLLOKIAN V, 1996, THESIS CONCORDIA U M
   Kruskal J. B., 1956, P AM MATH SOC, V7, P48, DOI DOI 10.1090/S0002-9939-1956-0078686-7
   Kwan RKS, 1999, IEEE T MED IMAGING, V18, P1085, DOI 10.1109/42.816072
   Laidlaw DH, 1998, IEEE T MED IMAGING, V17, P1094, DOI 10.1109/42.746728
   *MATHSWORKS INC, 1998, MATLAB
   *MNI, 1997, BRAI SIM BRAIN DAT
   Mount D. M., 1998, ANN LIB APPROXIMATE
   ORourke J., 1998, COMPUTATIONAL GEOMET
   Paus T, 1999, SCIENCE, V283, P1908, DOI 10.1126/science.283.5409.1908
   Pohl KM, 2002, LECT NOTES COMPUT SC, V2488, P564
   Schellenberg J. D., 1990, Proceedings of Third Annual IEEE Symposium on Computer-Based Medical Systems (Cat. No.90CH2845-6), DOI 10.1109/CBMSYS.1990.109419
   Talairach J, 1988, COPLANAR STEREOTAXIC
   Udupa JK, 1996, GRAPH MODEL IM PROC, V58, P246, DOI 10.1006/gmip.1996.0021
   YAN MXH, 1995, P 14 INT C INF PROC, P201
NR 61
TC 171
Z9 175
U1 0
U2 8
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1361-8415
J9 MED IMAGE ANAL
JI Med. Image Anal.
PD DEC
PY 2003
VL 7
IS 4
BP 513
EP 527
DI 10.1016/S1361-8415(03)00037-9
PG 15
WC Computer Science, Artificial Intelligence; Computer Science,
   Interdisciplinary Applications; Engineering, Biomedical; Radiology,
   Nuclear Medicine & Medical Imaging
SC Computer Science; Engineering; Radiology, Nuclear Medicine & Medical
   Imaging
GA 736VC
UT WOS:000186193000011
PM 14561555
ER

PT J
AU Joyce, N
   Annett, G
   Wirthlin, L
   Olson, S
   Bauer, G
   Nolta, JA
AF Joyce, Nanette
   Annett, Geralyn
   Wirthlin, Louisa
   Olson, Scott
   Bauer, Gerhard
   Nolta, Jan A.
TI Mesenchymal stem cells for the treatment of neurodegenerative disease
SO REGENERATIVE MEDICINE
LA English
DT Review
DE amyotrophic lateral sclerosis; clinical trial; human mesenchymal stem
   cell; Huntington's disease; hypoxia; neurite outgrowth;
   neurodegenerative disease; tissue repair
ID AMYOTROPHIC-LATERAL-SCLEROSIS; BONE-MARROW-CELLS; NEURAL PROGENITOR
   CELLS; IMMUNE-DEFICIENT MICE; HUNTINGTONS-DISEASE; STROMAL CELLS;
   PARKINSONS-DISEASE; MULTIPLE-SCLEROSIS; MOUSE MODEL; IN-VIVO
AB Mesenchymal stem cells/marrow stromal cells (MSCs) present a promising tool for cell therapy, and are currently being tested in US FDA-approved clinical trials for myocardial infarction, stroke, meniscus injury, limb ischemia, graft-versus-host disease and autoimmune disorders. They have been extensively tested and proven effective in preclinical studies for these and many other disorders. There is currently a great deal of interest in the use of MSCs to treat neurodegenerative diseases, in particular for those that are fatal and difficult to treat, such as Huntington's disease and amyotrophic lateral sclerosis. Proposed regenerative approaches to neurological diseases using MSCs include cell therapies in which cells are delivered via intracerebral or intrathecal injection. Upon transplantation into the brain, MSCs promote endogenous neuronal growth, decrease apoptosis, reduce levels of free radicals, encourage synaptic connection from damaged neurons and regulate inflammation, primarily through paracrine actions. MSCs transplanted into the brain have been demonstrated to promote functional recovery by producing trophic factors that induce survival and regeneration of host neurons. Therapies will capitalize on the innate trophic support from MSCs or on augmented growth factor support, such as delivering brain-derived neurotrophic factor or glial-derived neurotrophic factor into the brain to support injured neurons, using genetically engineered MSCs as the delivery vehicles. Clinical trials for MSC injection into the CNS to treat traumatic brain injury and stroke are currently ongoing. The current data in support of applying MSC-based cellular therapies to the treatment of neurodegenerative disorders are discussed.
C1 [Joyce, Nanette; Annett, Geralyn; Wirthlin, Louisa; Olson, Scott; Bauer, Gerhard; Nolta, Jan A.] Univ Calif Davis, Stem Cell Program, Div Hematol Oncol, Dept Internal Med, Sacramento, CA 95817 USA.
RP Nolta, JA (reprint author), Univ Calif Davis, Stem Cell Program, Div Hematol Oncol, Dept Internal Med, 2921 Stockton Blvd,Room 1300, Sacramento, CA 95817 USA.
EM jan.nolta@ucdmc.ucdavis.edu
OI Nolta, Jan/0000-0003-4576-8542
FU California Institute for Regenerative Medicine (CIRM) [TR1-01257]; NIH
   NHLBI [1RO1 HL073256-01, 5P30AG010129-19]
FX This work was funded by the California Institute for Regenerative
   Medicine (CIRM) grant number TR1-01257 (JA Nolta), CIRM Training Grant
   to UC Davis (N Joyce), NIH NHLBI 1RO1 HL073256-01 (JA Nolta) and
   5P30AG010129-19 (DeCarli PI: JA Nolta and S Olson - pilot project PIs).
   The authors have no other relevant affiliations or financial involvement
   with any organization or entity with a financial interest in or
   financial conflict with the subject matter or materials discussed in the
   manuscript apart from those disclosed.
CR Allen J, 2009, DEV BIOL, V327, P4, DOI 10.1016/j.ydbio.2008.12.013
   Amin EM, 2008, NEUROL RES, V30, P1086, DOI 10.1179/174313208X327955
   Pfister EL, 2009, CURR BIOL, V19, P774, DOI 10.1016/j.cub.2009.03.030
   Wang XL, 2003, BLOOD, V101, P4201, DOI 10.1182/blood-2002-05-1338
   Bouchez G, 2008, NEUROCHEM INT, V52, P1332, DOI 10.1016/j.neuint.2008.02.003
   Crigler L, 2006, EXP NEUROL, V198, P54, DOI 10.1016/j.expneurol.2005.10.029
   Sadan O, 2008, STEM CELLS, V26, P2542, DOI 10.1634/stemcells.2008-0240
   Nolta JA, 1996, P NATL ACAD SCI USA, V93, P2414, DOI 10.1073/pnas.93.6.2414
   Boudreau RL, 2009, MOL THER, V17, P1053, DOI 10.1038/mt.2009.17
   Bruijn LI, 2004, ANNU REV NEUROSCI, V27, P723, DOI 10.1146/annurev.neuro.27.070203.144244
   Liang J, 2009, MULT SCLER, V15, P644, DOI 10.1177/1352458509104590
   Sadan O, 2009, ISR MED ASSOC J, V11, P201
   Harper SQ, 2005, P NATL ACAD SCI USA, V102, P5820, DOI 10.1073/pnas.0501507102
   Bachoud-Levi AC, 2006, LANCET NEUROL, V5, P303, DOI 10.1016/S1474-4422(06)
   Etheridge SL, 2004, STEM CELLS, V22, P849, DOI 10.1634/stemcells.22-5-849
   Burt RK, 2009, LANCET NEUROL, V8, P244, DOI 10.1016/S1474-4422(09)70017-1
   Delcroix GJR, 2009, BRAIN RES, V1255, P18, DOI 10.1016/j.brainres.2008.12.013
   Capoccia BJ, 2009, BLOOD, V113, P5340, DOI 10.1182/blood-2008-04-154567
   Her LS, 2008, J NEUROSCI, V28, P13662, DOI 10.1523/JNEUROSCI.4144-08.2008
   Nagano I, 2005, J NEUROL SCI, V235, P61, DOI 10.1016/j.jns.2005.04.011
   Dryden GW, 2009, EXPERT OPIN BIOL TH, V9, P841, DOI 10.1517/14712590902956615
   Fischer LR, 2004, EXP NEUROL, V185, P232, DOI 10.1016/j.expneurol.2003.10.004
   Vucic S, 2009, CURR MOL MED, V9, P255
   Sadan O, 2009, STEM CELLS DEV, V18, P1179, DOI 10.1089/scd.2008.0411
   Jin GZ, 2008, CELL BIOL INT, V32, P1433, DOI 10.1016/j.cellbi.2008.08.014
   Ramaswamy S, 2009, PROG BRAIN RES, V175, P201, DOI 10.1016/S0079-6123(09)17514-3
   GALMICHE MC, 1993, BLOOD, V82, P66
   Peichev M, 2000, BLOOD, V95, P952
   Zuccato C, 2009, NAT REV NEUROL, V5, P311, DOI 10.1038/nrneurol.2009.54
   Bauer G, 2008, MOL THER, V16, P1308, DOI 10.1038/mt.2008.93
   Kinnaird T, 2004, CIRC RES, V94, P678, DOI 10.1161/01.RES.0000118601.37875.AC
   Mancardi G, 2008, LANCET NEUROL, V7, P626, DOI 10.1016/S1474-4422(08)70138-8
   Atkins Harold, 2009, V549, P231, DOI 10.1007/978-1-60327-931-4_16
   Saccardi R, 2006, MULT SCLER, V12, P814, DOI 10.1177/1352458506071301
   Lombardi MS, 2009, EXP NEUROL, V217, P312, DOI 10.1016/j.expneurol.2009.03.004
   Williams JT, 1999, AM SURGEON, V65, P22
   Dey ND, 2010, BEHAV BRAIN RES, V214, P193, DOI 10.1016/j.bbr.2010.05.023
   Hardy SA, 2008, CURR STEM CELL RES T, V3, P43
   NOLTA JA, 1994, BLOOD, V83, P3041
   Ting AE, 2008, CRIT REV ONCOL HEMAT, V65, P81, DOI 10.1016/j.critrevonc.2007.09.007
   Karussis D, 2008, J NEUROL SCI, V265, P131, DOI 10.1016/j.jns.2007.05.005
   Zhao CP, 2007, CYTOTHERAPY, V9, P414, DOI 10.1080/14653240701376413
   Lescaudron L, 2003, INT J NEUROSCI, V113, P945, DOI 10.1080/00207450390207759
   Croft AP, 2009, EXP NEUROL, V216, P329, DOI 10.1016/j.expneurol.2008.12.010
   Orlic D, 2001, NATURE, V410, P701, DOI 10.1038/35070587
   Tolar J, 2007, STEM CELLS, V25, P371, DOI 10.1634/stemcells.2005-0620
   Gaura V, 2004, BRAIN, V127, P65, DOI 10.1093/brain/awh003
   Spees JL, 2006, P NATL ACAD SCI USA, V103, P1283, DOI 10.1073/pnas.0510511103
   Rosova I, 2008, STEM CELLS, V26, P2173, DOI 10.1634/stemcells.2007-1104
   Le Blanc K, 2006, CYTOTHERAPY, V8, P559, DOI 10.1080/14653240601045399
   Endo Y, 2008, MOL CELL BIOL, V28, P2368, DOI 10.1128/MCB.01780-07
   Murphy JM, 2003, ARTHRITIS RHEUM, V48, P3464, DOI 10.1002/art.11365
   Nagano I, 2005, NEUROL RES, V27, P768, DOI 10.1179/016164105X39860
   Zhang ZX, 2008, CYTOTHERAPY, V10, P134, DOI 10.1080/14653240701883061
   Wu GD, 2003, TRANSPLANTATION, V75, P679, DOI 10.1097/01.TP.0000048488.35010.95
   Rechavi O, 2009, FEBS LETT, V583, P1792, DOI 10.1016/j.febslet.2009.03.014
   Jackson KA, 2001, J CLIN INVEST, V107, P1395, DOI 10.1172/JCI12150
   Zimmet JM, 2005, BASIC RES CARDIOL, V100, P471, DOI 10.1007/s00395-005-0553-4
   Watts C, 2000, CELL TRANSPLANT, V9, P65
   Davidoff AM, 2001, CLIN CANCER RES, V7, P2870
   Kadoyama K, 2007, NEUROSCI RES, V59, P446, DOI 10.1016/j.neures.2007.08.017
   Canals JM, 2004, J NEUROSCI, V24, P7727, DOI 10.1523/JNEUROSCI.1197-04.2004
   Alberch J, 2004, PROG BRAIN RES, V146, P195, DOI 10.1016/S0079-6123(03)46014-7
   Theise ND, 2000, HEPATOLOGY, V32, P11, DOI 10.1053/jhep.2000.9124
   Newman Robert E., 2009, Inflammation & Allergy Drug Targets, V8, P110
   Julien JP, 2006, BBA-MOL BASIS DIS, V1762, P1013, DOI 10.1016/j.bbadis.2006.03.006
   Gregory CA, 2003, J BIOL CHEM, V278, P28067, DOI 10.1074/jbc.M300373200
   Morita E, 2008, EXP NEUROL, V213, P431, DOI 10.1016/j.expneurol.2008.07.011
   Aizman I, 2009, J NEUROSCI RES, V87, P3198, DOI 10.1002/jnr.22146
   Rogojan C, 2009, ACTA NEUROL SCAND, V120, P371, DOI 10.1111/j.1600-0404.2009.01168.x
   Vercelli A, 2008, NEUROBIOL DIS, V31, P395, DOI 10.1016/j.nbd.2008.05.016
   Petersen BE, 1999, SCIENCE, V284, P1168, DOI 10.1126/science.284.5417.1168
   Klein SM, 2005, HUM GENE THER, V16, P509, DOI 10.1089/hum.2005.16.509
   Bantubungi K, 2008, MOL CELL NEUROSCI, V37, P454, DOI 10.1016/j.mcn.2007.11.001
   Gnecchi M, 2006, FASEB J, V20, P661, DOI 10.1096/fj.05-5211com
   Suzuki M, 2008, MOL THER, V16, P2002, DOI 10.1038/mt.2008.197
   Mazzini L, 2003, AMYOTROPH LATERAL SC, V4, P158, DOI 10.1080/14660820310014653
   Chen JL, 2003, J NEUROSCI RES, V73, P778, DOI 10.1002/jnr.10691
   DiFiglia M, 2007, P NATL ACAD SCI USA, V104, P17204, DOI 10.1073/pnas.0708285104
   Laflamme MA, 2005, NAT BIOTECHNOL, V23, P845, DOI 10.1038/nbt1117
   Wang YL, 2005, NEUROSCI RES, V53, P241, DOI 10.1016/j.neures.2005.06.021
   Meyerrose TE, 2008, STEM CELLS, V26, P1713, DOI 10.1634/stemcells.2008-0008
   Zhang Y, 2009, J NEUROCHEM, V108, P82, DOI 10.1111/j.1471-4159.2008.05734.x
   Kidd S, 2008, CYTOTHERAPY, V10, P657, DOI 10.1080/14653240802486517
   Meyerrose TE, 2007, STEM CELLS, V25, P220, DOI 10.1634/stemcells.2006-0243
   Mays RW, 2007, EXPERT OPIN BIOL TH, V7, P173, DOI 10.1517/14712598.7.2.173
   Peterson AL, 2008, NEUROTHERAPEUTICS, V5, P270, DOI 10.1016/j.nurt.2008.02.003
   Li JY, 2008, NAT MED, V14, P501, DOI 10.1038/nm1746
   Theise ND, 2000, HEPATOLOGY, V31, P235, DOI 10.1002/hep.510310135
   Munoz JR, 2005, P NATL ACAD SCI USA, V102, P18171, DOI 10.1073/pnas.0508945102
   Danielyan L, 2009, EUR J CELL BIOL, V88, P315, DOI 10.1016/j.ejcb.2009.02.001
   Kassis I, 2008, ARCH NEUROL-CHICAGO, V65, P753, DOI 10.1001/archneur.65.6.753
   Donsante A, 2007, SCIENCE, V317, P477, DOI 10.1126/science.1142658
   Kim HJ, 2009, STEM CELLS, V27, P390, DOI 10.1634/stemcells.2007-1047
   Kidd S, 2009, STEM CELLS, V27, P2614, DOI 10.1002/stem.187
   Manfredsson FP, 2009, CURR GENE THER, V9, P375
   Lagasse E, 2000, NAT MED, V6, P1229, DOI 10.1038/81326
   Kim SU, 2009, J NEUROSCI RES, V87, P2183, DOI 10.1002/jnr.22054
   Hare JM, 2009, J AM COLL CARDIOL, V54, P2277, DOI 10.1016/j.jacc.2009.06.055
   Gharami K, 2008, J NEUROCHEM, V105, P369, DOI 10.1111/j.1471-4159.2007.05137.x
   Crisa L, 1999, BLOOD, V94, P3928
   Dao MA, 1997, STEM CELLS, V15, P443
   Funakoshi Hiroshi, 2007, Brain and Nerve (Tokyo), V59, P1195
   Greene P, 2009, CURR NEUROL NEUROSCI, V9, P292, DOI 10.1007/s11910-009-0044-3
   Ionov ID, 2007, AMYOTROPH LATERAL SC, V8, P260, DOI 10.1080/17482960701523124
   Jenner P, 2008, ANN NEUROL, V64, pS16, DOI 10.1002/ana.21489
   Karussis D, 2010, MULTIPLE SCLEROSIS A
   Li Yi, 2005, Glia, V49, P407, DOI 10.1002/glia.20126
   Maxwell MM, 2009, CURR PHARM DESIGN, V15, P3977
   Mazzini L, 2009, EXP NEUROL, V223, P229
   Meyerrose T, 2006, ESTABLISHMENT TRANSD
   Mohyeddin Bonab M., 2007, IRAN J IMMUNOL, V4, P50
   Nolta J, 2006, GENETIC ENG MESENCHY
   NOLTA JA, 1990, HUM GENE THER, V1, P257, DOI 10.1089/hum.1990.1.3-257
   Sharp J, 2009, NEUROSCI LETT, V456, P107, DOI 10.1016/j.neulet.2008.04.106
   Shevchenko YL, 2008, EXP HEMATOL, V36, P922, DOI 10.1016/j.exphem.2008.03.001
   Suzuki M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000689
   Tsark EC, 2001, J IMMUNOL, V166, P170
   Wilkins A, 2009, STEM CELL RES
   Wu L. L. Y., 2009, J BIOL CHEM, V285, P5614
   2010, MULTIPLE SCLEROSIS A
NR 121
TC 156
Z9 168
U1 8
U2 55
PU FUTURE MEDICINE LTD
PI LONDON
PA UNITEC HOUSE, 3RD FLOOR, 2 ALBERT PLACE, FINCHLEY CENTRAL, LONDON, N3
   1QB, ENGLAND
SN 1746-0751
J9 REGEN MED
JI Regen. Med.
PD NOV
PY 2010
VL 5
IS 6
BP 933
EP 946
DI 10.2217/RME.10.72
PG 14
WC Cell & Tissue Engineering; Engineering, Biomedical
SC Cell Biology; Engineering
GA 686VP
UT WOS:000284724900015
PM 21082892
ER

PT J
AU Heneka, MT
   Landreth, GE
AF Heneka, Michael T.
   Landreth, Gary E.
TI PPARs in the brain
SO BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS
LA English
DT Review
DE neuroinflammation; Alzheimer's disease; multiple sclerosis; Parkinson's
   disease; amyotrophic lateral sclerosis; ischemic stroke; cerebral
   neoplasm
ID PROLIFERATOR-ACTIVATED-RECEPTOR; NITRIC-OXIDE SYNTHASE; EXPERIMENTAL
   AUTOIMMUNE ENCEPHALOMYELITIS; NONSTEROIDAL ANTIINFLAMMATORY DRUGS;
   AMYOTROPHIC-LATERAL-SCLEROSIS; AMYLOID PRECURSOR PROTEIN;
   CENTRAL-NERVOUS-SYSTEM; CELLS IN-VITRO; NF-KAPPA-B; EXPERIMENTAL
   ALLERGIC ENCEPHALOMYELITIS
AB The biology of peroxisome proliferator activated receptors (PPARs) in physiological and pathophysiological processes has been primarily studied in peripherial organs and tissues. Recently it became clear that PPARs play an important role for the pathogenesis of various disorders of the CNS. The finding that activation of PPARs, and in particular, the PPAR gamma isoform, suppresses inflammation in peripherial macrophages and in models of human autoimmune disease, instigated the experimental evaluation of these salutary actions for several CNS disorders that have an inflammatory component. Activation of all PPAR isoforms, but especially of PPAR gamma, has been found to be protective in murine in vitro and in vivo models of Multiple Sclerosis. The verification of these findings in human cells prompted the initiation of clinical studies evaluating PPAR gamma activation in Multiple Sclerosis patients. Likewise, Alzheimer's disease has a prominent inflammatory component that anises in response to neurodegeneration and to extracellular deposition of beta-amyloid peptides. The fact that non steroidal anti-inflammatory drugs (NSAIDs) delay the onset and reduce the risk to develop Alzheimer's disease, while they also bind to and activate PPAR gamma, led to the hypothesis that one dimension of NSAID protection in AD may be mediated by PPAR gamma. Several lines of evidence from in vitro and in vivo studies have supported this hypothesis, using Alzheimer disease related transgenic cellular and animal models. The ability of PPAR agonists to elicit anti-amyloidogeni c, anti-inflammatory and insulin sensitizing effects may account for the observed effects. A number of clinical trials employing PPAR agonists have yielded promising results and further trials are in preparation, which aim to delineate the exact mechanism of interaction. Animal models of other neurodegencrative diseases such as Parkinson's and Amyotrophic lateral sclerosis, both associated with a considerable degree of CNS inflammation, have been studied with a positive outcome. Yet it is not clear whether reduction of inflammation or additional mechanisms account for the observed neuroprotection. Less is known about the physiological role of PPARs for brain development, maintenance and function. Lesions from transgenic mouse models, however, provide evidence that PPARs may play pivotal roles for CNS development and function. (c) 2007 Elsevier B.V All rights reserved.
C1 Case Western Reserve Univ, Dept Neurosci, Cleveland, OH USA.
RP Heneka, MT (reprint author), Univ Munster, Dept Neurol, Mol Neurol Unit, Albert Schweitzer Str 33, D-48149 Munster, Germany.
EM heneka@uni-muenster.de
CR Akasaki Y, 2006, J BIOL CHEM, V281, P6165, DOI 10.1074/jbc.M505266200
   Heneka MT, 2001, ANN NEUROL, V49, P276, DOI 10.1002/1531-8249(20010201)49:2<276::AID-ANA53>3.0.CO;2-5
   Sundararajan S, 2004, DRUG NEWS PERSPECT, V17, P229, DOI 10.1358/dnp.2004.17.4.829049
   Rodway HA, 2004, BIOCHEM J, V382, P83
   Schutz B, 2005, J NEUROSCI, V25, P7805, DOI 10.1523/JNEUROSCI.2038-05.2005
   Ogawa S, 2005, CELL, V122, P707, DOI 10.1016/j.cell.2005.06.029
   Waite KJ, 2001, J BIOL CHEM, V276, P7062, DOI 10.1074/jbc.M007894200
   Barone FC, 1999, J CEREBR BLOOD F MET, V19, P819, DOI 10.1097/00004647-199908000-00001
   Peters JM, 2000, MOL CELL BIOL, V20, P5119, DOI 10.1128/MCB.20.14.5119-5128.2000
   Inestrosa NC, 2005, EXP CELL RES, V304, P91, DOI 10.1016/j.yexcr.2004.09.032
   Michalik L, 2006, PHARMACOL REV, V58, P726, DOI 10.1124/pr.58.4.5
   Inoue H, 2003, NEUROSCI LETT, V352, P203, DOI 10.1016/S0304-3940(03)01080-2
   Shimazu T, 2005, STROKE, V36, P353, DOI 10.1161/01.STR.0000152271.21943.a2
   Cristiano L, 2001, J NEUROCYTOL, V30, P671, DOI 10.1023/A:1016525716209
   Palmer CNA, 1998, MOL PHARMACOL, V53, P14
   Przedborski S, 1996, P NATL ACAD SCI USA, V93, P4565, DOI 10.1073/pnas.93.10.4565
   Heneka MT, 1999, J NEUROIMMUNOL, V100, P156, DOI 10.1016/S0165-5728(99)00192-7
   Ricote M, 1998, NATURE, V391, P79, DOI 10.1038/34178
   Qiu WQ, 2006, NEUROBIOL AGING, V27, P190, DOI 10.1016/j.neurobiolaging.2005.01.004
   Wang NP, 2002, J BIOL CHEM, V277, P34176, DOI 10.1074/jbc.M203436200
   Heneka MT, 2000, J NEUROSCI, V20, P6862
   Schmidt S, 2004, J LEUKOCYTE BIOL, V75, P478, DOI 10.1189/jlb.0803402
   Kintscher U, 2000, EUR J PHARMACOL, V401, P259, DOI 10.1016/S0014-2999(00)00461-1
   Cimini AM, 2005, INT J CANCER, V117, P923, DOI 10.1002/ijc.21272
   Craft S, 1999, NEUROENDOCRINOLOGY, V70, P146, DOI 10.1159/000054469
   Pedersen WA, 2004, NEUROBIOL DIS, V17, P500, DOI 10.1016/j.nbd.2004.08.003
   Yao CJ, 2006, INT J CANCER, V118, P773, DOI 10.1002/ijc.21361
   Valentiner U, 2005, TOXICOLOGY, V213, P157, DOI 10.1016/j.tox.2005.05.024
   Behin A, 2003, LANCET, V361, P323, DOI 10.1016/S0140-6736(03)12328-8
   Mukherjee R, 1997, J BIOL CHEM, V272, P8071
   Kielian T, 2003, J NEUROSCI RES, V71, P315, DOI 10.1002/jnr.10501
   Peila R, 2002, DIABETES, V51, P1256, DOI 10.2337/diabetes.51.4.1256
   Kiaei M, 2005, EXP NEUROL, V191, P331, DOI 10.1016/j.expneural.2004.10.007
   Kawahito Y, 2000, J CLIN INVEST, V106, P189, DOI 10.1172/JCI9652
   Willson TM, 2001, ANNU REV BIOCHEM, V70, P341, DOI 10.1146/annurev.biochem.70.1.341
   Marx N, 2000, J IMMUNOL, V164, P6503
   Victor NA, 2006, EUR J NEUROSCI, V24, P1653, DOI 10.1111/j.1460-9568.2006.05037.x
   Yan Q, 2003, J NEUROSCI, V23, P7504
   Sastre M, 2003, J NEUROSCI, V23, P9796
   Gimble JM, 1996, MOL PHARMACOL, V50, P1087
   Bernardo A, 2006, CURR PHARM DESIGN, V12, P93, DOI 10.2174/138161206780574579
   ZHANG RL, 1994, NEUROLOGY, V44, P1747
   Dormandy JA, 2005, LANCET, V366, P1279, DOI 10.1016/S0140-6736(05)67528-9
   Camacho IE, 2004, J NEUROSCI, V24, P10908, DOI 10.1523/JNEUROSCI.3987-04.2004
   Kudo M, 2004, ENDOCRINOLOGY, V145, P4948, DOI 10.1210/en.2004-0180
   Akiyama H, 2000, NEUROBIOL AGING, V21, P383, DOI 10.1016/S0197-4580(00)00124-X
   Kleihues P, 2002, J NEUROPATH EXP NEUR, V61, P215
   Diab A, 2002, J IMMUNOL, V168, P2508
   Heneka MT, 2001, J NEUROPATH EXP NEUR, V60, P906
   Niino M, 2001, J NEUROIMMUNOL, V116, P40, DOI 10.1016/S0165-5728(01)00285-5
   Braissant O, 1996, ENDOCRINOLOGY, V137, P354, DOI 10.1210/en.137.1.354
   Cunard R, 2002, J IMMUNOL, V168, P2795
   Chen HL, 2003, ARCH NEUROL-CHICAGO, V60, P1059, DOI 10.1001/archneur.60.8.1059
   Desreumaux P, 2001, J EXP MED, V193, P827, DOI 10.1084/jem.193.7.827
   Heneka MT, 2005, BRAIN, V128, P1442, DOI 10.1093/brain/awh452
   Krey G, 1997, MOL ENDOCRINOL, V11, P779, DOI 10.1210/me.11.6.779
   Pereira MP, 2006, J CEREBR BLOOD F MET, V26, P218, DOI 10.1038/sj.jcbfm.9600182
   Chen HL, 2005, ANN NEUROL, V58, P963, DOI 10.1002/ana.20682
   Arsenijevic D, 2006, J CEREBR BLOOD F MET, V26, P433, DOI 10.1038/sj.jcbfm.9600200
   Lovett-Racke AE, 2004, J IMMUNOL, V172, P5790
   Smith SA, 2004, J NEUROSCI RES, V77, P240, DOI 10.1002/jnr.20153
   Han SW, 2001, CLIN CANCER RES, V7, P98
   Iwashita A, 2007, J PHARMACOL EXP THER, V320, P1087, DOI 10.1124/jpet.106.115758
   Polak PE, 2005, J NEUROIMMUNOL, V168, P65, DOI 10.1016/j.jneuroim.2005.07.006
   Breidert T, 2002, J NEUROCHEM, V82, P615, DOI 10.1046/j.1471-4159.2002.00990.x
   Watson GS, 2005, AM J GERIAT PSYCHIAT, V13, P950, DOI 10.1176/appi.ajgp.13.11.950
   Ghisletti S, 2007, MOL CELL, V25, P57, DOI 10.1016/j.molcel.2006.11.022
   Grommes C, 2004, LANCET ONCOL, V5, P419, DOI 10.1016/S1470-2045(04)01509-8
   Liu DC, 2004, ACTA PHARMACOL SIN, V25, P1312
   Cellai I, 2006, BRIT J CANCER, V95, P879, DOI 10.1038/sj.bjc.6603344
   Rossi A, 2000, NATURE, V403, P103
   Cullingford TE, 1998, J NEUROCHEM, V70, P1366
   Zhao XR, 2006, BRAIN RES, V1073, P460, DOI 10.1016/j.brainres.2005.12.061
   Desvergne B, 1999, ENDOCR REV, V20, P649, DOI 10.1210/er.20.5.649
   Servidei T, 2004, ONCOL RES, V14, P345
   Collino M, 2006, EUR J PHARMACOL, V530, P70, DOI 10.1016/j.ejphar.2005.11.049
   Chen SD, 2006, BIOCHEM BIOPH RES CO, V351, P198, DOI 10.1016/j.bbrc.2006.10.017
   Schultze K, 2006, APOPTOSIS, V11, P1503, DOI 10.1007/s10495-006-8896-3
   d'Abramo C, 2005, BIOCHEM J, V391, P693, DOI 10.1042/BJ20050560
   Lehmann JM, 1997, J BIOL CHEM, V272, P3406
   Grommes C, 2006, MOL PHARMACOL, V70, P1524, DOI 10.1124/mol.106.022194
   Feinstein DL, 2002, ANN NEUROL, V51, P694, DOI 10.1002/ana.60612
   Auboeuf D, 1997, DIABETES, V46, P1319, DOI 10.2337/diabetes.46.8.1319
   Hantraye P, 1996, NAT MED, V2, P1017, DOI 10.1038/nm0996-1017
   Pedersen WA, 2006, EXP NEUROL, V199, P265, DOI 10.1016/j.expneurol.2006.01.018
   Palakurthi SS, 2001, CANCER RES, V61, P6213
   Chawla A, 2001, NAT MED, V7, P48
   Jiang CY, 1998, NATURE, V391, P82
   Marx N, 2002, CIRC RES, V90, P703, DOI 10.1161/01.RES.0000014225.20727.8F
   Allahtavakoli M, 2006, CLIN EXP PHARMACOL P, V33, P1052, DOI 10.1111/j.1440-1681.2006.04486.x
   Kim EJ, 2002, BRAIN RES, V941, P1, DOI 10.1016/S0006-8993(02)02480-0
   Park KS, 2004, EXP CELL RES, V297, P424, DOI 10.1016/j.yexcr.2004.03.034
   Weydt P, 2005, NEUROREPORT, V16, P527, DOI 10.1097/00001756-200504250-00001
   BARONE FC, 1995, MOL CHEM NEUROPATHOL, V24, P13
   Combs CK, 2000, J NEUROSCI, V20, P558
   Zheng Z, 2004, NEUROL RES, V26, P884, DOI 10.1179/016164104X2357
   Morosetti R, 2004, INT J ONCOL, V25, P493
   Keller JM, 2000, INT J DEV BIOL, V44, P429
   Braissant O, 1998, ENDOCRINOLOGY, V139, P2748, DOI 10.1210/en.139.6.2748
   Watson GS, 2003, CNS DRUGS, V17, P27, DOI 10.2165/00023210-200317010-00003
   Wada K, 2006, J BIOL CHEM, V281, P12673, DOI 10.1074/jbc.M513786200
   Chattopadhyay N, 2000, J NEUROSCI RES, V61, P67, DOI 10.1002/1097-4547(20000701)61:1<67::AID-JNR8>3.0.CO;2-7
   RELTON JK, 1992, BRAIN RES BULL, V29, P243, DOI 10.1016/0361-9230(92)90033-T
   Saluja I, 2001, GLIA, V33, P191, DOI 10.1002/1098-1136(200103)33:3<191::AID-GLIA1018>3.3.CO;2-D
   Barak Y, 1999, MOL CELL, V4, P585, DOI 10.1016/S1097-2765(00)80209-9
   Posch MG, 2004, MED SCI MONITOR, V10, pBR250
   Moreno S, 2004, NEUROSCIENCE, V123, P131, DOI 10.1016/j.neurosicence.2003.08.064
   Rosen ED, 2001, J BIOL CHEM, V276, P37731
   Delerive P, 1999, J BIOL CHEM, V274, P32048, DOI 10.1074/jbc.274.45.32048
   Kato M, 2002, JPN J CANCER RES, V93, P660
   Hunter RL, 2007, J NEUROCHEM, V100, P1375, DOI 10.1111/j.1471-4159.2006.04327.x
   Liberatore GT, 1999, NAT MED, V5, P1403
   Vodovotz Y, 1996, J EXP MED, V184, P1425, DOI 10.1084/jem.184.4.1425
   Yang GY, 1998, NEUROREPORT, V9, P2131, DOI 10.1097/00001756-199806220-00041
   Woods JW, 2003, BRAIN RES, V975, P10, DOI 10.1016/S0006-8993(03)02515-0
   Dehmer T, 2004, J NEUROCHEM, V88, P494, DOI 10.1046/j.1471-4159.2003.02210.x
   Feinstein DL, 2005, BIOCHEM PHARMACOL, V70, P177, DOI 10.1016/j.bcp.2005.03.033
   Chalimoniuk M, 2004, J NEUROCHEM, V90, P629, DOI 10.1111/j.1471-4159.2004.02535.x
   Dehmer T, 2000, J NEUROCHEM, V74, P2213, DOI 10.1046/j.1471-4159.2000.0742213.x
   Heneka MT, 2003, J NEUROCHEM, V85, P387, DOI 10.1046/j.1471-4159.2003.01694.x
   Risner ME, 2006, PHARMACOGENOMICS J, V6, P246, DOI 10.1038/sj.tpj.6500369
   RIECKMANN P, 1995, ANN NEUROL, V37, P82, DOI 10.1002/ana.410370115
   Zander T, 2002, J NEUROCHEM, V81, P1052, DOI 10.1046/j.1471-4159.2002.00899.x
   Su CG, 1999, J CLIN INVEST, V104, P383, DOI 10.1172/JCI7145
   Charo IF, 2006, NEW ENGL J MED, V354, P610, DOI 10.1056/NEJMra052723
   Luo YM, 2006, J NEUROCHEM, V97, P435, DOI 10.1011/j.1471-4159.2006.03758.x
   SCHULZ JB, 1995, J NEUROCHEM, V64, P936
   McGeer PL, 2002, MUSCLE NERVE, V26, P459, DOI 10.1002/mus.10191
   Becker KJ, 1998, CURR OPIN NEUROL, V11, P45, DOI 10.1097/00019052-199802000-00008
   Zhao Y, 2005, EUR J NEUROSCI, V22, P278, DOI 10.1111/j.1460-9568.2005.04200.x
   Landreth GE, 2001, NEUROBIOL AGING, V22, P937, DOI 10.1016/S0197-4580(01)00296-2
   Escriva H, 2000, BIOESSAYS, V22, P717
   Colville-Nash PR, 1998, J IMMUNOL, V161, P978
   Fuentealba RA, 2004, BRAIN RES REV, V47, P275, DOI 10.1016/j.brainresrev.2004.07.018
   Perez-Ortiz JM, 2004, J BIOL CHEM, V279, P8976, DOI 10.1074/jbc.M308518200
   Strakova N, 2004, J PHARMACOL EXP THER, V309, P1239, DOI 10.1124/jpet.103.063438
   Luchsinger JA, 2001, AM J EPIDEMIOL, V154, P635, DOI 10.1093/aje/154.7.635
   Kersten S, 2000, EXS, V89, P141
   Daynes RA, 2002, NAT REV IMMUNOL, V2, P748, DOI 10.1038/nri912
   Collet P, 2004, GENOMICS, V83, P1141, DOI 10.1016/j.ygeno.2004.01.002
   Luna-Medina R, 2005, J BIOL CHEM, V280, P21453, DOI 10.1074/jbc.M414390200
   Maggiora M, 2004, INT J CANCER, V112, P909, DOI 10.1002/ijc.20519
   Sundararajan S, 2005, NEUROSCIENCE, V130, P685, DOI 10.1016/j.neuroscience.2004.10.021
   Sastre M, 2006, P NATL ACAD SCI USA, V103, P443, DOI 10.1073/pnas.0503839103
   Escher P, 2001, ENDOCRINOLOGY, V142, P4195, DOI 10.1210/en.142.10.4195
   Pereira MP, 2005, J NEUROPATH EXP NEUR, V64, P797
   Lee SC, 1999, J NEUROPATH EXP NEUR, V58, P1163, DOI 10.1097/00005072-199911000-00006
   Grommes C, 2005, J PHARMACOL EXP THER, V313, P806, DOI 10.1124/jpet.104.078972
   Deplanque D, 2003, J NEUROSCI, V23, P6264
   Berge K, 2001, CARCINOGENESIS, V22, P1747, DOI 10.1093/carcin/22.11.1747
   Kreisler A, 2007, BRAIN RES, V1135, P77, DOI 10.1016/j.brainres.2006.12.011
   Barish GD, 2006, J NUTR, V136, P690
   BASUMODAK S, 1999, J BIOL CHEM, V274, P35811
   Bonfigli A, 2006, J CELL PHYSIOL, V207, P675, DOI 10.1002/jcp.20603
   Burdge GC, 2000, J CELL BIOCHEM, V80, P266
   Chopp M, 1996, J CEREBR BLOOD F MET, V16, P578
   Cimini A, 2003, GLIA, V41, P3, DOI 10.1002/glia.10143
   Collino M, 2006, FREE RADICAL BIO MED, V41, P579, DOI 10.1016/j.freeradbiomed.2006.04.030
   Craft S, 2000, ANN NY ACAD SCI, V903, P222, DOI 10.1111/j.1749-6632.2000.tb06371.x
   Cunard R, 2002, J IMMUNOL, V169, P6806
   EHRMANN J, 2002, OLOMOUC CZECH REPUB, V146, P11
   Emmans VC, 2004, BIOCHEM SOC T, V32, P840
   Engelhardt B, 2006, J NEUROIMMUNOL, V178, P32
   Farioli-Vecchioli S, 2001, J NEUROCYTOL, V30, P21, DOI 10.1023/A:1011913223541
   GELDMACHER D, 2004, PIOGLITAZONE ALZHEIM, P397
   Hull M, 2002, CURR MED CHEM, V9, P83
   Hunot S, 1997, P NATL ACAD SCI USA, V94, P7531, DOI 10.1073/pnas.94.14.7531
   Iadecola C, 1997, ANN NY ACAD SCI, V835, P203, DOI 10.1111/j.1749-6632.1997.tb48631.x
   Jones DC, 2002, FASEB J, V16, pA700
   Klotz L, 2005, J IMMUNOL, V175, P4948
   Kuusisto J, 1997, BRIT MED J, V315, P1045
   Lee BC, 2006, NEUROSCI LETT, V410, P141, DOI 10.1016/j.neulet.2006.08.024
   Lee J, 2007, NEUROCHEM RES, V32, P635, DOI 10.1007/s11064-006-9138-3
   Maeshiba Y, 1997, ARZNEIMITTEL-FORSCH, V47, P29
   MARTIN R, 1992, ANNU REV IMMUNOL, V10, P153
   Bright JJ, 2003, J IMMUNOL, V171, P5743
   Pershadsingh HA, 2004, EXPERT OPIN INV DRUG, V13, P215, DOI 10.1517/eoid.13.3.215.27349
   Raikwar HP, 2006, J NEUROIMMUNOL, V178, P76, DOI 10.1016/j.jneuroim.2006.05.013
   Stewart BW, 2003, WORLD CANC REPORT
   Strakova N, 2005, NEOPLASMA, V52, P126
   t' Veld BA, 2001, NEW ENGL J MED, V345, P1515
NR 181
TC 152
Z9 155
U1 0
U2 7
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1388-1981
J9 BBA-MOL CELL BIOL L
JI Biochim. Biophys. Acta Mol. Cell Biol. Lipids
PD AUG
PY 2007
VL 1771
IS 8
BP 1031
EP 1045
DI 10.1016/j.bbalip.2007.04.016
PG 15
WC Biochemistry & Molecular Biology; Biophysics; Cell Biology
SC Biochemistry & Molecular Biology; Biophysics; Cell Biology
GA 205XS
UT WOS:000249149100012
PM 17569578
ER

PT J
AU Dzwonek, J
   Rylski, M
   Kaczmarek, L
AF Dzwonek, J
   Rylski, M
   Kaczmarek, L
TI Matrix metalloproteinases and their endogenous inhibitors in neuronal
   physiology of the adult brain
SO FEBS LETTERS
LA English
DT Article; Proceedings Paper
CT 29th Congress of the Federation-of-European-Biochemical-Societies
CY 2004
CL Warsaw, POLAND
SP Federat European Biochem Soc
DE brain; neuron; neuronal plasticity; long term potentiation; memory
   matrix metalloproteinase-9
ID CENTRAL-NERVOUS-SYSTEM; MESSENGER-RNA EXPRESSION; TISSUE INHIBITOR;
   RAT-BRAIN; MATRIX-METALLOPROTEINASE-9 MMP-9; DIFFERENTIAL EXPRESSION;
   PLASMINOGEN-ACTIVATOR; EXTRACELLULAR-MATRIX; MULTIPLE-SCLEROSIS;
   REPERFUSION INJURY
AB More than 20 matrix metalloproteinases (MMPs) and four of their endogenous tissue inhibitors (TIMPs) act together to control tightly temporally restricted, focal proteolysis of extracellular matrix. In the neurons of the adult brain several components of the TIMP/MMP system are expressed and are responsive to changes in neuronal activity. Futhermore, functional studies, especially involving blocking of MMP activites, along with the identification of MMP substrates in the brain strongly suggest that this enzymatic system plays an important physiological role in adult brain neurons, possibly being pivotal for neuronal plasticity. (C) 2004 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.
C1 M Nencki Inst Expt Biol, Dept Mol & Cellular Neurobiol, PL-02093 Warsaw, Poland.
   Univ Warmia & Mazury, Fac Biol, Dept Genet, PL-10719 Olsztyn, Poland.
RP Kaczmarek, L (reprint author), M Nencki Inst Expt Biol, Dept Mol & Cellular Neurobiol, Pasteura 3, PL-02093 Warsaw, Poland.
EM leszek@nencki.gov.pl
RI Kaczmarek, Leszek/B-6171-2008
OI Kaczmarek, Leszek/0000-0002-7207-3490
CR Akool el S., 2003, MOL CELL BIOL, V23, P4901
   Wetzel M, 2003, EUR J NEUROSCI, V18, P1050, DOI 10.1046/j.1460-9568.2003.02838.x
   Uhm JH, 1998, GLIA, V22, P53, DOI 10.1002/(SICI)1098-1136(199801)22:1<53::AID-GLIA5>3.0.CO;2-9
   Tan HK, 2003, MOL CELL NEUROSCI, V22, P98, DOI 10.1016/S1044-7431(02)00024-6
   Zuo J, 1998, J NEUROSCI, V18, P5203
   Taraboletti G, 2002, AM J PATHOL, V160, P673, DOI 10.1016/S0002-9440(10)64887-0
   Leppert D, 2001, BRAIN RES REV, V36, P249, DOI 10.1016/S0165-0173(01)00101-1
   Reeves TM, 2003, J NEUROSCI, V23, P10182
   Backstrom JR, 1996, J NEUROSCI, V16, P7910
   Taishi P, 2001, AM J PHYSIOL-REG I, V281, pR839
   Rivera S, 2002, EUR J NEUROSCI, V15, P19, DOI 10.1046/j.0953-816x.2001.01838.x
   Rahkonen OP, 2002, BBA-GENE STRUCT EXPR, V1577, P45, DOI 10.1016/S0167-4781(02)00404-9
   Lee R, 2001, SCIENCE, V294, P1945, DOI 10.1126/science.1065057
   Vaillant C, 1999, J NEUROSCI, V19, P4994
   Evert BO, 2001, J NEUROSCI, V21, P5389
   Wright JW, 2003, BRAIN RES, V963, P252, DOI 10.1016/S0006-8993(02)04036-2
   Phillips LL, 2001, RESTOR NEUROL NEUROS, V19, P213
   Wallace JA, 2002, J CEREBR BLOOD F MET, V22, P1303, DOI 10.1097/01.WCB.0000040943.89393.cl
   Patrick MK, 2002, J VIROL, V76, P7923, DOI 10.1128/JVI.76.16.7923-7931.2002
   Kim GW, 2003, J NEUROSCI, V23, P8733
   Rivera S, 1997, J NEUROSCI, V17, P4223
   Johnston JB, 2002, J VIROL, V76, P2622, DOI 10.1128/JVI.76.6.2622-2633.2002
   Gardner J, 2003, J NEUROSCI RES, V74, P801, DOI 10.1002/jnr.10835
   Hayashita-Kinoh H, 2001, CELL GROWTH DIFFER, V12, P573
   Zhang KY, 2003, NAT NEUROSCI, V6, P1064, DOI 10.1038/nn1127
   Lohi J, 2001, J BIOL CHEM, V276, P10134, DOI 10.1074/jbc.M001599200
   McClung CA, 2003, NAT NEUROSCI, V6, P1208, DOI 10.1038/nn1143
   Van den Steen PE, 2002, CRIT REV BIOCHEM MOL, V37, P375
   Asahina M, 2001, CLIN NEUROPATHOL, V20, P60
   Lee SR, 2004, J NEUROSCI, V24, P671, DOI 10.1523/JNEUROSCI.4243-03.2004
   Yong VW, 2001, NAT REV NEUROSCI, V2, P502, DOI 10.1038/35081571
   Lorenzl S, 2002, EXP NEUROL, V178, P13, DOI 10.1006/exnr.2002.8019
   Asahi M, 2000, J CEREBR BLOOD F MET, V20, P1681
   Wang XY, 2003, NAT MED, V9, P1313, DOI 10.1038/nm926
   Rosenberg GA, 2001, BRAIN RES, V893, P104, DOI 10.1016/S0006-8993(00)03294-7
   Gu ZZ, 2002, SCIENCE, V297, P1186, DOI 10.1126/science.1073634
   Yamada H, 2001, HUM MOL GENET, V10, P1563, DOI 10.1093/hmg/10.15.1563
   NEDIVI E, 1993, NATURE, V363, P718, DOI 10.1038/363718a0
   Rathke-Hartlieb S, 2000, FEBS LETT, V481, P227, DOI 10.1016/S0014-5793(00)02011-1
   Vecil GG, 2000, J NEUROSCI RES, V61, P212, DOI 10.1002/1097-4547(20000715)61:2<212::AID-JNR12>3.0.CO;2-9
   Sternlicht MD, 2001, ANNU REV CELL DEV BI, V17, P463, DOI 10.1146/annurev.cellbio.17.1.463
   Jaworski J, 1999, J BIOL CHEM, V274, P28106, DOI 10.1074/jbc.274.40.28106
   Wang XY, 2000, J NEUROSCI, V20, P7037
   Newton SS, 2003, J NEUROSCI, V23, P10841
   Szklarczyk A, 2002, J NEUROSCI, V22, P920
   Hahn-Dantona E, 2001, J BIOL CHEM, V276, P15498, DOI 10.1074/jbc.M100121200
   Kaczmarek L, 2002, EMBO J, V21, P6643, DOI 10.1093/emboj/cdf676
   Vaillant C, 2003, MOL CELL NEUROSCI, V24, P395, DOI 10.1016/S1044-7431(03)00196-9
   Sekine-Aizawa Y, 2001, EUR J NEUROSCI, V13, P935, DOI 10.1046/j.0953-816x.2001.01462.x
   Pagenstecher A, 1998, AM J PATHOL, V152, P729
   Lim GP, 1996, J NEUROCHEM, V67, P251
   Khuth ST, 2001, J VIROL, V75, P8268, DOI 10.1128/JVI.75.17.8268-8282.2001
   Zhang JWJ, 2000, NEUROSCI LETT, V295, P9, DOI 10.1016/S0304-3940(00)01582-2
   Cuzner ML, 1999, J NEUROIMMUNOL, V94, P1, DOI 10.1016/S0165-5728(98)00241-0
   Kotra LP, 2002, BIOORG CHEM, V30, P356, DOI 10.1016/S0045-2068(02)00501-1
   Oh LYS, 1999, J NEUROSCI, V19, P8464
   Sugita S, 2001, J CELL BIOL, V154, P435, DOI 10.1083/jcb.200105003
   Rattenholl A, 2001, J MOL BIOL, V305, P523, DOI 10.1006/jmbi.2000.4295
   BACKSTROM JR, 1992, J NEUROCHEM, V58, P983, DOI 10.1111/j.1471-4159.1992.tb09352.x
   Jaworski DM, 2000, BRAIN RES, V860, P174, DOI 10.1016/S0006-8993(00)02035-7
   Szymocha R, 2000, AIDS RES HUM RETROV, V16, P1723, DOI 10.1089/08892220050193218
   Fager N, 2000, MECH DEVELOP, V98, P105, DOI 10.1016/S0925-4773(00)00437-8
   Jourquin J, 2003, EUR J NEUROSCI, V18, P1507, DOI 10.1046/j.1460-9568.2003.02876.x
   Planas AM, 2001, NEUROBIOL DIS, V8, P834, DOI 10.1006/nbdi.2001.0435
   Moore SA, 2002, NATURE, V418, P422, DOI 10.1038/nature000838
   Muir EM, 2002, MOL BRAIN RES, V100, P103, DOI 10.1016/S0169-328X(02)00132-8
   von Gertten C, 2003, J NEUROSCI RES, V73, P803, DOI 10.1002/jnr.10729
   Anthony DC, 1998, J NEUROIMMUNOL, V87, P62, DOI 10.1016/S0165-5728(98)00046-0
   Asahi M, 2001, NEUROREPORT, V12, P3003, DOI 10.1097/00001756-200109170-00050
   Jaworski DM, 2000, J NEUROSCI RES, V61, P396, DOI 10.1002/1097-4547(20000815)61:4<396::AID-JNR6>3.0.CO;2-S
   KACZMAREK L, 2002, HDB CHEM NEUROANATOM, P189
   MISSLER M, 2003, NATURE, V424, P939
   Shan JG, 2003, J NEUROSCI, V23, P8859
   Wang X, 1999, FEBS LETT, V462, P261, DOI 10.1016/S0014-5793(99)01534-3
   WOESSNER JF, 2000, PROTEIN PROFILE
   Zagulska-Szymczak S, 2001, NEUROCHEM INT, V38, P485, DOI 10.1016/S0197-0186(00)00101-7
   Zhang JW, 1998, EUR J NEUROSCI, V10, P3358, DOI 10.1046/j.1460-9568.1998.00347.x
NR 77
TC 151
Z9 164
U1 0
U2 13
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0014-5793
J9 FEBS LETT
JI FEBS Lett.
PD JUN 1
PY 2004
VL 567
IS 1
BP 129
EP 135
DI 10.1016/j.febslet.2004.03.070
PG 7
WC Biochemistry & Molecular Biology; Biophysics; Cell Biology
SC Biochemistry & Molecular Biology; Biophysics; Cell Biology
GA 827UB
UT WOS:000221925500022
PM 15165905
ER

PT J
AU Cantorna, MT
AF Cantorna, MT
TI Vitamin D and its role in immunology: Multiple sclerosis, and
   inflammatory bowel disease
SO PROGRESS IN BIOPHYSICS & MOLECULAR BIOLOGY
LA English
DT Article; Proceedings Paper
CT Workshop of the International-Commission-on-Non-Ionizing
   Radiation-Protection
CY OCT 17-18, 2005
CL Munich, GERMANY
SP Int Commission Non-Ionizing Radiat Protect
DE vitamin D and its role in immunology; multiple sclerosis; inflammatory
   bowel disease
ID D-RECEPTOR LIGANDS; 1,25-DIHYDROXYVITAMIN D-3; AUTOIMMUNE-DISEASES;
   T-CELLS; PROGRESSION; PREVALENCE; ACTIVATION
AB Autoimmune diseases like multiple sclerosis (MS) and inflammatory bowel disease (IBD) occur because of an inappropriate immune-mediated attack against self-tissue. Analyses of genetically identical twins shows that besides genetics there are important environmental factors that contribute to MS and IBD development. Vitamin D availability due to sunshine exposure or diet may play a role in the development of MS and IBD. Compelling data in mice show that vitamin D and signaling through the vitamin D receptor dictate the outcome of experimental MS and IBD. Furthermore, the evidence points to the direct and indirect regulation of T cell development and function by vitamin D. In the absence of vitamin D and signals delivered through the vitamin D receptor, auto reactive T cells develop and in the presence of active vitamin D (1,25(OH)(2)D-3) and a functional vitamin D receptor the balance in the T cell response is restored and autoimmunity avoided. (c) 2006 Elsevier Ltd. All rights reserved.
C1 Penn State Univ, Dept Vet & Biomed Sci, Ctr Mol Immunol & Infect Dis, University Pk, PA 16802 USA.
RP Cantorna, MT (reprint author), Penn State Univ, Dept Vet & Biomed Sci, Ctr Mol Immunol & Infect Dis, 115 Henning Bldg, University Pk, PA 16802 USA.
EM mxc69@psu.edu
CR Andreassen H, 1997, SCAND J GASTROENTERO, V32, P1247, DOI 10.3109/00365529709028155
   Munger KL, 2004, NEUROLOGY, V62, P60
   Zella JB, 2003, J CELL BIOCHEM, V88, P216, DOI 10.1002/jcb.10347
   Adorini L, 2002, INT IMMUNOPHARMACOL, V2, P1017, DOI 10.1016/S1567-5769(02)00049-8
   PROVVEDINI DM, 1983, SCIENCE, V221, P1181, DOI 10.1126/science.6310748
   Cantorna MT, 1998, J NUTR, V128, P68
   BHALLA AK, 1983, J CLIN ENDOCR METAB, V57, P1308
   Froicu M, 2003, MOL ENDOCRINOL, V17, P2386, DOI 10.1210/me.2003-0281
   Cantorna MT, 2000, P SOC EXP BIOL MED, V223, P230, DOI 10.1046/j.1525-1373.2000.22333.x
   SONNENBERG A, 1991, GASTROENTEROLOGY, V100, P143
   Cantorna MT, 2004, EXP BIOL MED, V229, P1136
   Cantorna MT, 2000, J NUTR, V130, P2648
   PODOLSKY DK, 1991, NEW ENGL J MED, V325, P1008, DOI 10.1056/NEJM199110033251406
   Mahon BD, 2003, J CELL BIOCHEM, V89, P922, DOI 10.1002/jcb.10580
   Andreassen H, 1998, SCAND J GASTROENTERO, V33, P1087
   Adorini L, 2003, J CELL BIOCHEM, V88, P227, DOI 10.1002/jcb.10340
   Cantorna MT, 1996, P NATL ACAD SCI USA, V93, P7861, DOI 10.1073/pnas.93.15.7861
   HOLICK MF, 1981, SCIENCE, V211, P590, DOI 10.1126/science.6256855
   Cantorna MT, 2004, AM J CLIN NUTR, V80, p1717S
   DeLuca HF, 1993, NUTR TODAY, V28, P6
   Hayes CE, 2000, P NUTR SOC, V59, P531, DOI 10.1017/S0029665100000768
   PODOLSKY DK, 1991, NEW ENGL J MED, V325, P928, DOI 10.1056/NEJM199109263251306
NR 22
TC 147
Z9 161
U1 1
U2 10
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0079-6107
J9 PROG BIOPHYS MOL BIO
JI Prog. Biophys. Mol. Biol.
PD SEP
PY 2006
VL 92
IS 1
BP 60
EP 64
DI 10.1016/j.pbiomolbio.2006.02.020
PG 5
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA 060EW
UT WOS:000238786200009
PM 16563470
ER

PT J
AU Cohen, Y
   Assaf, Y
AF Cohen, Y
   Assaf, Y
TI High b-value q-space analyzed diffusion-weighted MRS and MRI in neuronal
   tissues - a technical review
SO NMR IN BIOMEDICINE
LA English
DT Review
DE diffusion MRI; high b-value DWI; q-space diffusion; white matter
   disorders; multiple sclerosis; MS; spinal cord trauma; neuronal
   degeneration; neuronal maturation
ID NUCLEAR-MAGNETIC-RESONANCE; CENTRAL-NERVOUS-SYSTEM; RAT SPINAL-CORD;
   PROGRESSIVE MULTIPLE-SCLEROSIS; GRADIENT STIMULATED ECHO; FOCAL
   CEREBRAL-ISCHEMIA; APPEARING WHITE-MATTER; BOVINE OPTIC-NERVE; WATER
   DIFFUSION; BRAIN-TISSUE
AB This review deals with high b-value cl-space diffusion-weighted MRI (DW-MRI) of neuronal tissues. It is well documented that at sufficiently high b-values (and high q-values) neuronal water signal decay in diffusion experiments is not mono-exponential. This implies the existence of more than one apparent diffusing component or evidence for restriction. The assignment of the different apparent diffusing components to real physical entities is not straightforward. However. the apparent slow diffusing component that was found to be restricted to a compartment of a few microns, if originating mainly from a specific pool and if assigned correctly, may potentially be used to obtain more specific MR images with regard to specific pathologies of the CNS. This review examines the utility of analyzing high b-value diffusion MRS and MRI data using the q-space approach introduced by Callaghan and by Cory and Garroway. This approach provides displacement probability maps that emphasize, at long diffusion times, the characteristics of the apparent slow diffusing component. Examples from excised spinal cord, where the experimental conditions for which the q-space analysis of MR diffusion data was developed can be met or approached will be presented. Then examples from human MS patients, where q-space requirement for the short gradient pulse is clearly violated, are presented. In the excised spinal cord studies, this approach was used to study spinal cord maturation and trauma, and was found to be more sensitive than other conventional methods in following spinal cord Z, degeneration in an experimental model of vascular dementia (VaD). High b-value q-space DWI was also recently used to study healthy and MS diseased human brains. This approach was found to be very sensitive to the disease load in MS, compared with other conventional MR[ methods, especially in the normal appearing white matter (NAWM) of MS brains. Finally, the potential diagnostic capacity embedded in high b-value q-space analyzed diffusion MR images is discussed. The potentials and caveats of this approach are outlined and experimental data are presented that show the effect of violating the short gradient pulse (SGP) approximation on the extracted parameters from the q-space analysis. Copyright (C) 2002 John Wiley Sons, Ltd.
C1 Tel Aviv Univ, Raymond & Beverly Sackler Fac Exact Sci, Sch Chem, IL-69978 Tel Aviv, Israel.
   Tel Aviv Sourasky Med Ctr, Wohl Inst Adv Imaging, IL-64239 Tel Aviv, Israel.
RP Cohen, Y (reprint author), Tel Aviv Univ, Raymond & Beverly Sackler Fac Exact Sci, Sch Chem, IL-69978 Tel Aviv, Israel.
CR Ahrens ET, 1998, MAGNET RESON MED, V40, P119, DOI 10.1002/mrm.1910400117
   ANDRASKO J, 1976, BIOCHIM BIOPHYS ACTA, V428, P304, DOI 10.1016/0304-4165(76)90038-6
   Inglis BA, 2001, MAGNET RESON MED, V45, P580, DOI 10.1002/mrm.1079
   MINTOROVITCH J, 1991, MAGNET RESON MED, V18, P39, DOI 10.1002/mrm.1910180106
   LEBIHAN D, 1988, RADIOLOGY, V168, P497
   Takano K, 1996, ANN NEUROL, V39, P308, DOI 10.1002/ana.410390307
   Assaf Y, 2000, MAGNET RESON MED, V44, P713, DOI 10.1002/1522-2594(200011)44:5<713::AID-MRM9>3.0.CO;2-6
   Assaf Y, 2002, MAGNET RESON MED, V47, P115, DOI 10.1002/mrm.10040
   MOSELEY ME, 1990, RADIOLOGY, V176, P439
   COY A, 1994, J CHEM PHYS, V101, P4599, DOI 10.1063/1.467447
   Tortorella C, 2000, NEUROLOGY, V54, P186
   Inglis BA, 1997, MAGN RESON IMAGING, V15, P441, DOI 10.1016/S0730-725X(96)00242-1
   Ries M, 2000, MAGNET RESON MED, V44, P884, DOI 10.1002/1522-2594(200012)44:6<884::AID-MRM9>3.0.CO;2-Q
   CHENEVERT TL, 1990, RADIOLOGY, V177, P401
   LEBIHAN D, 1986, RADIOLOGY, V161, P401
   Amar K, 1996, BRIT MED J, V312, P227
   EIS M, 1995, MAGN RESON MED, V34, P835, DOI 10.1002/mrm.1910340608
   Nossin-Manor R, 2002, MAGN RESON IMAGING, V20, P231, DOI 10.1016/S0730-725X(02)00470-8
   HOSSMANN KA, 1995, CEREBROVAS BRAIN MET, V7, P187
   Price WS, 1997, CONCEPT MAGNETIC RES, V9, P299, DOI 10.1002/(SICI)1099-0534(1997)9:5<299::AID-CMR2>3.0.CO;2-U
   ONO J, 1995, BRAIN RES, V671, P141, DOI 10.1016/0006-8993(94)01335-F
   Clark CA, 2000, MAGNET RESON MED, V44, P852, DOI 10.1002/1522-2594(200012)44:6<852::AID-MRM5>3.0.CO;2-A
   Alsop DC, 1996, J NEUROTRAUM, V13, P515, DOI 10.1089/neu.1996.13.515
   Barkhof F, 1999, PHILOS T ROY SOC B, V354, P1675, DOI 10.1098/rstb.1999.0511
   Assaf Y, 2000, MAGNET RESON MED, V43, P191, DOI 10.1002/(SICI)1522-2594(200002)43:2<191::AID-MRM5>3.0.CO;2-B
   JENNER CF, 1988, NATURE, V336, P399, DOI 10.1038/336399a0
   Werring DJ, 1999, NEUROLOGY, V52, P1626
   VANBRUGGEN N, 1992, STROKE, V23, P576
   Horner PJ, 2000, NATURE, V407, P963
   HoehnBerlage M, 1995, NMR BIOMED, V8, P345, DOI 10.1002/nbm.1940080708
   MINEMATSU K, 1992, NEUROLOGY, V42, P235
   BASSER PJ, 1994, BIOPHYS J, V66, P259
   Kuchel PW, 1997, MAGNET RESON MED, V37, P637, DOI 10.1002/mrm.1910370502
   Klingberg T, 2000, NEURON, V25, P493, DOI 10.1016/S0896-6273(00)80911-3
   Torres AM, 1998, MAGN RESON IMAGING, V16, P423, DOI 10.1016/S0730-725X(98)00005-8
   Schaefer PW, 2000, RADIOLOGY, V217, P331
   NIENDORF T, 1994, MAGNET RESON MED, V32, P672, DOI 10.1002/mrm.1910320520
   BUSZA AL, 1992, STROKE, V23, P1602
   CALLAGHAN PT, 1991, NATURE, V351, P467, DOI 10.1038/351467a0
   MITRA PP, 1995, J MAGN RESON SER A, V113, P94, DOI 10.1006/jmra.1995.1060
   Nicolay K, 2001, NMR BIOMED, V14, P94, DOI 10.1002/nbm.686
   VANZIJL PCM, 1991, P NATL ACAD SCI USA, V88, P3228, DOI 10.1073/pnas.88.8.3228
   KING MD, 1994, MAGNET RESON MED, V32, P707, DOI 10.1002/mrm.1910320605
   Fazekas F, 1999, NEUROLOGY, V53, P448
   Assaf Y, 1999, NMR BIOMED, V12, P335, DOI 10.1002/(SICI)1099-1492(199910)12:6<335::AID-NBM581>3.0.CO;2-A
   STEJSKAL EO, 1965, J CHEM PHYS, V42, P288, DOI 10.1063/1.1695690
   Bastin ME, 1998, MAGN RESON IMAGING, V16, P773, DOI 10.1016/S0730-725X(98)00098-8
   CALLAGHAN PT, 1995, J MAGN RESON SER A, V113, P53, DOI 10.1006/jmra.1995.1055
   Peled S, 1999, MAGNET RESON MED, V42, P911
   Mulkern RV, 1999, NMR BIOMED, V12, P51, DOI 10.1002/(SICI)1099-1492(199902)12:1<51::AID-NBM546>3.0.CO;2-E
   Cercignani M, 2000, NEUROLOGY, V54, P1139
   Mulkern RV, 2000, MAGNET RESON MED, V44, P292, DOI 10.1002/1522-2594(200008)44:2<292::AID-MRM17>3.0.CO;2-Q
   Norris DG, 2001, NMR BIOMED, V14, P77, DOI 10.1002/nbm.682
   Scheenen TWJ, 2001, J MAGN RESON, V151, P94, DOI 10.1006/jmre.2001.2362
   Callaghan PT, 1999, CONCEPT MAGNETIC RES, V11, P181, DOI 10.1002/(SICI)1099-0534(1999)11:4<181::AID-CMR1>3.0.CO;2-T
   Fenyes DA, 1999, MAGN RESON IMAGING, V17, P717, DOI 10.1016/S0730-725X(98)00220-3
   Basser PJ, 2000, MAGNET RESON MED, V44, P625, DOI 10.1002/1522-2594(200010)44:4<625::AID-MRM17>3.0.CO;2-O
   CALLAGHAN PT, 1988, J PHYS E SCI INSTRUM, V21, P820, DOI 10.1088/0022-3735/21/8/017
   Bammer R, 2000, MAGNET RESON MED, V44, P583, DOI 10.1002/1522-2594(200010)44:4<583::AID-MRM12>3.0.CO;2-O
   Torres AM, 1999, J MAGN RESON, V138, P135, DOI 10.1006/jmre.1998.1701
   Assaf Y, 1998, J MAGN RESON, V131, P69, DOI 10.1006/jmre.1997.1313
   Scheenen TWJ, 2000, J MAGN RESON, V142, P207, DOI 10.1006/jmre.1999.1916
   Niendorf T, 1996, MAGNET RESON MED, V36, P847, DOI 10.1002/mrm.1910360607
   Assaf Y, 1999, J NEUROTRAUM, V16, P1165, DOI 10.1089/neu.1999.16.1165
   Assaf Y, 1996, J MAGN RESON SER B, V112, P151, DOI 10.1006/jmrb.1996.0125
   ASSAF Y, 1998, P INT SOC MAGN RES M, V6, P1263
   ASSAF Y, 2000, P INT SOC MAGN RESON, V8, P401
   Assaf Y, 1998, NMR BIOMED, V11, P67, DOI 10.1002/(SICI)1099-1492(199804)11:2<67::AID-NBM503>3.0.CO;2-5
   ASSAF Y, 2001, P INT SOC MAGN RES M, V9, P509
   ASSAF Y, 2001, P INT SOC MAGN RES M, V9, P150
   ASSAF Y, 1999, P INT SOC MAGN RES M, V7, P555
   ASSAF Y, 1997, P INT SOC MAGN RES M, V5, P1254
   Assaf Y, 2002, MAGNET RESON MED, V48, P71, DOI 10.1002/mrm.10183
   Basser PJ, 1998, MAGNET RESON MED, V39, P928, DOI 10.1002/mrm.1910390610
   CLARK CA, 2001, P INT SOC MAGN RES M, V9, P167
   CORY DG, 1990, MAGNET RESON MED, V14, P435, DOI 10.1002/mrm.1910140303
   Cucurella MG, 2000, NMR BIOMED, V13, P57, DOI 10.1002/(SICI)1099-1492(200004)13:2<57::AID-NBM609>3.3.CO;2-X
   DECANNIERE C, 1995, MAGNET RESON MED, V34, P343, DOI 10.1002/mrm.1910340311
   Ditunno J F Jr, 1997, Adv Neurol, V72, P325
   Franconi F, 2000, MAGNET RESON MED, V44, P893, DOI 10.1002/1522-2594(200012)44:6<893::AID-MRM10>3.0.CO;2-G
   Johnson PT, 1998, EXP BRAIN RES, V118, P93, DOI 10.1007/s002210050258
   King MD, 1997, MAGN RESON MED, V38, P930, DOI 10.1002/mrm.1910380612
   Kuchel PW, 1999, J MAGN RESON, V139, P258, DOI 10.1006/jmre.1999.1766
   Leary SM, 1999, J NEUROL, V246, P1023, DOI 10.1007/s004150050507
   Li TQ, 1997, LANGMUIR, V13, P3570, DOI 10.1021/la970045m
   MAIER SE, 2001, P INT SOC MAGN RES M, V9, P503
   MOSELEY ME, 1990, MAGNET RESON MED, V14, P330, DOI 10.1002/mrm.1910140218
   Neumann-Haefelin T, 2000, STROKE, V31, P1965
   NOSSINMANOR R, 2001, P INT SOC MAGN RES M, V9, P150
   Phillips JT, 2001, ARCH NEUROL-CHICAGO, V58, P30, DOI 10.1001/archneur.58.1.30
   Snaar JEM, 1997, MAGN RESON IMAGING, V15, P983, DOI 10.1016/S0730-725X(97)00036-2
   Stanisz GJ, 1997, MAGNET RESON MED, V37, P103, DOI 10.1002/mrm.1910370115
   Stark D.D., 1999, MAGNETIC RESONANCE I
   TUCH DS, 2001, P INT SOC MAGN RES M, V9, P502
   VANGIJN J, 1998, NEUROLOGY, V51, P53
   WIEGELL MR, 2001, P INT SOC MAG RES M, V9, P504
NR 96
TC 143
Z9 145
U1 3
U2 19
PU JOHN WILEY & SONS LTD
PI W SUSSEX
PA BAFFINS LANE CHICHESTER, W SUSSEX PO19 1UD, ENGLAND
SN 0952-3480
J9 NMR BIOMED
JI NMR Biomed.
PD NOV-DEC
PY 2002
VL 15
IS 7-8
BP 516
EP 542
DI 10.1002/nbm.778
PG 27
WC Biophysics; Radiology, Nuclear Medicine & Medical Imaging; Spectroscopy
SC Biophysics; Radiology, Nuclear Medicine & Medical Imaging; Spectroscopy
GA 631KC
UT WOS:000180166100007
PM 12489099
ER

PT J
AU Guger, C
   Schlogl, A
   Neuper, C
   Walterspacher, D
   Strein, T
   Pfurtscheller, G
AF Guger, C
   Schlogl, A
   Neuper, C
   Walterspacher, D
   Strein, T
   Pfurtscheller, G
TI Rapid prototyping of an EEG-based brain-computer interface (BCI)
SO IEEE TRANSACTIONS ON NEURAL SYSTEMS AND REHABILITATION ENGINEERING
LA English
DT Article
DE brain-computer interface (BCI); event-related desynchronization (ERD);
   rapid prototyping; real-time software; single-trial electroencephalogram
   (EEG) classification
ID CLASSIFICATION; COMMUNICATION; COMPONENTS; MOVEMENT; DEVICE; DESIGN;
   HUMANS; TIME
AB The electroencephalogram (EEG) is modified by motor imagery and can be used by patients with severe motor impairments (e.g., late stage of amyotrophic lateral sclerosis) to communicate with their environment, Such a direct connection between the brain and the computer is known as an EEG-based brain-computer interface (BCI),
   This paper describes a new type of BCI system that uses rapid prototyping to enable a fast transition of various types of parameter estimation and classification algorithms to real-time implementation and testing. Rapid prototyping is possible by using Matlab, Simulink, and the Real-Time Workshop. It is shown how to automate real-time experiments and perform the interplay between on-line experiments and offline analysis. The system is able to process multiple EEG channels on-line and operates under Windows 95 in real-time on a standard PC without an additional digital signal processor (DSP) board.
   The BCI can be controlled over the Internet, LAN or modem. This BCI was tested on 3 subjects whose task it was to imagine either left or right hand movement. A classification accuracy between 70% and 95% could be achieved with two EEG channels after some sessions with Feedback using an adaptive autoregressive (AAR) model and linear discriminant analysis (LDA).
C1 Graz Univ Technol, Dept Med Informat, Inst Biomed Engn, A-8010 Graz, Austria.
   Graz Univ Technol, Ludwig Boltzmann Inst Med Informat & Neuroinforma, A-8010 Graz, Austria.
RP Guger, C (reprint author), Graz Univ Technol, Dept Med Informat, Inst Biomed Engn, A-8010 Graz, Austria.
RI Hong, Jie/L-7638-2013
OI Hong, Jie/0000-0002-2831-7523
CR Birbaumer N, 1999, NATURE, V398, P297, DOI 10.1038/18581
   Pfurtscheller G, 1996, ELECTROEN CLIN NEURO, V99, P416, DOI 10.1016/S0013-4694(96)95689-8
   Vaughan T M, 1996, IEEE Trans Rehabil Eng, V4, P425, DOI 10.1109/86.547945
   POPOVIC DB, 1993, IEEE T BIO-MED ENG, V40, P1024, DOI 10.1109/10.247801
   HJORTH B, 1970, ELECTROEN CLIN NEURO, V29, P306, DOI 10.1016/0013-4694(70)90143-4
   Muller-Gerking J, 1999, CLIN NEUROPHYSIOL, V110, P787, DOI 10.1016/S1388-2457(98)00038-8
   WOLPAW JR, 1994, ELECTROEN CLIN NEURO, V90, P444, DOI 10.1016/0013-4694(94)90135-X
   Schlogl A, 1997, BIOMED TECH, V42, P162, DOI 10.1515/bmte.1997.42.6.162
   Kubler A, 1999, EXP BRAIN RES, V124, P223, DOI 10.1007/s002210050617
   Pfurtscheller G, 1997, ELECTROEN CLIN NEURO, V103, P642, DOI 10.1016/S0013-4694(97)00080-1
   Kalcher J, 1996, MED BIOL ENG COMPUT, V34, P382, DOI 10.1007/BF02520010
   McFarland DJ, 1997, BEHAV RES METH INS C, V29, P337, DOI 10.3758/BF03200585
   Pfurtscheller G, 1997, NEUROSCI LETT, V239, P65, DOI 10.1016/S0304-3940(97)00889-6
   Bishop C.M., 1995, NEURAL NETWORKS PATT
   FLOTZINGER D, 1992, BIOMED TECH, V37, P303, DOI 10.1515/bmte.1992.37.12.303
   GONCHAROVA LI, 1990, ELECTROEN CLIN NEURO, V76, P197
   Guger C, 1999, BIOMED TECH, V44, P12, DOI 10.1515/bmte.1999.44.1-2.12
   GUGER C, 1997, THESIS U TECHNOLOGY
   Haykin S., 1986, ADAPTIVE FILTER THEO
   Lugger K, 1998, MED BIOL ENG COMPUT, V36, P309, DOI 10.1007/BF02522476
   *MATHW INC, 1997, SIM REAL TIM WORKSH
   *MATHW INC, 1997, SIM DYN SYST SIM MAT
   NEUPER C, 1999, J CLIN NEUROPHYSIOL, V16
   Pfurtscheller G, 1998, IEEE Trans Rehabil Eng, V6, P316, DOI 10.1109/86.712230
   SCHLOGL A, P IEEE EMBS 97, P1533
   SUTTER EE, 1992, J MICROCOMPUT APPL, V15, P31, DOI 10.1016/0745-7138(92)90045-7
   VIDAL J, 1973, ANNU REV BIOPHYS BIO, P157
NR 27
TC 142
Z9 149
U1 2
U2 14
PU IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC
PI NEW YORK
PA 345 E 47TH ST, NEW YORK, NY 10017-2394 USA
SN 1534-4320
J9 IEEE T NEUR SYS REH
JI IEEE Trans. Neural Syst. Rehabil. Eng.
PD MAR
PY 2001
VL 9
IS 1
BP 49
EP 58
DI 10.1109/7333.918276
PG 10
WC Engineering, Biomedical; Rehabilitation
SC Engineering; Rehabilitation
GA 453ZB
UT WOS:000169947100007
PM 11482363
ER

PT J
AU Kinoshita, M
   Nakatsuji, Y
   Kimura, T
   Moriya, M
   Takata, K
   Okuno, T
   Kumanogoh, A
   Kajiyama, K
   Yoshikawa, H
   Sakoda, S
AF Kinoshita, Makoto
   Nakatsuji, Yuji
   Kimura, Takashi
   Moriya, Masayuki
   Takata, Kazushiro
   Okuno, Tatsusada
   Kumanogoh, Atsushi
   Kajiyama, Koji
   Yoshikawa, Hiroo
   Sakoda, Saburo
TI Neuromyelitis optica: Passive transfer to rats by human immunoglobulin
SO BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
LA English
DT Article
DE Neuromyelitis optica; Aquaporin-4; Astrocyte; Passive transfer;
   Complement; Multiple sclerosis; Animal model; Experimental autoimmune
   encephalomyelitis
ID SPINAL-CORD LESIONS; MULTIPLE-SCLEROSIS; ANTI-AQUAPORIN-4 ANTIBODY;
   DIAGNOSTIC-CRITERIA; WATER CHANNEL; AQUAPORIN-4; ENCEPHALOMYELITIS;
   DISTINCTION; NECROSIS; JAPANESE
AB Recurrent attacks of optic neuritis and myelitis are the hallmarks of both neuromyelitis optica (NMO) and multiple sclerosis (MS). NMO immunoglobulin G (NMO-IgG), which recognizes astrocytic aquaporin-4 (AQP4) water channels, is a specific serum autoantibody that distinguishes NMO from MS. The pathogenic role of the anti-AQP4 antibody (AQP4-Ab, NMO-IgG) in NMO has been speculated based on several studies in vitro. The aim of this study was to demonstrate the pathogenicity of AQP4-Ab in vivo. We obtained IgG from patients who underwent therapeutic plasmapheresis, and developed an animal model by passive transfer of IgG to rats. The active lesions of the rats exhibited pathological characteristics strikingly similar to those of NMO, marked by astrocytic loss and perivascular deposition of immunoglobulin and complements. These findings provide the first evidence of the pathogenicity of AQP4-Ab in vivo and support the therapeutic efficacy of eliminating the antibodies by plasmapheresis. (C) 2009 Elsevier Inc. All rights reserved.
C1 [Kinoshita, Makoto; Nakatsuji, Yuji; Moriya, Masayuki; Takata, Kazushiro; Sakoda, Saburo] Osaka Univ, Grad Sch Med, Dept Neurol, Suita, Osaka 5650871, Japan.
   [Okuno, Tatsusada; Kumanogoh, Atsushi] Osaka Univ, Microbial Dis Res Inst, Dept Immunopathol, Suita, Osaka 5650871, Japan.
   [Kimura, Takashi; Kajiyama, Koji; Yoshikawa, Hiroo] Hyogo Coll Med, Div Neurol, Dept Internal Med, Nishinomiya, Hyogo 6638501, Japan.
RP Nakatsuji, Y (reprint author), Osaka Univ, Grad Sch Med, Dept Neurol, D4,2-2 Yamadaoka, Suita, Osaka 5650871, Japan.
EM yuji@neurol.med.osaka-u.ac.jp
RI Kumanogoh, Atsushi/C-7354-2009
FU National Institute of Biomedical Innovation (NIBIO); Ministry of Health,
   Labour and Welfare of Japan
FX We thank Dr. Tomoyuki Sugimoto for expert statistical assistance and Dr.
   Keiko Tanaka for the serum AQP4-Ab test. This study was supported in
   part by the Program of Fundamental Studies in Health Sciences of the
   National Institute of Biomedical Innovation (NIBIO) and by Health and
   Labour Sciences Research Grants for research on intractable diseases
   from Ministry of Health, Labour and Welfare of Japan.
CR Jarius S, 2008, NAT CLIN PRACT NEURO, V4, P202, DOI 10.1038/ncpneuro0764
   Hinson SR, 2008, J EXP MED, V205, P2473, DOI 10.1084/jem.20081241
   Kinoshita M, 2009, NEUROREPORT, V20, P508, DOI 10.1097/WNR.0b013e32832776f4
   Mathey EK, 2007, J EXP MED, V204, P2363, DOI 10.1084/jem.20071053
   Vincent T, 2008, J IMMUNOL, V181, P5730
   Lennon VA, 2004, LANCET, V364, P2106, DOI 10.1016/S0140-6736(04)17551-X
   Lennon VA, 2005, J EXP MED, V202, P473, DOI 10.1084/jem.20050304
   LININGTON C, 1988, AM J PATHOL, V130, P443
   Takahashi T, 2007, BRAIN, V130, P1235, DOI 10.1093/brain/awm062
   Matiello M, 2007, CURR OPIN NEUROL, V20, P255, DOI 10.1097/WCO.0b013e32814f1c6b
   Krysko DV, 2008, METHODS, V44, P205, DOI 10.1016/j.ymeth.2007.12.001
   Roemer SF, 2007, BRAIN, V130, P1194, DOI 10.1093/brain/aw1371
   Fujimoto T, 1999, J NEUROIMMUNOL, V95, P35, DOI 10.1016/S0165-5728(98)00251-3
   Hinson SR, 2007, NEUROLOGY, V69, P2221, DOI 10.1212/01.WNL.0000289761.64862.ce
   Misu T, 2007, BRAIN, V130, P1224, DOI 10.1093/brain/awm047
   Wingerchuk DM, 2006, NEUROLOGY, V66, P1485, DOI 10.1212/01.wnl.0000216139.44259.74
   Tani T, 2009, J NEUROIMMUNOL, V211, P110, DOI 10.1016/j.jneuroim.2009.04.001
   Irani S, 2008, AUTOIMMUNITY, V41, P55, DOI 10.1080/08916930701619490
   Matsuoka T, 2007, BRAIN, V130, P1206, DOI 10.1093/brain/awm027
   Sommer C, 2005, LANCET, V365, P1406, DOI 10.1016/S0140-6736(05)66376-3
   Tanaka K, 2007, MULT SCLER, V13, P850, DOI 10.1177/1352458507076976
   NICCHIA GP, 2009, GLIA
   POSER CM, 1983, ANN NEUROL, V13, P227, DOI 10.1002/ana.410130302
NR 23
TC 123
Z9 134
U1 0
U2 5
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0006-291X
J9 BIOCHEM BIOPH RES CO
JI Biochem. Biophys. Res. Commun.
PD SEP 4
PY 2009
VL 386
IS 4
BP 623
EP 627
DI 10.1016/j.bbrc.2009.06.085
PG 5
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA 476RS
UT WOS:000268462100015
PM 19545538
ER

PT J
AU Martinez-Bisbal, MC
   Marti-Bonmati, L
   Piquer, J
   Revert, A
   Ferrer, P
   Llacer, JL
   Piotto, M
   Assemat, O
   Celda, B
AF Martinez-Bisbal, MC
   Marti-Bonmati, L
   Piquer, J
   Revert, A
   Ferrer, P
   Llacer, JL
   Piotto, M
   Assemat, O
   Celda, B
TI H-1 and C-13 HR-MAS spectroscopy of intact biopsy samples ex vivo and in
   vivo H-1 MRS study of human high grade gliomas
SO NMR IN BIOMEDICINE
LA English
DT Article
DE HR-MAS; ex vivo MRS; in vivo MRS; brain tumours; biopsy tissues; PCA
   extracts
ID MAGNETIC-RESONANCE SPECTROSCOPY; SHORT ECHO TIME; BRAIN-TUMORS;
   MULTIPLE-SCLEROSIS; SINGLE-VOXEL; SPECTRA; CLASSIFICATION; ASTROCYTOMAS;
   CANCER; TISSUE
AB High-resolution magic angle spinning (HR-MAS) one- and two-dimensional H-1 and C-13 nuclear magnetic resonance (NMR) spectroscopy has been used to study intact glioblastoma (GBM) brain tumour tissue. The results were compared with in vitro chemical extract and in vivo spectra. The resolution of H-1 one-dimensional, H-1 TOCSY and C-13 HSQC HR-MAS spectra is comparable to that obtained on perchloric extracts. C-13 HSQC HR-MAS spectra have been particularly useful for the identification of 37 different metabolites in intact biopsy tumours, excluding water and DSS components. To our knowledge, this is the most detailed assignment of biochemical compounds obtained in intact human tissue, in particular in brain turnout tissue. Tissue degradation during the recording of the NMR experiment was avoided by keeping the sample at a temperature of 4 degreesC. Detailed metabolical compositions of 10 GBM (six primary, two secondary and two unclassified) were obtained. A good correlation between ex vivo and in vivo MRS has been found. Copyright (C) 2004 John Wiley Sons, Ltd.
C1 Univ Valencia, Dept Quim Fis, E-46100 Valencia, Spain.
   Serv Radiol Clin Quiron, Valencia, Spain.
   Hosp Ribera Alzira, Valencia, Spain.
   Bruker Biospin, Wissembourg, France.
RP Celda, B (reprint author), Univ Valencia, Dept Quim Fis, C Dr Moliner,50 Burjassot, E-46100 Valencia, Spain.
EM bernardo.celda@uv.es
RI Martinez-Bisbal, M.Carmen/L-7059-2014; Marti-Bonmati, Luis/A-1147-2015
OI Martinez-Bisbal, M.Carmen/0000-0002-8526-4413; Marti-Bonmati,
   Luis/0000-0002-8234-010X
CR WISHART DS, 1994, J BIOMOL NMR, V4, P171
   Govindaraju V, 2000, NMR BIOMED, V13, P129, DOI 10.1002/1099-1492(200005)13:3<129::AID-NBM619>3.3.CO;2-M
   Tate AR, 2003, MAGNET RESON MED, V49, P29, DOI 10.1002/mrm.10315
   Kaminogo M, 2001, NEURORADIOLOGY, V43, P353
   Grand S, 1999, RADIOLOGY, V213, P785
   Castillo M, 2000, AM J NEURORADIOL, V21, P1645
   Casanova B, 2003, J NEUROL, V250, P22, DOI 10.1007/s00415-003-0928-0
   KUESEL AC, 1994, NMR BIOMED, V7, P172, DOI 10.1002/nbm.1940070404
   Cheng LL, 2000, NEURO-ONCOLOGY, V2, P87, DOI 10.1215/15228517-2-2-87
   Sitter B, 2002, NMR BIOMED, V15, P327, DOI 10.1002/nbm.775
   SWEATMAN BC, 1993, J PHARMACEUT BIOMED, V11, P651, DOI 10.1016/0731-7085(93)80171-V
   KUESEL AC, 1994, NMR BIOMED, V7, P149, DOI 10.1002/nbm.1940070308
   Rijpkema M, 2003, NMR BIOMED, V16, P12, DOI 10.1002/nbm.807
   Cheng LL, 1998, CANCER RES, V58, P1825
   Bartlett JG, 1999, INFECT DIS CLIN PRAC, V8, P121
   BOTTOMLEY PA, 1994, Patent No. 4480228
   *BRUK BIOSP GMBH, 2001, XWIN NMR 3 1
   Burtscher IM, 2001, NEURORADIOLOGY, V43, P345
   Castillo M, 1999, Top Magn Reson Imaging, V10, P104, DOI 10.1097/00002142-199904000-00003
   CELDA B, 1993, J MAGN RESON SER B, V101, P189, DOI 10.1006/jmrb.1993.1030
   CHIENG LL, 1997, P NATL ACAD SCI USA, V94, P6408
   DANIELSEN ER, 1998, MAGNETIC RESONANCE S, P5
   DANIELSEN ER, 1998, MAGNETIC RESONANCE S, P259
   DEGRAAF RA, 1998, IN VIVO NMR SPECTROS, P41
   Fan WMT, 1996, PROG NUCL MAG RES SP, V28, P161
   GARCIAMARTIN ML, 1998, 15 ANN SCI M EUR SOC
   Goddard TD, 1999, SPARKY 3
   LEVIN VA, CANC PRINCIPLES PRAC, V2, P2022
   Mader I, 1996, MAGN RESON MATER PHY, V4, P139, DOI 10.1007/BF01772521
   Martinez-Bisbal MC, 2002, REV NEUROLOGIA, V34, P309
   Martinez-Bisbal MC, 2002, REV NEUROLOGIA, V34, P807
   Maxwell RJ, 1998, MAGNET RESON MED, V39, P869, DOI 10.1002/mrm.1910390604
   NICHOLSON JK, 1995, ANAL CHEM, V67, P793, DOI 10.1021/ac00101a004
   ORTEGA MS, 2003, TUMORES SISTEMA NERV, pCH18
   Pascual JM, 1998, NEUROCIRUGIA, V9, P4
   *PHIL MED SYST, 1998, SPECTR PACK GYR ACSN
   POLEDNAK AP, 1995, CANCER, V75, P330, DOI 10.1002/1097-0142(19950101)75:1+<330::AID-CNCR2820751315>3.0.CO;2-5
   SARDINA FJ, 2000, MESTRE C 2 2
   *UPSTR SOL GMBH, 1999, UPSOL NMR PRED VERS
   WUTHRICH K, 1976, NMR BIOL RES PEPTIDE, P171
   Wuthrich K., 1986, NMR PROTEINS NUCLEIC, P17
NR 41
TC 122
Z9 128
U1 0
U2 21
PU JOHN WILEY & SONS LTD
PI CHICHESTER
PA THE ATRIUM, SOUTHERN GATE, CHICHESTER PO19 8SQ, W SUSSEX, ENGLAND
SN 0952-3480
J9 NMR BIOMED
JI NMR Biomed.
PD JUN
PY 2004
VL 17
IS 4
BP 191
EP 205
DI 10.1002/nbm.888
PG 15
WC Biophysics; Radiology, Nuclear Medicine & Medical Imaging; Spectroscopy
SC Biophysics; Radiology, Nuclear Medicine & Medical Imaging; Spectroscopy
GA 839UL
UT WOS:000222810300004
PM 15229932
ER

PT J
AU Gratwohl, A
   Passweg, J
   Bocelli-Tyndall, C
   Fassas, A
   van Laar, JM
   Farge, D
   Andolina, M
   Arnold, R
   Carreras, E
   Finke, J
   Kotter, I
   Kozak, T
   Lisukov, I
   Lowenberg, B
   Marmont, A
   Moore, J
   Saccardi, R
   Snowden, JA
   van den Hoogen, F
   Wulffraat, NM
   Zhao, XW
   Tyndall, A
AF Gratwohl, A
   Passweg, J
   Bocelli-Tyndall, C
   Fassas, A
   van Laar, JM
   Farge, D
   Andolina, M
   Arnold, R
   Carreras, E
   Finke, J
   Kotter, I
   Kozak, T
   Lisukov, I
   Lowenberg, B
   Marmont, A
   Moore, J
   Saccardi, R
   Snowden, JA
   van den Hoogen, F
   Wulffraat, NM
   Zhao, XW
   Tyndall, A
CA EBMT
TI Autologous hematopoietic stem cell transplantation for autoimmune
   diseases
SO BONE MARROW TRANSPLANTATION
LA English
DT Article
DE autoimmune disease; autologous hematopoietic stem cell transplantation;
   immunosuppression; survival; therapy
ID SYSTEMIC-LUPUS-ERYTHEMATOSUS; BONE-MARROW TRANSPLANTATION; HIGH-DOSE
   CYCLOPHOSPHAMIDE; REFRACTORY RHEUMATOID-ARTHRITIS; JUVENILE CHRONIC
   ARTHRITIS; TERM-FOLLOW-UP; MULTIPLE-SCLEROSIS; RANDOMIZED-TRIAL;
   IMMUNOSUPPRESSIVE THERAPY; PROLONGED REMISSION
AB Experimental data and early phase I/II studies suggest that high-dose chemotherapy followed by autologous hematopoietic stem cell transplantation (HSCT) can arrest progression of severe autoimmune diseases. We have evaluated the toxicity and disease response in 473 patients with severe autoimmune disease treated with autologous HSCT between 1995 and 2003, from 110 centers participating in the European Group for Blood and Marrow Transplantation (EBMT) autoimmune disease working party database. Survival, transplant-related mortality, treatment response and disease progression were assessed. In all, 420 patients (89%; 86 +/- 4% at 3 years, median follow-up 20 months) were alive, 53 (11%) had died from transplant-related mortality (N=31; 7 +/- 3% at 3 years) or disease progression (N=22; 9 +/- 4% at 3 years). Of 370 patients, 299 evaluable for response (81%) showed a treatment response, which was sustained in 213 (71% of responders). Response was associated with disease (P<0.001), was better in patients who received cyclophosphamide during mobilization (relative risk (RR)3.28 (1.57-6.83)) and was worse with increasing age (>40 years, RR0.29 (0.11-0.82)). Disease progression was associated with disease (P<0.001) and conditioning intensity (high intensity, RR1; intermediate intensity, RR1.81 (0.96-3.42)); low intensity, RR2.34 (1.074-5.11)). These data from the collective EBMT experience support the hypothesis that autologous HSCT can alter disease progression in severe autoimmune disease.
C1 Univ Basel, Dept Rheumatol, Stem Cell Transplant Team, Felix Platter Spital, CH-4012 Basel, Switzerland.
   Univ Basel Hosp, CH-4031 Basel, Switzerland.
   George Papanicolaou Hosp, Thessaloniki, Greece.
   Leiden Univ, Med Ctr, Leiden, Netherlands.
   Hop St Louis, Paris, France.
   Ist Infanzia Burlo Garofolo, Trieste, Italy.
   Univ Klinikum Charite, Berlin, Germany.
   Hosp Clin Barcelona, Barcelona, Spain.
   Univ Freiburg Klinikum, Freiburg, Germany.
   Univ Tubingen, Med Klin, D-7400 Tubingen, Germany.
   Univ Hosp Kralovske Vinohrady, Prague, Czech Republic.
   Inst Clin Immunol, Novosibirsk, Russia.
   Erasmus Univ, Med Ctr, Rotterdam, Netherlands.
   Osped San Martino Genova, Genoa, Italy.
   St Vincents Hosp, Sydney, NSW 2010, Australia.
   Osped Careggi, Florence, Italy.
   Sheffield Teaching Hosp NHS Trust, Sheffield, S Yorkshire, England.
   Univ Med Ctr St Radboud, Nijmegen, Netherlands.
   Univ Hosp Children, Utrecht, Netherlands.
   Third People Hosp Zhengzhou, Zhengzhou, Peoples R China.
RP Tyndall, A (reprint author), Univ Basel, Dept Rheumatol, Stem Cell Transplant Team, Felix Platter Spital, CH-4012 Basel, Switzerland.
EM alan.tyndall@fps-basel.ch
RI Kozak, Tomas/K-3561-2012
CR Farge D, 2004, ANN RHEUM DIS, V63, P974, DOI 10.1136/ard.2003.011205
   Bingham S, 2001, BRIT J HAEMATOL, V113, P840, DOI 10.1046/j.1365-2141.2001.02804-2.x
   Binks M, 2001, ANN RHEUM DIS, V60, P577, DOI 10.1136/ard.60.6.577
   Burt RK, 2002, INT J HEMATOL, V76, P226
   Tisdale JF, 2000, LANCET, V356, P1554, DOI 10.1016/S0140-6736(00)03126-3
   Openshaw H, 2000, BIOL BLOOD MARROW TR, V6, P563, DOI 10.1016/S1083-8791(00)70066-8
   van Bekkum DW, 2004, BEST PRACT RES CL HA, V17, P201, DOI 10.1016/j.beha.2004.04.003
   McColl G, 1999, ANN INTERN MED, V131, P507
   Fassas A, 2000, J CLIN IMMUNOL, V20, P24, DOI 10.1023/A:1006686426090
   Davidson A, 2001, NEW ENGL J MED, V345, P340
   Marmont AM, 2004, BEST PRACT RES CL HA, V17, P223, DOI 10.1016/j.beha.2004.04.004
   Tyndall A, 1997, LANCET, V349, P254, DOI 10.1016/S0140-6736(05)64864-7
   Passweg JR, 2004, BRIT J HAEMATOL, V125, P749, DOI 10.1111/j.1365-2141.2004.04978.x
   PHILIP T, 1995, NEW ENGL J MED, V333, P1540, DOI 10.1056/NEJM199512073332305
   Jayne D, 2004, LUPUS, V13, P168, DOI 10.1191/0961203304lu525oa
   Milpied N, 2004, NEW ENGL J MED, V350, P1287, DOI 10.1056/NEJMoa031770
   Durez P, 1998, LANCET, V352, P881, DOI 10.1016/S0140-6736(05)60008-6
   Snowden JA, 2004, J RHEUMATOL, V31, P482
   Attal M, 2003, NEW ENGL J MED, V349, P2495, DOI 10.1056/NEJMoa032290
   Huhn RD, 2003, BLOOD, V101, P71, DOI 10.1182/blood-2001-12-0171
   Openshaw H, 2000, NEUROLOGY, V54, P2147
   Verburg RJ, 2001, ARTHRITIS RHEUM, V44, P754, DOI 10.1002/1529-0131(200104)44:4<754::AID-ANR131>3.0.CO;2-N
   Carreras E, 2003, HAEMATOLOGICA, V88, P306
   Mancardi GL, 2001, NEUROLOGY, V57, P62
   Schmitz N, 1996, LANCET, V347, P353, DOI 10.1016/S0140-6736(96)90536-X
   Moore J, 2002, ARTHRITIS RHEUM, V46, P2301, DOI 10.1002/art.10495
   Rosen O, 2000, ARTHRITIS RES, V2, P327, DOI 10.1186/ar107
   Kozak T, 2000, BONE MARROW TRANSPL, V25, P525, DOI 10.1038/sj.bmt.1702180
   Farge D, 2002, BRIT J HAEMATOL, V119, P726, DOI 10.1046/j.1365-2141.2002.03895.x
   Baron F, 2000, BRIT J HAEMATOL, V110, P339, DOI 10.1046/j.1365-2141.2000.02191.x
   Kozak T, 2002, J NEUROL, V249, P1088
   Gratwohl A, 2001, BEST PRACT RES CL HA, V14, P755, DOI 10.1053/beha.2001.0171
   Ikehara S, 2001, EXP HEMATOL, V29, P661, DOI 10.1016/S0301-472X(01)00645-2
   KASHYAP A, 2001, AUTOLOGOUS BLOOD MAR
   Kim KC, 2002, J KOREAN MED SCI, V17, P129
   Lanza F, 2000, BONE MARROW TRANSPL, V25, P1307, DOI 10.1038/sj.bmt.1702435
   MARMONT A, 1995, LANCET, V345, P978, DOI 10.1016/S0140-6736(95)90720-3
   MYLLYKANGASLUOSUJA, 2000, SCAND J RHEUMATOL, V29, P326
   Petri M, 2003, ARTHRITIS RHEUM, V48, P166, DOI 10.1002/art.10752
   Quartier P, 1999, LANCET, V353, P1885, DOI 10.1016/S0140-6736(05)75094-7
   Shaughnessy PJ, 2001, BONE MARROW TRANSPL, V27, P221, DOI 10.1038/sj.bmt.1702767
   STORB RF, 2003, HEMATOLOGY, V1, P372
   Traynor AE, 2002, ARTHRITIS RHEUM, V46, P2917, DOI 10.1002/art.10594
   Tyndall A, 1996, ANN RHEUM DIS, V55, P149, DOI 10.1136/ard.55.3.149
   Van Laar Jacob M, 2003, Cancer Control, V10, P57
   van Laar JM, 2004, BEST PRACT RES CL HA, V17, P233, DOI 10.1016/j.beha.2004.05.005
   Wulffraat N, 1999, LANCET, V353, P550, DOI 10.1016/S0140-6736(98)05399-9
   Wulffraat NM, 2001, ARTHRITIS RHEUM, V44, P728, DOI 10.1002/1529-0131(200103)44:3<728::AID-ANR123>3.0.CO;2-D
   Wulffraat N M, 2000, Curr Rheumatol Rep, V2, P316, DOI 10.1007/s11926-000-0069-8
   Wulffraat NM, 2003, BONE MARROW TRANSPL, V32, pS61, DOI 10.1038/sj.bmt.1703946
NR 50
TC 120
Z9 137
U1 2
U2 4
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 0268-3369
J9 BONE MARROW TRANSPL
JI Bone Marrow Transplant.
PD MAY
PY 2005
VL 35
IS 9
BP 869
EP 879
DI 10.1038/sj.bmt.1704892
PG 11
WC Biophysics; Oncology; Hematology; Immunology; Transplantation
SC Biophysics; Oncology; Hematology; Immunology; Transplantation
GA 918DW
UT WOS:000228520700003
PM 15765114
ER

PT J
AU Vieth, R
AF Vieth, R
TI What is the optimal vitamin D status for health?
SO PROGRESS IN BIOPHYSICS & MOLECULAR BIOLOGY
LA English
DT Article; Proceedings Paper
CT Workshop of the International-Commission-on-Non-Ionizing
   Radiation-Protection
CY OCT 17-18, 2005
CL Munich, GERMANY
SP Int Commission Non-Ionizing Radiat Protect
ID PARATHYROID-HORMONE LEVELS; SERUM 25-HYDROXYVITAMIN-D;
   MULTIPLE-SCLEROSIS; CALCIUM-ABSORPTION; D SUPPLEMENTATION;
   CONTROLLED-TRIAL; RHESUS MACAQUES; D INSUFFICIENCY; BLOOD-PRESSURE; SKIN
   COLOR
AB The most objectively substantiated health-related reason for tanning is that it improves vitamin D status. The serum 25-hydroxyvitamin D concentration (25(OH)D) is the measure of vitamin D nutrition status. Human biology was probably optimized through natural selection for a sun-rich environment that maintained serum 25(OH)D higher than 100 nmol/L. These levels are now only prevalent in people who spend an above-average amount of time outdoors, with the sun high in the sky. The best-characterized criteria for vitamin D adequacy are based on randomized clinical trials that show fracture prevention and preservation of bone mineral density. Based upon these studies, 25(OH)D concentrations should exceed 75 nmol/L. This concentration is near the upper end of the 25(OH)D reference ("normal") range for populations living in temperate climates, or for people who practice sun-avoidance, or who wear head coverings. Officially mandated nutrition guidelines restrict vitamin D intake from fortified food and supplements to less than 25 mcg/day, a dose objectively shown to raise serum 25(OH)D in adults by about 25 nmol/L. The combined effect of current nutrition guidelines and current sun-avoidance advice is to ensure that adults who follow these recommendations will have 25(OH)D concentrations lower than 75 nmol/L. Therefore, advice to avoid UVB light should be accompanied by encouragement to supplement with vitamin D in an amount that will correct for the nutrient deficit that sun-avoidance will cause. (c) 2006 Elsevier Ltd. All rights reserved.
C1 Univ Toronto, Mt Sinai Hosp, Dept Nutr Sci, Toronto, ON M5G 1X5, Canada.
   Univ Toronto, Mt Sinai Hosp, Dept Lab Med & Pathobiol, Toronto, ON M5G 1X5, Canada.
RP Vieth, R (reprint author), Univ Toronto, Mt Sinai Hosp, Dept Nutr Sci, 600 Univ Ave, Toronto, ON M5G 1X5, Canada.
EM rvieth@mtsinai.on.ca
CR ADAMS JE, 1985, PLATYRRHINI CATHRRHI, P219
   Rucker D, 2002, CAN MED ASSOC J, V166, P1517
   Lips P, 2004, J STEROID BIOCHEM, V89-90, P611, DOI 10.1016/j.jsbmb.2004.03.040
   Pfeifer M, 2001, J CLIN ENDOCR METAB, V86, P1633, DOI 10.1210/jc.86.4.1633
   Bischoff-Ferrari HA, 2005, JAMA-J AM MED ASSOC, V293, P2257, DOI 10.1001/jama.293.18.2257
   Heaney RP, 2003, AM J CLIN NUTR, V77, P204
   Vieth R, 2001, EUR J CLIN NUTR, V55, P1091, DOI 10.1038/sj.ejcn.1601275
   Heaney RP, 2003, J AM COLL NUTR, V22, P142
   [Anonymous], 1997, DIET REF INT CALC PH
   Vieth R, 2001, AM J CLIN NUTR, V73, P288
   Law MR, 2002, BRIT MED J, V324, P1570, DOI 10.1136/bmj.324.7353.1570
   Krause R, 1998, LANCET, V352, P709, DOI 10.1016/S0140-6736(05)60827-6
   Relethford JH, 1997, AM J PHYS ANTHROPOL, V104, P449, DOI 10.1002/(SICI)1096-8644(199712)104:4<449::AID-AJPA2>3.0.CO;2-N
   Dawson-Hughes B, 2005, OSTEOPOROSIS INT, V16, P713, DOI 10.1007/s00198-005-1867-7
   Jablonski NG, 2000, J HUM EVOL, V39, P57, DOI 10.1006/jhev.2000.0403
   Heaney RP, 2005, J STEROID BIOCHEM, V97, P13, DOI 10.1016/j.jsbmb.2005.06.020
   MARX SJ, 1989, J CLIN ENDOCR METAB, V69, P1282
   Heaney RP, 1997, J CLIN ENDOCR METAB, V82, P4111, DOI 10.1210/jc.82.12.4111
   Kewenig S, 1999, GASTROENTEROLOGY, V116, P1115, DOI 10.1016/S0016-5085(99)70014-4
   Bischoff-Ferrari HA, 2004, AM J MED, V116, P634, DOI 10.1016/j.amjmed.2003.12.029
   Eaton SB, 1996, J NUTR, V126, P1732
   Chiu KC, 2004, AM J CLIN NUTR, V79, P820
   Davies G, 2003, SCHIZOPHRENIA BULL, V29, P587
   Embry AF, 2000, ANN NEUROL, V48, P271, DOI 10.1002/1531-8249(200008)48:2<271::AID-ANA28>3.0.CO;2-O
   Vieth R, 2005, ANN MED, V37, P278, DOI 10.1080/07853890510007313
   Diamond J, 2005, NATURE, V435, P283, DOI 10.1038/435283a
   Barger-Lux MJ, 2002, J CLIN ENDOCR METAB, V87, P4952, DOI 10.1210/jc.2002-020636
   Dietrich T, 2004, AM J CLIN NUTR, V80, P108
   Pfeifer M, 2001, EXP CLIN ENDOCR DIAB, V109, P87, DOI 10.1055/s-2001-14831
   Chapuy MC, 1996, J CLIN ENDOCR METAB, V81, P1129, DOI 10.1210/jc.81.3.1129
   Feskanich D, 2004, CANCER EPIDEM BIOMAR, V13, P1502
   Vieth R, 2005, J ENDOCRINOL INVEST, V28, P183
   Grant AM, 2005, LANCET, V365, P1621, DOI 10.1016/S0140-6736(05)63013-9
   BARGERLUX MJ, 1994, J NUTR, V124, pS1406
   Doll R, 1998, Stat Methods Med Res, V7, P87, DOI 10.1191/096228098668199908
   *EXP GROUP VIT MIN, 2003, SAF LEV VIT MIN
   GACAD MA, 1992, ENDOCRINOLOGY, V131, P2581, DOI 10.1210/en.131.6.2581
   GARLAND CF, 1989, LANCET, V2, P1176
   Heaney RP, 2005, J ENDOCRINOL INVEST, V28, P180
   *HLTH CONS PROT DI, 2002, OP SCI COMM FOOD TOL
   Jablonski NG, 2002, SCI AM, V287, P74
   Porthouse J, 2005, BRIT MED J, V330, P1003, DOI 10.1136/bmj.330.7498.1003
   Steingrimsdottir L, 2005, JAMA-J AM MED ASSOC, V294, P2336, DOI 10.1001/jama.294.18.2336
   Vieth R, 2005, VITAMIN D: VOLS 1 AND 2, 2ND EDITION, P995
   Vieth R, 1999, AM J CLIN NUTR, V69, P842
   Vieth R, 2004, INT J CANCER, V111, P468, DOI 10.1002/ijc.20218
   VIETH R, 2003, BONE LOSS OSTEOPOROS
   VIETH R, 2005, IN PRESS AM J THERAP
   Vieth R., 2001, Nutritional aspects of osteoporosis, P173
   VIETH R, 1987, J MED PRIMATOL, V16, P349
   Vieth R, 2004, NUTR J, V3, DOI 10.1186/1475-2891-3-8
   Willer CJ, 2005, BRIT MED J, V330, P120, DOI 10.1136/bmj.38301.686030.63
NR 52
TC 119
Z9 129
U1 0
U2 6
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0079-6107
J9 PROG BIOPHYS MOL BIO
JI Prog. Biophys. Mol. Biol.
PD SEP
PY 2006
VL 92
IS 1
BP 26
EP 32
DI 10.1016/j.pbiomolbio.2006.02.003
PG 7
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA 060EW
UT WOS:000238786200005
PM 16766239
ER

PT J
AU Theoharides, TC
   Alysandratos, KD
   Angelidou, A
   Delivanis, DA
   Sismanopoulos, N
   Zhang, BD
   Asadi, S
   Vasiadi, M
   Weng, ZY
   Miniati, A
   Kalogeromitros, D
AF Theoharides, Theoharis C.
   Alysandratos, Konstantinos-Dionysios
   Angelidou, Asimenia
   Delivanis, Danae-Anastasia
   Sismanopoulos, Nikolaos
   Zhang, Bodi
   Asadi, Shahrzad
   Vasiadi, Magdalini
   Weng, Zuyi
   Miniati, Alexandra
   Kalogeromitros, Dimitrios
TI Mast cells and inflammation
SO BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
LA English
DT Review
DE Skin inflammation; Mast cell; Multiple sclerosis; Selective release
ID CORTICOTROPIN-RELEASING HORMONE; BLOOD-BRAIN-BARRIER; FC-EPSILON-RI;
   CENTRAL-NERVOUS-SYSTEM; MULTIPLE-SCLEROSIS PATIENTS; ENDOTHELIAL
   GROWTH-FACTOR; TOLL-LIKE RECEPTORS; EXPERIMENTAL AUTOIMMUNE
   ENCEPHALOMYELITIS; EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS;
   ANTIGEN-PRESENTING CELLS
AB Mast cells are well known for their role in allergic and anaphylactic reactions, as well as their involvement in acquired and innate immunity. Increasing evidence now implicates mast cells in inflammatory diseases where they are activated by non-allergic triggers, such as neuropeptides and cytokines, often exerting synergistic effects as in the case of IL-33 and neurotensin. Mast cells can also release pro-inflammatory mediators selectively without degranulation. In particular, IL-1 induces selective release of IL-6, while corticotropin-releasing hormone secreted under stress induces the release of vascular endothelial growth factor. Many inflammatory diseases involve mast cells in cross-talk with T cells, such as atopic dermatitis, psoriasis and multiple sclerosis, which all worsen by stress. How mast cell differential responses are regulated is still unresolved. Preliminary evidence suggests that mitochondrial function and dynamics control mast cell degranulation, but not selective release. Recent findings also indicate that mast cells have immunomodulatory properties. Understanding selective release of mediators could explain how mast cells participate in numerous diverse biologic processes, and how they exert both immunostimulatory and immunosuppressive actions. Unraveling selective mast cell secretion could also help develop unique mast cell inhibitors with novel therapeutic applications. This article is part of a Special Issue entitled: Mast cells in inflammation. (C) 2010 Elsevier B.V. All rights reserved.
C1 [Theoharides, Theoharis C.; Alysandratos, Konstantinos-Dionysios; Angelidou, Asimenia; Delivanis, Danae-Anastasia; Sismanopoulos, Nikolaos; Zhang, Bodi; Asadi, Shahrzad; Vasiadi, Magdalini; Weng, Zuyi; Miniati, Alexandra] Tufts Univ, Sch Med, Dept Mol Physiol & Pharmacol, Lab Mol Immunopharmacol & Drug Discovery, Boston, MA 02111 USA.
   [Theoharides, Theoharis C.; Zhang, Bodi] Tufts Univ, Sch Med, Dept Biochem, Boston, MA 02111 USA.
   [Theoharides, Theoharis C.] Tufts Univ, Sch Med, Dept Internal Med, Boston, MA 02111 USA.
   [Theoharides, Theoharis C.] Tufts Med Ctr, Boston, MA USA.
   [Theoharides, Theoharis C.; Alysandratos, Konstantinos-Dionysios; Angelidou, Asimenia; Vasiadi, Magdalini; Miniati, Alexandra; Kalogeromitros, Dimitrios] Attikon Gen Hosp, Athens Med Sch, Allergy Sect, Allergy Clin Res Ctr, Athens, Greece.
RP Theoharides, TC (reprint author), Tufts Univ, Sch Med, Dept Mol Physiol & Pharmacol, Lab Mol Immunopharmacol & Drug Discovery, Room M&V 208,136 Harrison Ave, Boston, MA 02111 USA.
EM theoharis.theoharides@tufts.edu;
   Konstantinos-Dionysios.Alysandratos@tufts.edu;
   Asimenia.Angelidou@tufts.edu; Danae.Delivanis@tufts.edu;
   Nikolaos.Sismanopoulos@tufts.edu; Bodizhang@post.harvard.edu;
   ShahrzadAsadi@tufts.edu; Magdalini.Vasiadi@tufts.edu;
   Zuyi.Weng@tufts.edu; Alexandra.Miniati@tufts.edu; dicrikal@yahoo.gr
RI weng, zuyi/J-4147-2015
FU US National Institutes of Health (NIH) [AR47652, NS71361, NS55681,
   NS66205]; Hellenic State Scholarships Foundation (Athens, Greece);
   Galenica, SA (Athens, Greece)
FX Aspects of our work discussed here were supported in part by the US
   National Institutes of Health (NIH) grants: AR47652, NS71361, NS55681
   and NS66205 to TCT. Konstantinos-Dionysios Alysandratos and Asimenia
   Angelidou are recipients of postgraduate scholarships from the Hellenic
   State Scholarships Foundation (Athens, Greece). Bodi Zhang is partially
   supported by a graduate fellowship from Galenica, SA (Athens, Greece).
CR Ackerman KD, 2003, BRAIN BEHAV IMMUN, V17, P141, DOI 10.1016/S0889-1591(03)00047-3
   Supajatura V, 2002, J CLIN INVEST, V109, P1351, DOI 10.1172/JCI200214704
   Sayed BA, 2010, J IMMUNOL, V184, P6891, DOI 10.4049/jimmunol.1000126
   Crompton R, 2003, J CLIN ENDOCR METAB, V88, P5427, DOI 10.1210/jc.2003-030377
   LEVISCHAFFER F, 1986, P NATL ACAD SCI USA, V83, P6485, DOI 10.1073/pnas.83.17.6485
   THEOHARIDES TC, 1990, LIFE SCI, V46, P607, DOI 10.1016/0024-3205(90)90129-F
   LEALBERUMEN I, 1994, J IMMUNOL, V152, P5468
   Kitamura Y, 2005, P NATL ACAD SCI USA, V102, P11129, DOI 10.1073/pnas.0505073102
   Cao J, 2006, MOL PHARMACOL, V69, P998, DOI 10.1124/mol.105.019539
   Yadav M, 2008, ANN NY ACAD SCI, V1144, P83, DOI 10.1196/annals.1418.020
   Chandler N, 2002, BRAIN BEHAV IMMUN, V16, P757, DOI 10.1016/S0889-1591(02)00028-4
   BENYON RC, 1989, BRIT J PHARMACOL, V97, P898
   Cherwinski HM, 2005, J IMMUNOL, V174, P1348
   Siraganian RP, 2003, CURR OPIN IMMUNOL, V15, P639, DOI 10.1016/j.coi.2003.09.010
   Mekori YA, 1999, J ALLERGY CLIN IMMUN, V104, P517, DOI 10.1016/S0091-6749(99)70316-7
   THEOHARIDES TC, 1982, NATURE, V297, P229, DOI 10.1038/297229a0
   Kempuraj D, 2004, ENDOCRINOLOGY, V145, P43, DOI 10.1210/en.2003-0805
   Matsumoto I, 2001, J EXP MED, V194, P71, DOI 10.1084/jem.194.1.71
   Zhang BD, 2011, J ALLERGY CLIN IMMUN, V127, P1522, DOI 10.1016/j.jaci.2011.02.005
   Song IS, 2000, EXP DERMATOL, V9, P42, DOI 10.1034/j.1600-0625.2000.009001042.x
   Kulka M, 2004, J ALLERGY CLIN IMMUN, V114, P174, DOI 10.1016/j.jaci.2004.03.049
   Letourneau R, 1996, BRIT J UROL, V77, P41, DOI 10.1046/j.1464-410X.1996.08178.x
   Wilhelm M, 2005, EUR J NEUROSCI, V22, P2238, DOI 10.1111/j.1460-9568.2005.04429.x
   Zhang Y, 2000, NAT IMMUNOL, V1, P392, DOI 10.1038/80826
   Andrasfalvy M, 2005, J IMMUNOL, V175, P2801
   Benou C, 2005, J IMMUNOL, V174, P5407
   Rottem M, 2005, AUTOIMMUN REV, V4, P21, DOI 10.1016/j.autrev.2004.05.001
   Zappulla JP, 2002, J NEUROIMMUNOL, V131, P5, DOI 10.1016/S0165-5728(02)00250-3
   Papadopoulou N, 2005, J INVEST DERMATOL, V125, P952, DOI 10.1111/j.0022-202X.2005.23913.x
   Kay LJ, 2006, BRIT J PHARMACOL, V147, P707, DOI 10.1038/sj.bjp.0706664
   Li J, 2004, NEUROLOGY, V62, P726
   Blank U, 2004, TRENDS IMMUNOL, V25, P266, DOI 10.1016/j.it.2004.03.005
   Baram D, 2001, J IMMUNOL, V167, P4008
   Lassmann H, 2004, TRENDS IMMUNOL, V25, P132, DOI 10.1016/j.it.2004.01.007
   Okayama Y, 2005, CHEM IMMUNOL ALLERGY, V87, P101
   Galli SJ, 2005, NAT IMMUNOL, V6, P135, DOI 10.1038/ni1158
   Paus R, 2006, TRENDS IMMUNOL, V27, P32, DOI 10.1016/j.it.2005.10.002
   Seebeck J, 1998, ANN NY ACAD SCI, V865, P141, DOI 10.1111/j.1749-6632.1998.tb11172.x
   Lytinas M, 2003, INT ARCH ALLERGY IMM, V130, P224, DOI 10.1159/000069516
   Cocchiara R, 1998, NEUROREPORT, V9, P95, DOI 10.1097/00001756-199801050-00019
   Maurer M, 2004, NATURE, V432, P512, DOI 10.1038/nature03085
   Hendriks JJA, 2003, BIOCHEM PHARMACOL, V65, P877, DOI 10.1016/S0006-2952(02)01609-X
   Chen CC, 2005, P NATL ACAD SCI USA, V102, P11408, DOI 10.1073/pnas.0504197102
   GOLDSCHMIDT RC, 1985, J NEUROCHEM, V44, P1943, DOI 10.1111/j.1471-4159.1985.tb07191.x
   DeVries HE, 1997, PHARMACOL REV, V49, P143
   Shefler I, 2010, J IMMUNOL, V185, P4206, DOI 10.4049/jimmunol.1000409
   Grutzkau A, 1998, MOL BIOL CELL, V9, P875
   KRUGER PG, 1990, ACTA NEUROL SCAND, V81, P31
   Lessmann E, 2006, INT IMMUNOL, V18, P767, DOI 10.1093/intimm/dxl012
   Saraceno R, 2006, BRIT J DERMATOL, V155, P876, DOI 10.1111/j.1365-2133.2006.07518.x
   Ho LH, 2007, J LEUKOCYTE BIOL, V82, P1481, DOI 10.1189/jlb.0407200
   Slominski A, 2000, PHYSIOL REV, V80, P979
   Kunder CA, 2009, J EXP MED, V206, P2455, DOI 10.1084/jem.20090805
   Lee EB, 2010, PEDIAT ALLERG IMM-UK, V21, pE457, DOI 10.1111/j.1399-3038.2009.00919.x
   AlAbadie MSK, 1995, CLIN EXP DERMATOL, V20, P384, DOI 10.1111/j.1365-2230.1995.tb01354.x
   Letourneau R, 2003, J NEUROIMMUNOL, V145, P18, DOI 10.1016/j.jneuroim.2003.09.004
   Yoshimoto T, 2010, INT IMMUNOL, V22, P543, DOI 10.1093/intimm/dxq052
   PAUS R, 1995, ARCH DERMATOL RES, V287, P500, DOI 10.1007/BF00373436
   Nakayama T, 2006, J LEUKOCYTE BIOL, V79, P95, DOI 10.1189/jlb.0405226
   Kempuraj D, 2008, BRIT J PHARMACOL, V155, P1076, DOI 10.1038/bjp.2008.356
   Moulin D, 2007, CYTOKINE, V40, P216, DOI 10.1016/j.cyto.2007.09.013
   Bethin KE, 2000, P NATL ACAD SCI USA, V97, P9317, DOI 10.1073/pnas.97.16.9317
   Robbie-Ryan M, 2002, CURR OPIN IMMUNOL, V14, P728, DOI 10.1016/S0952-7915(02)00394-1
   KERMODE AG, 1990, BRAIN, V113, P1477, DOI 10.1093/brain/113.5.1477
   GADEKMICHALSKA A, 1991, AGENTS ACTIONS, V32, P203
   SLOMINSKI A, 1995, FEBS LETT, V374, P113, DOI 10.1016/0014-5793(95)01090-2
   Kawana S, 2006, J DERMATOL SCI, V42, P47, DOI 10.1016/j.jdermsci.2005.12.004
   He SH, 2004, ACTA PHARMACOL SIN, V25, P822
   OLSSON Y, 1974, ACTA NEUROL SCAND, V50, P611
   MERCHENTHALER I, 1983, BRAIN RES, V275, P373, DOI 10.1016/0006-8993(83)91001-6
   Cima K, 2010, REGUL PEPTIDES, V160, P42, DOI 10.1016/j.regpep.2009.12.013
   CHEN RP, 1993, P NATL ACAD SCI USA, V90, P8967, DOI 10.1073/pnas.90.19.8967
   Shanas U, 1998, J NEUROIMMUNOL, V90, P207, DOI 10.1016/S0165-5728(98)00137-4
   THEOHARIDES TC, 1978, SCIENCE, V201, P1143, DOI 10.1126/science.684435
   LEVISCHAFFER F, 1989, INT ARCH ALLER A IMM, V90, P352
   Kimata H, 2003, BRAIN BEHAV IMMUN, V17, P134, DOI 10.1016/S0889-1591(03)00025-4
   Tal M, 1997, NEUROSCI LETT, V221, P129, DOI 10.1016/S0304-3940(96)13318-8
   Silver R, 1996, TRENDS NEUROSCI, V19, P25, DOI 10.1016/0166-2236(96)81863-7
   Charles N, 2010, NAT MED, V16, P701, DOI 10.1038/nm.2159
   Aderem A, 2000, NATURE, V406, P782, DOI 10.1038/35021228
   O'Connor W, 2010, NAT IMMUNOL, V11, P471, DOI 10.1038/ni.1882
   Pang X, 1996, NEUROSCIENCE, V73, P889, DOI 10.1016/0306-4522(95)00606-0
   Molino M, 1997, J BIOL CHEM, V272, P4043
   Naukkarinen A, 1996, J PATHOL, V180, P200, DOI 10.1002/(SICI)1096-9896(199610)180:2<200::AID-PATH632>3.0.CO;2-Z
   Theoharides TC, 2007, ADV EXP MED BIOL, V601, P423
   Buljevac D, 2003, BRIT MED J, V327, P646, DOI 10.1136/bmj.327.7416.646
   Kajiwara N, 2010, J ALLERGY CLIN IMMUN, V125, P1137, DOI 10.1016/j.jaci.2010.01.056
   Allakhverdi Z, 2007, J EXP MED, V204, P253, DOI 10.1084/jem.20062211
   Qiao HH, 2006, BLOOD, V107, P610, DOI 10.1182/blood-2005-06-2271
   Theoharides TC, 1996, INT J TISSUE REACT, V18, P1
   Theoharides TC, 2010, P NATL ACAD SCI USA, V107, P4448, DOI 10.1073/pnas.1000803107
   Alysandratos KD, 2010, ANN ALLERG ASTHMA IM, V105, P403, DOI 10.1016/j.anai.2010.09.017
   McCurdy JD, 2003, J IMMUNOL, V170, P1625
   Woolhiser MR, 2004, CLIN IMMUNOL, V110, P172, DOI 10.1016/j.clim.2003.11.007
   Forssell J, 2005, AM J RESP CELL MOL, V32, P511, DOI 10.1165/rcmb.2004-0348OC
   Heesen C, 2002, BRAIN BEHAV IMMUN, V16, P282, DOI 10.1006/brbi.2001.0628
   Stempelj M, 2005, INFLAMM RES, V54, P344, DOI 10.1007/s00011-005-1364-7
   SCHWARTZ LB, 1987, ANN ALLERGY, V58, P226
   Kepley CL, 2005, INT ARCH ALLERGY IMM, V138, P29, DOI 10.1159/000087355
   Abbott NJ, 2000, CELL MOL NEUROBIOL, V20, P131, DOI 10.1023/A:1007074420772
   KWON EE, 1994, J NEUROPATH EXP NEUR, V53, P625, DOI 10.1097/00005072-199411000-00010
   Kempuraj D, 2005, BRIT J PHARMACOL, V145, P934, DOI 10.1038/sj.bjp.0706246
   Yoshimoto T, 2009, NAT IMMUNOL, V10, P706, DOI 10.1038/ni.1737
   Xiang Z, 2000, CLIN EXP ALLERGY, V30, P1379, DOI 10.1046/j.1365-2222.2000.00906.x
   Kjaer A, 1998, EUR J ENDOCRINOL, V139, P238, DOI 10.1530/eje.0.1390238
   Kassiotis G, 2001, J EXP MED, V193, P427, DOI 10.1084/jem.193.4.427
   Bachelet I, 2005, J IMMUNOL, V175, P7989
   Nishida K, 2005, J CELL BIOL, V170, P115, DOI 10.1083/jcb.200501111
   Matsushima H, 2004, J IMMUNOL, V173, P531
   Karra L, 2009, CURR OPIN IMMUNOL, V21, P708, DOI 10.1016/j.coi.2009.09.010
   Stelekati E, 2009, IMMUNITY, V31, P665, DOI 10.1016/j.immuni.2009.08.022
   SERAFIN WE, 1987, NEW ENGL J MED, V317, P30, DOI 10.1056/NEJM198707023170106
   Huang M, 2003, CARDIOVASC RES, V59, P241, DOI 10.1016/S0008-6363(03)00340-7
   Nakae S, 2006, J IMMUNOL, V176, P2238
   Klemm S, 2006, J EXP MED, V203, P337, DOI 10.1084/jem.20051982
   MATSUDA H, 1989, J IMMUNOL, V142, P927
   Ochi H, 2000, P NATL ACAD SCI USA, V97, P10509, DOI 10.1073/pnas.180318697
   Redegeld FA, 2003, TRENDS IMMUNOL, V24, P181, DOI 10.1016/S1471-4906(03)00059-0
   Tang H, 2010, NAT IMMUNOL, V11, P608, DOI 10.1038/ni.1883
   Odum L, 1998, INFLAMM RES, V47, P488, DOI 10.1007/s000110050363
   Piliponsky AM, 2008, NAT MED, V14, P392, DOI 10.1038/nm1738
   Abdel-Majid RM, 2004, J IMMUNOL, V172, P1227
   Cao J, 2005, J IMMUNOL, V174, P7665
   MOOR ACE, 1994, BIOCHEM PHARMACOL, V47, P1717, DOI 10.1016/0006-2952(94)90297-6
   BRADDING P, 1995, J IMMUNOL, V155, P297
   Hultner L, 2005, TRENDS IMMUNOL, V26, P235, DOI 10.1016/j.it.2005.03.007
   Gold SM, 2005, TRENDS IMMUNOL, V26, P644, DOI 10.1016/j.it.2005.09.010
   Marquardt DL, 1996, J IMMUNOL, V156, P1942
   TAMIR H, 1982, J CELL BIOL, V93, P638, DOI 10.1083/jcb.93.3.638
   Gibbs BF, 2001, EXP DERMATOL, V10, P312, DOI 10.1034/j.1600-0625.2001.100503.x
   Novak N, 2004, CURR ALLERGY ASTHM R, V4, P263, DOI 10.1007/s11882-004-0069-2
   Rivera J, 2006, J ALLERGY CLIN IMMUN, V117, P1214, DOI 10.1016/j.jaci.2006.04.015
   Liu JY, 2006, BRIT J DERMATOL, V155, P657, DOI 10.1111/j.1365-2133.2006.07408.x
   Oka T, 2004, AM J PHYSIOL-CELL PH, V286, pC256, DOI 10.1152/ajpcell.00197.2003
   THEOHARIDES TC, 1993, NEUROSCIENCE, V57, P861, DOI 10.1016/0306-4522(93)90030-J
   Hundley TR, 2004, BLOOD, V104, P2410, DOI 10.1182/blood-2004-02-0631
   ROZNIECKI JJ, 1995, ANN NEUROL, V37, P63, DOI 10.1002/ana.410370112
   Nakae S, 2007, BLOOD, V109, P3640, DOI 10.1182/blood-2006-09-046128
   Sokol CL, 2010, CURR OPIN IMMUNOL, V22, P73, DOI 10.1016/j.coi.2010.01.012
   MASTORAKOS G, 1993, J CLIN ENDOCR METAB, V77, P1690, DOI 10.1210/jc.77.6.1690
   Verbeek R, 2004, BIOCHEM PHARMACOL, V68, P621, DOI 10.1016/j.bcp.2004.05.012
   HONIG PK, 1993, JAMA-J AM MED ASSOC, V269, P1513, DOI 10.1001/jama.269.12.1513
   IBRAHIM MZM, 1974, J NEUROL SCI, V21, P431, DOI 10.1016/0022-510X(74)90043-4
   Katsarou-Katsari A, 1999, INT J IMMUNOPATH PH, V12, P7
   Conti P, 1997, BLOOD, V89, P4120
   Metz M, 2004, EXP DERMATOL, V13, P273, DOI 10.1111/j.0906-6705.2004.00115.x
   Dimitriadou V, 1997, NEUROSCIENCE, V77, P829, DOI 10.1016/S0306-4522(96)00488-5
   EDVINSSON L, 1976, BRAIN RES, V115, P377, DOI 10.1016/0006-8993(76)90356-5
   Theoharides TC, 1998, ENDOCRINOLOGY, V139, P403, DOI 10.1210/en.139.1.403
   Lu CM, 2010, P NATL ACAD SCI USA, V107, P18967, DOI 10.1073/pnas.1008816107
   Bischoff SC, 2001, INT ARCH ALLERGY IMM, V124, P151, DOI 10.1159/000053695
   SKOFITSCH G, 1985, PEPTIDES, V6, P307, DOI 10.1016/0196-9781(85)90057-9
   Robbie-Ryan M, 2003, J IMMUNOL, V170, P1630
   Chen XJ, 2007, EUR J IMMUNOL, V37, P434, DOI 10.1002/eji.200636379
   Theoharides TC, 2007, IMMUNOL REV, V217, P65, DOI 10.1111/j.1600-065X.2007.00519.x
   LOVENBERG TW, 1995, ENDOCRINOLOGY, V136, P4139, DOI 10.1210/en.136.9.4139
   Seow CJ, 2002, EUR J PHARMACOL, V443, P189, DOI 10.1016/S0014-2999(02)01534-0
   O'Connor TM, 2004, J CELL PHYSIOL, V201, P167, DOI 10.1002/jcp.20061
   Furumoto Y, 2006, J IMMUNOL, V176, P5167
   Bomprezzi R, 2003, HUM MOL GENET, V12, P2191, DOI 10.1093/hmg/ddg221
   Theoharides TC, 2004, J NEUROIMMUNOL, V146, P1, DOI 10.1016/j.jneuroim.2003.10.041
   VAUGHAN J, 1995, NATURE, V378, P287, DOI 10.1038/378287a0
   THEOHARIDES TC, 1995, ENDOCRINOLOGY, V136, P5745, DOI 10.1210/en.136.12.5745
   Esposito P, 2002, J PHARMACOL EXP THER, V303, P1061, DOI 10.1124/jpet.102.038497
   Fiorani M, 2010, J NUTR BIOCHEM, V21, P397, DOI 10.1016/j.jnutbio.2009.01.014
   ALOE L, 1977, BRAIN RES, V133, P358, DOI 10.1016/0006-8993(77)90772-7
   Nestle FO, 2009, NEW ENGL J MED, V361, P496, DOI 10.1056/NEJMra0804595
   Redegeld FA, 2002, NAT MED, V8, P694, DOI 10.1038/nm722
   Lewis K, 2001, P NATL ACAD SCI USA, V98, P7570, DOI 10.1073/pnas.121165198
   Rozniecki JJ, 1999, BRAIN RES, V849, P1, DOI 10.1016/S0006-8993(99)01855-7
   Poncet P, 1999, J LEUKOCYTE BIOL, V66, P105
   Conti P, 2003, IMMUNOL LETT, V86, P123, DOI 10.1016/S0165-2478(03)00002-6
   Singh LK, 1999, J PHARMACOL EXP THER, V288, P1349
   Xu D, 2008, P NATL ACAD SCI USA, V105, P10913, DOI 10.1073/pnas.0801898105
   Gondokaryono SP, 2007, J LEUKOCYTE BIOL, V82, P657, DOI 10.1189/jlb.1206730
   Galli SJ, 2008, NAT REV IMMUNOL, V8, P478, DOI 10.1038/nri2327
   LOVENBERG TW, 1995, P NATL ACAD SCI USA, V92, P836, DOI 10.1073/pnas.92.3.836
   Pedotti R, 2003, TRENDS IMMUNOL, V24, P479, DOI 10.1016/S1471-4906(03)00233-3
   Lin TJ, 2000, J IMMUNOL, V165, P211
   Theoharides TC, 2007, FRONT BIOSCI, V12, P1615, DOI 10.2741/2174
   Tagen M, 2009, J IMMUNOL, V183, P6313, DOI 10.4049/jimmunol.0803422
   Rodewald HR, 1996, SCIENCE, V271, P818, DOI 10.1126/science.271.5250.818
   Brown MA, 2002, MOL IMMUNOL, V38, P1373, DOI 10.1016/S0161-5890(02)00091-3
   Harvima RJ, 1996, ACTA DERM-VENEREOL, V76, P467
   Middleton E, 2000, PHARMACOL REV, V52, P673
   Soumelis V, 2002, NAT IMMUNOL, V3, P673, DOI 10.1038/ni805
   Slominski A, 2000, ENDOCR REV, V21, P457, DOI 10.1210/er.21.5.457
   Woolley DE, 2003, NEW ENGL J MED, V348, P1709, DOI 10.1056/NEJMcibr023206
   Fischer M, 2006, J CLIN INVEST, V116, P2748, DOI 10.1172/JC124274
   Esposito P, 2001, BRAIN RES, V888, P117, DOI 10.1016/S0006-8993(00)03026-2
   Bischoff SC, 1999, P NATL ACAD SCI USA, V96, P8080, DOI 10.1073/pnas.96.14.8080
   Kraneveld AD, 2005, P NATL ACAD SCI USA, V102, P1578, DOI 10.1073/pnas.0406808102
   Theoharides TC, 2004, J CLIN PSYCHOPHARM, V24, P577, DOI 10.1097/01.jcp.0000148026.86483.4f
   Ito N, 2010, J INVEST DERMATOL, V130, P995, DOI 10.1038/jid.2009.387
   Nakae S, 2005, P NATL ACAD SCI USA, V102, P6467, DOI 10.1073/pnas.0501912102
   Chalmers DT, 1996, TRENDS PHARMACOL SCI, V17, P166, DOI 10.1016/0165-6147(96)81594-X
   VANLOVEREN H, 1984, EUR J IMMUNOL, V14, P40, DOI 10.1002/eji.1830140108
   FEWTRELL CMS, 1982, J PHYSIOL-LONDON, V330, P393
   Bachelet I, 2007, TRENDS IMMUNOL, V28, P360, DOI 10.1016/j.it.2007.06.007
   Odom S, 2004, J EXP MED, V199, P1491, DOI 10.1084/jem.20040382
   Dhabhar FS, 1999, P NATL ACAD SCI USA, V96, P1059, DOI 10.1073/pnas.96.3.1059
   Aktas O, 2004, J IMMUNOL, V173, P5794
   Piconese S, 2009, BLOOD, V114, P2639, DOI 10.1182/blood-2009-05-220004
   Metz M, 2006, SCIENCE, V313, P526, DOI 10.1126/science.1128877
   Akira S, 2001, NAT IMMUNOL, V2, P675, DOI 10.1038/90609
   Fortune DG, 2005, DERMATOL CLIN, V23, P681, DOI 10.1016/j.det.2005.05.022
   WARREN S, 1982, J CHRON DIS, V35, P821, DOI 10.1016/0021-9681(82)90047-9
   KIM KS, 1992, LYMPHOKINE CYTOK RES, V11, P293
   Campbell T, 2001, BRAIN BEHAV IMMUN, V15, P235, DOI 10.1006/brbi.2000.0598
   Ozdamar SO, 1996, DERMATOLOGY, V192, P190
   VANHAASTER CMCJ, 1995, BBA-MOL CELL RES, V1265, P79, DOI 10.1016/0167-4889(94)00210-6
   Slominski A, 2001, FASEB J, V15, P1678, DOI 10.1096/fj.00-0850rev
   Kraft S, 2007, NAT REV IMMUNOL, V7, P365, DOI 10.1038/nri2072
   Jang S, 2008, P NATL ACAD SCI USA, V105, P7534, DOI 10.1073/pnas.0802865105
   Tam SY, 1997, BLOOD, V90, P1807
   Mohr DC, 2000, NEUROLOGY, V55, P55
   Harvima IT, 2008, ARCH DERMATOL RES, V300, P461, DOI 10.1007/s00403-008-0874-x
   Leeman SE, 2000, NEUROPEPTIDES, V34, P249, DOI 10.1054/npep.2000.0826
   Peters EMJ, 2005, BRAIN BEHAV IMMUN, V19, P252, DOI 10.1016/j.bbi.2004.08.005
   Abraham SN, 2010, NAT REV IMMUNOL, V10, P440, DOI 10.1038/nri2782
   Bischoff SC, 2007, NAT REV IMMUNOL, V7, P93, DOI 10.1038/nri2018
   Galli SJ, 2005, ANNU REV IMMUNOL, V23, P749, DOI 10.1146/annurev.immunol.21.120601.141025
   Mohr DC, 2004, BRIT MED J, V328, P731, DOI 10.1136/bmj.38041.724421.55
   Lorentz A, 2007, NEUROGASTROENT MOTIL, V19, P301, DOI 10.1111/j.1365-2982.2007.00899.x
   Gagari E, 1997, BLOOD, V89, P2654
   Davis BJ, 2004, J IMMUNOL, V173, P6914
   Jang SW, 2010, P NATL ACAD SCI USA, V107, P2687, DOI 10.1073/pnas.0913572107
   Dvorak AM, 1997, INT ARCH ALLERGY IMM, V114, P1
   Laham RJ, 2003, ANN VASC SURG, V17, P245, DOI 10.1007/s10016-001-0299-x
   Sokol CL, 2009, NAT IMMUNOL, V10, P713, DOI 10.1038/ni.1738
   Spencer LA, 2006, P NATL ACAD SCI USA, V103, P3333, DOI 10.1073/pnas.0508946103
   Theoharides TC, 2004, TRENDS PHARMACOL SCI, V25, P563, DOI 10.1016/j.tips.2004.09.007
   Singh LK, 1999, BRAIN BEHAV IMMUN, V13, P225, DOI 10.1006/brbi.1998.0541
   Klinkert WEF, 1997, J NEUROIMMUNOL, V72, P163, DOI 10.1016/S0165-5728(96)00183-X
   Frossi B, 2010, TRENDS IMMUNOL, V31, P97, DOI 10.1016/j.it.2009.12.007
   Lock C, 2002, NAT MED, V8, P500, DOI 10.1038/nm0502-500
   Gomez G, 2005, J IMMUNOL, V175, P7602
   Galli SJ, 2010, EUR J IMMUNOL, V40, P1843, DOI 10.1002/eji.201040559
   GORDON JR, 1990, NATURE, V346, P274, DOI 10.1038/346274a0
   Bashyam B, 2007, J EXP MED, V204, P209
   BIENENSTOCK J, 1987, INT ARCH ALLER A IMM, V82, P238
   BUGAJSKI AJ, 1994, AGENTS ACTIONS, V41, pC75, DOI 10.1007/BF02007774
   Bugajski A J, 1995, Inflamm Res, V44 Suppl 1, pS50, DOI 10.1007/BF01674391
   Bunnett NW, 2006, SEMIN THROMB HEMOST, V32, P39, DOI 10.1055/s-2006-939553
   CARRAWAY R, 1982, J PHYSIOL-LONDON, V323, P403
   CARRAWAY RE, 1986, ENDOCRINOLOGY, V119, P1519
   CARRAWAY RE, 1989, J IMMUNOL, V143, P1680
   Castellani ML, 2009, J BIOL REG HOMEOS AG, V23, P11
   Chan J, 1997, ARCH DERMATOL RES, V289, P611, DOI 10.1007/s004030050249
   CHROUSOS GP, 1995, NEW ENGL J MED, V332, P1351
   Church MK, 1999, ANN ALLERG ASTHMA IM, V83, P471, DOI 10.1016/S1081-1206(10)62853-0
   Cirulli F., 1997, Society for Neuroscience Abstracts, V23, P714
   Clifton VL, 2002, J CLIN ENDOCR METAB, V87, P267, DOI 10.1210/jc.87.1.267
   COCHRANE DE, 1993, PEPTIDES, V14, P117, DOI 10.1016/0196-9781(93)90018-C
   COCHRANE DE, 1991, PEPTIDES, V12, P1187, DOI 10.1016/0196-9781(91)90193-S
   DAMERAU B, 1975, N-S ARCH PHARMACOL, V287, P141, DOI 10.1007/BF00510446
   DESIMONE R, 1990, BRAIN BEHAV IMMUN, V4, P74, DOI 10.1016/0889-1591(90)90008-E
   DIMITRIADOU V, 1991, NEUROSCIENCE, V44, P97
   DIMITRIADOU V, 1987, NEUROSCIENCE, V22, P621, DOI 10.1016/0306-4522(87)90358-7
   Dirscherl K, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-3
   DVORAK AM, 1992, INT ARCH ALLERGY IMM, V99, P74
   FOREMAN JC, 1987, BRIT MED BULL, V43, P386
   GALLI SJ, 1993, NEW ENGL J MED, V328, P257
   GOETZL EJ, 1990, CLIN EXP ALLERGY, V20, P3, DOI 10.1111/j.1365-2222.1990.tb02469.x
   GOETZL EJ, 1985, J IMMUNOL, V135, pS802
   Gong JA, 2010, BMC IMMUNOL, V11, DOI 10.1186/1471-2172-11-34
   Gonzalez-Espinosa C, 2003, J EXP MED, V197, P1453, DOI 10.1084/jem.20021806
   Goodin DS, 1999, NEUROLOGY, V52, P1737
   GRIFFIN DE, 1986, CELL IMMUNOL, V97, P454, DOI 10.1016/0008-8749(86)90414-4
   HARVIMA IT, 1993, PSYCHOTHER PSYCHOSOM, V60, P168
   Hendricks JJA, 2004, J EXP MED, V200, P1667, DOI 10.1084/jem.20040819
   Hepp Regine, 2005, Journal of Biological Chemistry, V280, P6610, DOI 10.1074/jbc.M412126200
   Holgate ST, 2000, CLIN EXP ALLERGY, V30, P28
   Ikeda RK, 2003, J IMMUNOL, V171, P4860
   JANISZEWSKI J, 1994, AM J PHYSIOL, V267, pC138
   Jayapal M, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-210
   Jeyaraju DV, 2009, BBA-BIOENERGETICS, V1787, P1363, DOI 10.1016/j.bbabio.2008.12.005
   Kandere-Grzybowska K, 2006, BRIT J PHARMACOL, V148, P208, DOI 10.1038/sj.bjp.0706695
   Kandere-Grzybowska K, 2003, BRAIN RES, V980, P213, DOI 10.1016/S0006-8993(03)02975-5
   Kandere-Grzybowska K, 2003, J IMMUNOL, V171, P4830
   Kaneko K, 2003, EXP DERMATOL, V12, P47, DOI 10.1034/j.1600-0625.2003.120106.x
   Karalis K, 1997, J NEUROIMMUNOL, V72, P131, DOI 10.1016/S0165-5728(96)00178-6
   Kimata H, 2003, EUR J CLIN INVEST, V33, P513, DOI 10.1046/j.1365-2362.2003.01177.x
   KUBLER A, 1994, CLIN INVESTIGATOR, V72, P331
   Lalive PH, 2002, BEHAV NEUROSCI, V116, P1093, DOI 10.1037//0735-7044.116.6.1093
   LAMBRACHTHALL M, 1990, DEV BRAIN RES, V56, P151, DOI 10.1016/0165-3806(90)90077-C
   LIKURA M, 2007, LAB INVEST, V87, P971
   LIU CS, 1991, BIOCHIM BIOPHYS ACTA, V1077, P362, DOI 10.1016/0167-4838(91)90552-B
   Malamud V, 2003, J NEUROIMMUNOL, V138, P115, DOI 10.1016/S0165-5728(03)00090-0
   MASUDA A, 2003, EUR J IMMUNOL, V33, P899
   Million M, 2002, AM J PHYSIOL-GASTR L, V282, pG34
   MOLDERINGS GJ, 2010, BIOTREND REV
   POLLARD H, 1976, BRAIN RES, V118, P509, DOI 10.1016/0006-8993(76)90322-X
   Probert L, 1997, J NEUROIMMUNOL, V72, P137, DOI 10.1016/S0165-5728(96)00184-1
   Pushparaj PN, 2009, P NATL ACAD SCI USA, V106, P9773, DOI 10.1073/pnas.0901206106
   Remrod C, 2007, ARCH DERMATOL RES, V299, P85, DOI 10.1007/s00403-007-0745-x
   Rivera J, 2006, TRENDS IMMUNOL, V27, P251, DOI 10.1016/j.it.2006.04.001
   Sato S, 1999, ARCH DERMATOL RES, V291, P614, DOI 10.1007/s004030050463
   Schmidlin Fabien, 2001, Current Opinion in Pharmacology, V1, P575, DOI 10.1016/S1471-4892(01)00099-6
   Sternberg Z, 2009, J NEUROINFLAMM, V6, DOI 10.1186/1742-2094-6-28
   SYNDULKO K, 1993, J NEUROIMMUNOL, V46, P185, DOI 10.1016/0165-5728(93)90248-W
   Tagen M, 2007, J INVEST DERMATOL, V127, P1789, DOI 10.1038/sj.jid.5700757
   Teunis MAT, 2002, J NEUROIMMUNOL, V133, P30, DOI 10.1016/S0165-5728(02)00351-X
   Theoharides TC, 2009, J NEUROINFLAMM, V6, DOI 10.1186/1742-2094-6-29
   THEOHARIDES TC, 1981, PERSPECT BIOL MED, V24, P499
   Theoharides TC, 2000, BRIT J PHARMACOL, V131, P1039, DOI 10.1038/sj.bjp.0703672
   Toyoda M, 2000, ARCH DERMATOL RES, V292, P418, DOI 10.1007/s004030000149
   VONDURING M, 1990, ANAT EMBRYOL, V182, P363
   Zhang B, 2010, J IMMUNOL, V184, P11
NR 309
TC 112
Z9 125
U1 3
U2 31
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0925-4439
J9 BBA-MOL BASIS DIS
JI Biochim. Biophys. Acta-Mol. Basis Dis.
PD JAN
PY 2012
VL 1822
IS 1
SI SI
BP 21
EP 33
DI 10.1016/j.bbadis.2010.12.014
PG 13
WC Biochemistry & Molecular Biology; Biophysics; Cell Biology
SC Biochemistry & Molecular Biology; Biophysics; Cell Biology
GA 867NP
UT WOS:000298461400005
PM 21185371
ER

PT J
AU Chen, N
   Debnath, J
AF Chen, Nan
   Debnath, Jayanta
TI Autophagy and tumorigenesis
SO FEBS LETTERS
LA English
DT Review
DE Autophagy; Cancer; Genome instability; Cell death; Chemotherapy
ID TUBEROUS SCLEROSIS COMPLEX; MALIGNANT GLIOMA-CELLS; BREAST-CANCER CELLS;
   BCL-X-L; TUMOR-SUPPRESSOR; BECLIN 1; PHOSPHATIDYLINOSITOL 3-KINASE;
   MICROSATELLITE INSTABILITY; INDUCED CYTOTOXICITY; REGULATES AUTOPHAGY
AB Autophagy, or cellular self-digestion, is activated in cancer cells in response to multiple stresses and has been demonstrated to promote tumor cell survival and drug resistance. Nonetheless, genetic evidence supports that autophagy functions as a tumor suppressor mechanism. Hence, the precise role of autophagy during cancer progression and treatment is both tissue and context dependent. Here, we discuss our current understanding of the biological functions of autophagy during cancer development, overview how autophagy is regulated by cancer-associated signaling pathways, and review how autophagy inhibition is being exploited to improve clinical outcomes. (C) 2009 Federation of European Biochemical Societies. Published by Elsevier B. V. All rights reserved.
C1 [Chen, Nan; Debnath, Jayanta] Univ Calif San Francisco, Dept Pathol, Diller Comprehens Canc Ctr, San Francisco, CA 94143 USA.
RP Debnath, J (reprint author), Univ Calif San Francisco, Dept Pathol, Diller Comprehens Canc Ctr, 513 Parnassus Ave,HSW450B, San Francisco, CA 94143 USA.
EM Jayanta.Debnath@ucsf.edu
FU NIH [RO1CA126792, CA126792-S1 ARRA]; California Tobacco Related Disease
   Research Program [18XT-0106]; HHMI Physician Scientist Early Career
   Award
FX J.D. is supported by grants from the NIH (RO1CA126792; CA126792-S1
   ARRA), the California Tobacco Related Disease Research Program
   (18XT-0106), and an HHMI Physician Scientist Early Career Award.
CR Amaravadi RK, 2007, J CLIN INVEST, V117, P326, DOI 10.1172/JCI28833
   Eisenberg-Lerner A, 2009, APOPTOSIS, V14, P376, DOI 10.1007/s10495-008-0307-5
   Tee AR, 2003, CURR BIOL, V13, P1259, DOI 10.1016/S0960-9822(03)00506-2
   Marino G, 2007, J BIOL CHEM, V282, P18573, DOI 10.1074/jbc.M701194200
   Itoh T, 2006, BBA-MOL CELL BIOL L, V1761, P897, DOI 10.1016/j.bbalip.2006.06.015
   Furuya N, 2005, AUTOPHAGY, V1, P46
   Ertmer A, 2007, LEUKEMIA, V21, P936, DOI 10.1038/sj.leu.2404606
   Hoyer-Hansen M, 2008, AUTOPHAGY, V4, P574
   Sun QM, 2008, P NATL ACAD SCI USA, V105, P19211, DOI 10.1073/pnas.0810452105
   Yamamoto A, 1998, CELL STRUCT FUNCT, V23, P33
   Yue ZY, 2003, P NATL ACAD SCI USA, V100, P15077, DOI 10.1073/pnas.2436255100
   Mathew R, 2009, CELL, V137, P1062, DOI 10.1016/j.cell.2009.03.048
   Salazar M, 2009, J CLIN INVEST, V119, P1359, DOI 10.1172/JCI37948
   Tormo D, 2009, CANCER CELL, V16, P103, DOI 10.1016/j.ccr.2009.07.004
   Zhou XM, 2009, P NATL ACAD SCI USA, V106, P8923, DOI 10.1073/pnas.0903621106
   Young ARJ, 2009, GENE DEV, V23, P798, DOI 10.1101/gad.519709
   Tasdemir E, 2008, NAT CELL BIOL, V10, P676, DOI 10.1038/ncb1730
   Maiuri MC, 2009, CELL CYCLE, V8, P1571
   Guertin DA, 2007, CANCER CELL, V12, P9, DOI 10.1016/j.ccr.2007.05.008
   Watanabe M, 2009, INT J CANCER, V124, P55, DOI 10.1002/ijc.23897
   Crighton D, 2006, CELL, V126, P121, DOI 10.1016/j.cell.2006.05.034
   Maclean KH, 2008, J CLIN INVEST, V118, P79, DOI 10.1172/JCI33700
   Liang CY, 2008, NAT CELL BIOL, V10, P776, DOI 10.1038/ncb1740
   Pattingre S, 2005, CELL, V122, P927, DOI 10.1016/j.cell.2005.07.002
   Itakura E, 2008, MOL BIOL CELL, V19, P5360, DOI 10.1091/mbc.E08-01-0080
   Petiot A, 2000, J BIOL CHEM, V275, P992, DOI 10.1074/jbc.275.2.992
   Liang XH, 1999, NATURE, V402, P672
   Kaushik S, 2008, MOL BIOL CELL, V19, P2179, DOI 10.1091/mbc.E07-11-1155
   Liang C, 2006, NAT CELL BIOL, V8, P688, DOI 10.1038/ncb1426
   Liang JY, 2007, NAT CELL BIOL, V9, P218, DOI 10.1038/ncb1537
   Lomonaco SL, 2009, INT J CANCER, V125, P717, DOI 10.1002/ijc.24402
   Qu XP, 2003, J CLIN INVEST, V112, P1809, DOI 10.1172/JCI200320039
   Chipuk JE, 2004, SCIENCE, V303, P1010, DOI 10.1126/science.1092734
   Coppola D, 2008, CANCER, V113, P2665, DOI 10.1002/cncr.23892
   Nardella C, 2008, GENE DEV, V22, P2172, DOI 10.1101/gad.1699608
   Apel A, 2008, CANCER RES, V68, P1485, DOI 10.1158/0008-5472.CAN-07-0562
   Carew JS, 2007, BLOOD, V110, P313, DOI 10.1182/blood-2006-10-050260
   Luiken JJFP, 1996, EUR J BIOCHEM, V235, P564
   Kim MS, 2008, HUM PATHOL, V39, P1059, DOI 10.1016/j.humpath.2007.11.013
   Mizushima N, 2007, ANNU REV NUTR, V27, P19, DOI 10.1146/annurev.nutr.27.061406.093749
   Inoki K, 2006, CELL, V126, P955, DOI 10.1016/j.cell.2006.06.055
   Zhong Y, 2009, NAT CELL BIOL, V11, P468, DOI 10.1038/ncb1854
   Kim RH, 2009, CANCER RES, V69, P700, DOI 10.1158/0008-5472.CAN-08-3157
   Mathew R, 2007, GENE DEV, V21, P1367, DOI 10.1101/gad.1545107
   Arico S, 2001, J BIOL CHEM, V276, P35243, DOI 10.1074/jbc.C100319200
   Kamitsuji Y, 2008, CELL DEATH DIFFER, V15, P1712, DOI 10.1038/cdd.2008.107
   Maiuri MC, 2007, EMBO J, V26, P2527, DOI 10.1038/sj.emboj.7601689
   Abedin MJ, 2007, CELL DEATH DIFFER, V14, P500, DOI 10.1038/sj.cdd.4402039
   Pimkina J, 2009, J BIOL CHEM, V284, P2803, DOI 10.1074/jbc.M804705200
   Shingu T, 2009, AUTOPHAGY, V5, P537
   Lu Z, 2008, J CLIN INVEST, V118, P3917, DOI 10.1172/JCI35512
   Takahashi Y, 2007, NAT CELL BIOL, V9, P1142, DOI 10.1038/ncb1634
   Degtyarev M, 2008, J CELL BIOL, V183, P101, DOI 10.1083/jcb.200801099
   Kanzawa T, 2004, CELL DEATH DIFFER, V11, P448, DOI 10.1038/sj.cdd.4401359
   Fung C, 2008, MOL BIOL CELL, V19, P797, DOI 10.1091/mbc.E07-10-1092
   Levine B, 2008, CELL, V132, P27, DOI 10.1016/j.cell.2007.12.018
   Kondo Y, 2005, NAT REV CANCER, V5, P726, DOI 10.1038/nrc1692
   Feng ZH, 2007, CANCER RES, V67, P3043, DOI 10.1158/0008-5472.CAN-06-4149
   Turcotte S, 2008, CANCER CELL, V14, P90, DOI 10.1016/j.ccr.2008.06.004
   Kumar SH, 2009, J VIROL, V83, P8565, DOI 10.1128/JVI.00603-09
   Meek DW, 2009, NAT REV CANCER, V9, P714, DOI 10.1038/nrc2716
   Erlich S, 2007, AUTOPHAGY, V3, P561
   Saeki K, 2000, CELL DEATH DIFFER, V7, P1263, DOI 10.1038/sj.cdd.4400759
   Jorgensen HG, 2007, BLOOD, V109, P4016, DOI 10.1182/blood-2006-11-057521
   DeNardo DG, 2008, CANCER METAST REV, V27, P11, DOI 10.1007/s10555-007-9100-0
   Bjorkoy G, 2005, J CELL BIOL, V171, P603, DOI 10.1083/jcb.200507002
   DeNardo DG, 2009, CANCER CELL, V16, P91, DOI 10.1016/j.ccr.2009.06.018
   Copland M, 2006, BLOOD, V107, P4532, DOI 10.1182/blood-2005-07-2947
   He CC, 2009, ANNU REV GENET, V43, P67, DOI 10.1146/annurev-genet-102808-114910
   Akar U, 2008, AUTOPHAGY, V4, P669
   Matsunaga K, 2009, NAT CELL BIOL, V11, P385, DOI 10.1038/ncb1846
   Wei YJ, 2008, MOL CELL, V30, P678, DOI 10.1016/j.molcel.2008.06.001
   Kroemer G, 2008, NAT REV MOL CELL BIO, V9, P1004, DOI 10.1038/nrm2529
   Gwinn DM, 2008, MOL CELL, V30, P214, DOI 10.1016/j.molcel.2008.03.003
   Ito H, 2005, INT J ONCOL, V26, P1401
   Degenhardt K, 2006, CANCER CELL, V10, P51, DOI 10.1016/j.ccr.2006.06.001
   Shackelford DB, 2009, NAT REV CANCER, V9, P563, DOI 10.1038/nrc2676
   Corradetti MN, 2004, GENE DEV, V18, P1533, DOI 10.1101/gad.1199104
   Zalckvar E, 2009, EMBO REP, V10, P285, DOI 10.1038/embor.2008.246
   Iqbal J, 2009, LEUKEMIA, V23, P1139, DOI 10.1038/leu.2009.3
   Wang YJ, 2008, J BIOL CHEM, V283, P4766, DOI 10.1074/jbc.M706666200
   Shanmugam M, 2009, J BIOL CHEM, V284, P26816, DOI 10.1074/jbc.M109.000646
   Bellodi C, 2009, J CLIN INVEST, V119, P1109, DOI 10.1172/JCI35660
   Ionov Y, 2004, ONCOGENE, V23, P639, DOI 10.1038/sj.onc.1207178
   Zhang J, 2009, CELL DEATH DIFFER, V16, P939, DOI 10.1038/cdd.2009.16
   GESER A, 1989, AM J EPIDEMIOL, V129, P740
   Budanov AV, 2008, CELL, V134, P451, DOI 10.1016/j.cell.2008.06.028
   Yee KS, 2009, CELL DEATH DIFFER, V16, P1135, DOI 10.1038/cdd.2009.28
   Simonsen A, 2009, J CELL BIOL, V186, P773, DOI 10.1083/jcb.200907014
   Bingle L, 2002, J PATHOL, V196, P254, DOI 10.1002/path.1027
   Zeng XH, 2006, J CELL SCI, V119, P259, DOI 10.1242/jcs.02735
   Carew JS, 2009, J CELL MOL MED
   Karantza-Wadsworth V, 2007, GENE DEV, V21, P1621, DOI 10.1101/gad.1565707
   Vazquez-Martin A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006251
NR 94
TC 108
Z9 121
U1 2
U2 13
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0014-5793
J9 FEBS LETT
JI FEBS Lett.
PD APR 2
PY 2010
VL 584
IS 7
BP 1427
EP 1435
DI 10.1016/j.febslet.2009.12.034
PG 9
WC Biochemistry & Molecular Biology; Biophysics; Cell Biology
SC Biochemistry & Molecular Biology; Biophysics; Cell Biology
GA 571GD
UT WOS:000275738900022
PM 20035753
ER

EF